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1. General introduction
General introduction
Adolescence is a period of life in which developmental pathways gear up to a sexually 
mature biology, cognition reaches a degree of abstract logical thinking and peer relations, 
and intimate interpersonal relations prime above parent-child bonding as primary source 
of bonding. In adolescence the youngsters focus shifts from the family towards peers. 
Identifi cation with idols and subculture groups offers wonderful developmental chances, 
but is at the same time fraud with pitfalls and risks. It is also a period when certain mental 
health problems fi rst surface. Emotional and behavioral problems increase and prior to 
adolescence, substance use is, even in high risk populations, very rare (Kessler et al., 
2007; Clark et al., 1998). Only a small proportion of youngsters who experiment with 
substance use in adolescence develop serious substance abuse problems, but in many 
who do, these are further complicated by other mental health problems (Armstrong and 
Costello 2002).
Why the use of substances is so strongly associated with the onset and simultaneous 
presence of psychiatric disorders is at yet not fully understood. However, it is very clear 
that adolescents and young adults with co-occurring substance abuse and mental health 
problems face tremendous problems as substance use and psychiatric problems interact 
in a vicious circular manner enhancing severe social and family dysfunction, criminality, 
suicidal behavior, the risk of sexual or physical abuse, and is often seen in combination with 
parental drug use and parental psychopathology (Grella et al., 2001; Kelly et al., 2001; King 
et al., 2000; Rowe et al., 2004; Tims et al., 2002). 
And although adolescents with co-occurring substance abuse and mental health problems 
have more service use, the outcome for these youths in substance abuse treatment is 
often poor (Grella et al., 2001; Tomlinson et al., 2004). As such, this group lays a big social 
and fi nancial burden on society and the public health care system (King et al., 2000). 
Early and adequate detection of youth at high risk for developing co-occurring substance 
abuse and mental health problems could allow for better interventions before either 
substance use, mental health problems or associated problems progress to more severe levels 
and cause lifelong problems. But in practice, just like their adult counterparts, adolescents 
with co-occurring substance abuse and mental health problems are diffi cult to identify as 
they are scattered widely over different health and social service systems: juvenile justice, 
child welfare, education, mental-health and substance abuse clinics (McLellan & Meyers, 
2004). Referral trajectories seem random and services for youngsters are not adequately 
equipped to provide the right care for these adolescents. Clinicians are not suffi ciently 
trained in dealing with co-occurring substance abuse and mental health problems and 
generally have a negative attitude towards engaging in treatment of patients with substance 
use related problems (Renner, Jr., 2004). The substance use related problems are often 
diagnosed too late or mostly not detected at all (Kessler, 2004). 
In this chapter the contextual information relevant to the central theme of this thesis 
is presented: co-occurring substance abuse and psychopathology in adolescence and 
young adulthood, the associated background characteristics, and the identifi cation of such 
problems in treatment settings. 
The ultimate goal of the study is to improve the early identifi cation of co-occurring 
substance abuse and mental health problems among adolescents and young adults and the 
assessment of their psychosocial needs.
Substance use
Adolescence is the time that we normally fi rst start experimenting with substance use. 
The most commonly used substance in adolescence is alcohol, followed by nicotine and 
cannabis. By age 18, more than two thirds of adolescents in the Western world have had 
some experience with drinking alcohol, about half of them with smoking tobacco and up to 
one third with cannabis (Hibell et al., 2004; Johnston et al., 2007). The lifetime prevalence 
of any hard drug use is generally (much) lower than 10% (Hibell et al., 2004; Johnston 
et al., 2007). In the Netherlands, these numbers are very similar. The only exception is 
alcohol. Almost all Dutch adolescents have been in touch with alcohol by the age of 18 
and Dutch youngsters are among the heaviest drinkers in Europe (Monshouwer et al., 
2008). The good news is, however, that alcohol consumption in youth is on it s´ decline and 
especially the very concerning habit of binge drinking among very young adolescents in the 
Netherlands seems to have come to a halt (WHO, 2008).
Epidemiologic studies have consistently shown that, although the majority of young people 
experiment with drugs in a recreational fashion in their mid–late teens, progression 
towards abuse or dependence is far less common (Fergusson & Horwood, 2000; Kandel 
et al., 1992). Nevertheless, for those who do progress to severe levels of substance use, 
adolescence is a critical time for the development of substance use disorders (SUD) (Clark 
et al., 2006). The onset of substance abuse usually shows a sharp increase in this period 
(Kessler et al., 2007). As far as any SUD is concerned, past year prevalence in adolescence 
is estimated to be 5.3 %, although this rate varies by age and setting (Roberts et al., 
2007). 
In the DSM-IV, substance use disorders (SUD) appear as two mutually exclusive disorder 
categories: substance abuse and substance dependence. The abuse symptoms of the DSM-
IV diagnostic system (American Psychiatric Association, 2001) refl ect substance use that 
has a negative impact on general health and has bad social consequences. Examples of the 
indicators that are used are school or work drop-out (e.g. truancy and not showing up at 
work) and substance related social diffi culties (e.g. isolation). If substance use has progressed 
to a more severe level, a substance dependence diagnosis will be considered. Substance 
dependence has both a psychosocial and physiological component. The psychosocial dimension 
is defi ned as a continuous and compulsive preoccupation with the substance involved and 
perpetuating use despite obvious negative consequences. The physiological dimension refers 
to tolerance and withdrawal symptoms. In everyday language, substance abuse also refers to 
excessive use, which in youngsters is translated into substance use inappropriate for age. 
The strict separation between a SUD diagnosis and a pathological syndrome consisting of 
a cluster of symptoms is debatable. Substance abuse can be conceptualized as a continuum 
from symptoms to disorder rather than a dichotomous entity (Helzer et al., 2006). The 
labelling of positive cases is based solely on whether their symptoms collectively rise above 
a defi ned threshold. Whereas on the other hand there is growing evidence that specifi c 
diagnostic criteria, and their degree of seriousness, may moderate the effect of treatments 
(Kraemer, 2008; Kraemer et al., 2002). In addition, the appropriateness of DSM-IV criteria 
for SUD for adolescents, which are based on adults, has been questioned (Winters et al., 
1999). The signifi cance of the same behavior at different developmental stages changes as 
development progresses. For example, regular drinking of alcohol at age 10 is a complete 
different story in comparison with the same behavior at age 18. Thus, the same underlying 
process, for example substance abuse, will manifest in very different behaviors during 
adolescence and for both sexes. This phenomenon is referred to as heterotypic continuity 
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(Costello et al., 2003; Kagan, 1971).
Dimensional measures with low cut-off score can help detect starting substance abuse 
in adolescents that do not yet meet the full criteria for an adult DSM diagnosis. This is 
important since early experimentation and early regular use of alcohol and drugs are 
important predictors for future substance use disorders and other (co-occurring) mental 
health problems and even of higher mortality in young adulthood (Clark et al., 2008; 
Costello et al., 1999; Roberts et al., 2007).
Mental health problems
During adolescence mood swings, impulsivity, and thrill-seeking behavior are common. 
Yet there is no clear cut distinction between normality and pathology in this period of 
development. (Cicchetti & Toth, 2006). Luckily, adolescent turmoil appears in general to be 
a myth as epidemiologic studies show that most adolescents develop well. A comparative 
study in 41 Western European and Northern American countries shows that over 80% of 
all school going youth reports high life satisfaction. Dutch adolescents appear even to be the 
most content of all (WHO, 2008). 
Nevertheless, approximately one in fi ve of Dutch adolescents reports having mental health 
problems to the extend that professional help is needed (ter Bogt et al., 2003). Overall, 
girls report more internalizing mental health problems and boys more externalizing health 
problems. In general, self-harm and suicidal ideation are also much higher among girls 
than boys (7.7% vs. 2.4%) (Tick et al., 2008). Gender differences in externalizing behaviors 
diminished over the past decade (Tick et al., 2008). Furthermore, older adolescents and 
adolescents with a low educational level report more mental health problems (ter Bogt et 
al., 2003). 
Not all of these adolescents with symptoms of mental health problem progress to a clinical 
level in terms of DSM symptoms, but studies, both clinical and epidemiological, show a sharp 
increase of incidence in some disorders during adolescence. Among these are depression, 
conduct disorder and, as mentioned before, substance abuse (Kessler et al., 2007). With 
regard to substance use disorders, these are most strongly associated with conduct disorder. 
Conduct disorder is associated both with an early exposure and start of substance use and 
with a stronger progression towards a broader range of types of substances involved (Rutter 
et al., 2006). In ADHD samples, rates of later substance abuse also appear to be elevated, 
but these effects may be largely mediated via associated conduct problems. The link with 
affective conditions (e.g. depression and anxiety disorders) is also strong, but more complex. 
Substance use among depressed or anxious individuals has been suggested to refl ect an 
attempt to alleviate discomfort through self-medication. Longitudinal studies show that this 
may indeed be the case with anxiety disorders (especially social phobia and panic disorders), 
but for depression the results are more mixed (Falk et al., 2008; Costello et al., 2003). Some 
follow-up studies on individuals with depression do not support the evidence for subsequent 
alcohol or other drug abuse in these individuals (Costello et al., 2003). Reversely there 
is evidence that substance abuse increases the risk for developing depressive conditions 
(Rao et al., 2000). Moreover longitudinal studies on drug abusing adolescents highlight the 
increased risk for physical and psychopathological problems – including both early death 
through somatic diseases or accidents along with completed suicide as a consequence of 
early onset teenage substance abuse (see, e.g., Brook et al., 1998).
On the other hand, why do severe mental health problems in some adolescents seem 
to evaporate? To answer these questions studies in adolescence should take a broader 
developmental perspective on psychopathology beyond the limits of DSM IV disorders. 
From a developmental psychopathology perspective, studying the interface between 
normality and abnormality helps to understand the course of development. And the crucial 
period of adolescence is particularly interesting in this regard (Cicchetti & Toth, 2006). 
Therefore, along with clear cut categorical DSM IV diagnoses, subclinical manifestations in 
otherwise normally functioning individuals should be taken into account. Developmental 
pathways seldomly have clear and unidirectional causal relations. One similar starting point 
may lead to very diverse outcomes in different individuals (multifi nality), while on the other 
hand outcome in terms of psychopathology can stem from very different starting points 
(equifi nality). For example, childhood abuse and neglect are very powerful predictors for 
later substance abuse and malfunction (Langeland & Hartgers, 1998), but by far not all 
maltreated children develop into substance abusers. The principles of multifi nality and 
equifi nality suggest that investigations examining adolescent psychopathology should occur 
within a broad framework of psychosocial correlates. All potential risk and protective 
factors should be taken into account. 
All in all, mental health problems should be perceived within a broad developmental 
perspective. They often interact with psychosocial adversities. And the association between 
concurrent psychopathology and substance abuse is strong. 
Co-occurrence and comorbidity
The term “comorbidity” is controversial. First of all, there are different ways in which 
co-occurrence of substance abuse and other mental health problems are defi ned and 
measured. As mentioned earlier, from a developmental perspective, it is very important 
to use (subclinical) dimensional measures with high sensitivity for substance abuse and 
mental health problems. However, the current clinical approach is to use categorical 
distinctions according to the DSM IV. These categories are the actual basis of clinical 
decision-making and serve as effi cient means of communication in health care. Moreover, 
these standardized defi nitions of a disorder facilitate studies that, for example, measure 
treatment effectiveness. If DSM IV criteria are used to defi ne substance abuse and other 
forms of psychopathology, the more restricted term ‘comorbidity’ can be used. If some 
more dimensional measures are used, the more general term ‘co-occurrence’ is more 
appropriate, since it is not sure whether the individuals who report symptoms, actually 
meet the full DSM IV criteria for a disorder or not. The type of measures that are used, have 
a great impact on the prevalence rates of co-occurring substance abuse and mental health 
problems. Due to the more inclusive, low-threshold dimensional measures for subclinical 
problems, more ‘mild’ cases will be included and a higher prevalence of co-occurrence will 
be observed. With DSM IV measures, only the most severe and disfunctioning cases will 
be included and a lower prevalence of comorbidity will be observed.
Secondly, the time frame that is chosen to measure the substance abuse and mental health 
problems also affects the prevalence rates of their co-occurrence. Comorbidity or 
co-occurrence may refer to conditions which occur at the same time in the same individual 
(concurrent comorbidity). It is also interpreted as conditions which have occurred in the 
same individual in short succession of each other (sequential comorbidity), or even at any 
time in the person’s life and not necessarily sequentially in a short period of time (lifetime 
comorbidity) (Armstrong & Costello, 2002). The time frame that is chosen to evaluate 
comorbidity, has a strong impact on the prevalence of comorbidity. 
Obviously, the highest prevalence rates are reported when using a low threshold 
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dimensional approach in the widest possible time frame, i.e. lifetime. In this thesis we will 
look at “concurrent” substance abuse and mental health problems. But in some different 
ways: in chapters 2, 5 and 6 comorbidity will be approached from a categorical DSM IV 
point of view, whereas in chapters 3 and 4 dimensional measures will be considered. These 
choices related to the goal of each study, as will be described later. 
Yet regardless of the way in which they are measured, the observed prevalence of 
co-occurring substance abuse and other mental health problems exceeds the prevalence 
expected by chance by far, suggesting a causal relation between mental health problems 
and heavy substance use (Armstrong & Costello, 2002). However, the temporal and causal 
pathways of co-occurring substance abuse and mental health problems are still in debate. 
But some consensus is emerging on possible underlying explanations for the observed 
associations. First, individuals with psychiatric disorders may use substances to self-medicate 
their psychiatric symptoms, which could in turn lead to dependence on these substance(s) 
(Khantzian, 1997). Second, substance use may worsen pre-existing psychiatric symptoms 
or precipitate the development of a psychiatric disorder (Weissman et al., 1999). Third, 
general withdrawal syndromes include several symptoms that overlap phenotypically with 
depressive disorders and panic disorder (Zimmermann et al., 2003; Nunes et al., 2006). 
Fourth, the recursive model suggested by Bukstein et al. (1989) suggests that it is possible 
that a psychiatric condition can alter the course of substance use, or vice versa. Fifth, 
psychiatric conditions and problematic substance use may share an underlying genetic or 
environmental vulnerability or predisposition to both conditions (Brady & Sinha, 2005). 
Kaplan et al. (2001) impute the high rates of comorbid developmental disorders in children 
and adolescents to atypical brain development. This developmental approach suggests that 
the term ’comorbidity’, referring to distinct disease categories, may be misleading when 
referring to overlapping symptoms or symptom clusters or syndromes. In that case, 
comorbidity could be perceived as a classifi cation artefact, which does not account for the 
brain-environment interactions that mould development. 
These fi ve potential causes are not mutually exclusive and some may coexist. It is very 
well possible that different types of comorbidity have different causal pathways. For 
example, some studies show that substance abuse can lead to depression, possibly because 
of psychopharmacological effects of substance abuse or interference with psychosocial 
functioning and high levels of stress (Stice et al., 2004; Brook et al., 1998; Rao, 2006). 
On the other hand, social phobias often precede alcohol abuse, possibly in an attempt to 
sedate earlier feelings of distress (Falk et al., 2008). 
Due to the cross-sectional nature of the studies, this thesis will refrain from further 
speculations on these temporal and causal pathways of co-occurring substance abuse and 
mental health problems. Regardless of the aetiology, co-occurring substance abuse among 
adolescents and young adults is a complex reality that clinicians experience on daily basis. 
This thesis will focus on fi nding ways to improve early identifi cation and the assessment 
of the associated psychosocial needs of these youngsters. King et al. (2000) suggest that 
adolescents with comorbid conditions cause an even greater challenge to clinicians, as they 
present with a complex mixture of symptoms which renders it diffi cult to make a clear-cut 
diagnosis. 
Detection of co-occurring substance abuse and pathology and service use
Studies have consistently reported that only a small percentage of adolescents with 
substance abuse and co-occurring mental health problems receive adequate treatment 
(Zwaanswijk et al., 2003b; Wu et al., 2006). One major barrier-to-care is that adolescents 
and young adults do not consider their substance use as problematic. And even if they feel 
a need for help, they are not sure where or to whom to turn to (Johnson et al., 2001). 
This limited knowledge of mental health problems and paucity of available treatments 
may partly refl ect the failure of existing mental health services to reach and engage young 
people (Van Heusden et al., 2008). 
Many studies on access to mental health services for adolescent psychopathology consider 
help-seeking as a one-step process, whereas in practice it is often intricate and constituted 
by different levels of referral. Goldberg and Huxley provide a framework for understanding 
the pathway by which individuals become defi ned as mentally ill and eventually reach mental 
health care services in countries, such as the Netherlands, where direct referral is unusual 
(see picture one).
Picture 1: The pathway to psychiatric care: fi ve levels and four fi lters (Goldberg & Huxley, 1992)
Increasing prevalence of
co-occurring substance 
abuse and psychopathology
Chapter 1
Mental
Health 
Services
(hospitalized)
Mental Health 
Services
(total)
Primary Care
(detected)
Primary Care
(total)
Community
4th fi lter: 
admission
3rd fi lter: 
referral
2nd fi lter: 
ability to 
detect disorder
1st fi lter: 
illness 
behavior
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This model also shows that the prevalence of mental disorders increases at each fi lter 
level. This may especially prove true for the proportion of patients with co-occurring 
substance abuse and mental health problems as it is more likely for patients with two 
or more illnesses to seek treatment than for people with either one of those conditions 
separately (Berkson, 1946). Samples of mental health services may, therefore, show an 
overrepresentation of co-occurring problems.
In line with Goldberg and Huxley, Verhulst & Koot (1992) described a distinct pattern for 
the help-seeking process in children and adolescents. Parental acknowledgment of the 
problematic nature of the child’s behavior is of uttermost importance for the decision to 
consult a general practitioner. The amount of distress or the burden parents experience 
greatly infl uences the help-seeking process, even more than the level of psychopathology 
per se (Angold et al., 1998; Wu et al., 1999). School-related problems were also found to 
play an important role in the help-seeking process, infl uencing both parental help seeking 
and problem recognition in primary care (Zwaanswijk et al., 2003a).
If substance abusing adolescents do seek professional help, very few are admitted in 
specialized substance abuse services and most of these youngsters end up in mental health 
facilities (Kramer et al., 2003). Despite of the high level of co-occurring substance abuse 
and mental health problems, substance use problems are simply not detected or diagnosed 
far too late (King et al., 2000). Only a small (18% among adults) percentage of all substance 
abusing patients in mental health care are likely to receive the necessary substance abuse 
treatment. Moreover, boys are more likely to get the adequate treatment than girls in 
whom substance abuse is even less often acknowledged (Wu et al., 2003).
Thus appropriate substance abuse treatment for adolescents is not provided at all or 
offered much too late. Lack of knowledge and training in how to manage positive screens, 
insuffi cient time for screening, lack of familiarity with treatment programs and options, 
and negative attitudes toward substance abuse (treatment) are other potential barriers in 
detecting and treating adolescents with SUD (van Hook et al., 2007). 
These fi ndings highlight the importance of a more pro-active detection of co-occurring 
substance abuse and mental health problems in adolescents and young adults. But at what 
level of Goldberg and Huxley’s model would it prove appropriate to apply pro-active 
screening? 
Goldberg (2000) points out that categorical classifi cation systems (i.e. DSM disorders) 
are most relevant in determining which individuals are suffi ciently affected in order to 
justify treatment. Thus if one wants to actively screen for subsequent treatment, it would 
be most appropriate and effective to screen for DSM disorders in clinical settings. This is 
why in Chapters 5 and 6 a sample of adolescents in mental health care is chosen to test 
and validate two potential screeners. As described earlier, youngsters with co-occurring 
problems are most likely to end up in general youth mental health care. In the Netherlands 
there were only two units in the whole country specialized in substance abuse treatment 
for adolescents when this study started (seventeen are opening as this thesis is completed). 
In the U.S. this type of specialized substance abuse treatment already exists for some 
time and it would be interesting to see whether adolescents with co-occurring substance 
abuse and mental health problems will fi nd their way to such facilities. Therefore the co-
occurrence study reported in Chapter 2 focuses on this specifi c type of clinical setting.
However it is obvious that these treatment seeking adolescents constitute but a very small 
already ‘fi ltered’ proportion whose daily functioning is impaired by substance use in the total 
population. In Chapter 3 and 4 we chose dimensional instruments with a low threshold and 
thus high sensitivity in a community sample to establish the prevalence and psychosocial 
correlates of co-occurring (subclinical) substance and mental health problems. Such a 
dimensional approach with sensitive cut-offs, appears to be more effi cient for detection of 
(developing) problems in large population samples. The prevalence of categorical disorders 
in the general population is so low that it would be very time-consuming and ineffi cient and 
unethical to let all participants undergo an elaborate psychiatric examination. Furthermore, 
preventive actions should be targeted at this subclinical group of high risk youngsters in 
which co-occurring problems have not yet progressed to more severe clinical levels. From 
previous studies we know that even subclinical mental health symptoms in adolescence 
predict relapse and psychosocial impairments in adulthood (Pine et al., 1998). Application 
of subclinical measures of heavy substance use in this age-group may be relevant as 
early onset of subclinical substance use is a strong predictor of later dependence and 
persistent dysfunction (King & Chassin, 2007; Trim et al., 2007). Unnecessary high costs 
for the community, a lot of personal and social distress can hopefully be avoided by early 
identifi cation and subsequently preventive action. 
Sometimes however, we have chosen to dichotomize the dimensional measures of symptoms 
in our statistical analyses to facilitate a more straightforward way of interpretation of the 
results. 
Aims and outline of the thesis
1) To review the currently available international research on prevalence and characteristics 
of adolescents with co-occurring substance abuse and mental health problems in substance 
abuse treatment settings. We selected all eligible studies that reported on prevalence of 
comorbid SUD and psychopathology in substance abuse settings using categorical DSM 
criteria. We compared these fi ndings with prevalence rates reported in community 
samples and juvenile justice samples. 
2) To explore the prevalence and psychosocial characteristics of co-occurrence of 
substance abuse and mental health problems among adolescents and young adults in 
the Dutch general population. We used dimensional measures with high sensitivity in a 
community sample to establish prevalence and psychosocial correlates of co-occurring 
substance and mental health problems. 
3) To investigate whether specifi c patterns of symptomatology and type of substance use 
exist for both genders and in different age categories. To examine these patterns we used 
dimensional measures with high sensitivity in a community sample. 
4) To test the predictive power of a concise screener for substance misuse. We validated 
the CAGE -adapted to include drugs (CAGE-AID) scale in a clinical mental health care 
setting using categorical DSM IV diagnoses as a gold standard. 
5) To test the predictive power of a concise screener for psychopathology among treatment 
seeking adolescents. We validated the Strengths and Diffi culties Questionnaire (SDQ) in a 
clinical mental health care setting using clinical DSM IV diagnoses as golden standard.
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Introduction
The use of psychoactive substances, such as alcohol and drugs, is associated with the onset 
and simultaneous presence of psychiatric disorders (Ferdinand et al., 2001). Comorbidity 
and dual diagnosis are terms used for conditions in which the criteria for a substance 
use disorder (SUD) and for another psychiatric diagnosis are met in the same individual 
(Rassool, 2002). The temporal and causal pathways of dual diagnosis are still being debated. 
Individuals with psychiatric disorders may use substances to self-medicate their psychiatric 
symptoms (Khantzian, 1997). Substance-use may also worsen preexisting psychiatric symptoms 
or precipitate the development of a psychiatric disorder (Weissman et al., 1999). While 
psychiatric comorbidity among adult substance abusers is well documented (de Graaf R. 
et al., 2004; Kessler, 2004; Kranzler & Tinsley, 2004), it is less well understood among 
adolescents (Hovens et al., 1994). Yet it is a very important issue for national policies on 
drugs and public mental health. Adolescents with dual diagnosis put a tremendous social 
and fi nancial strain on the public health care system as substance use and psychiatric 
problems interact in a circular manner thus exacerbating subsequent problems such as 
family and scholar dysfunction and criminality (King et al., 2000; Renner, Jr., 2004).
The literature on the prevalence of diagnostic comorbidity of SUD and psychopathology 
among adolescents is relatively sparse. In their review on community studies, Armstrong 
& Costello (2002) identifi ed 15 studies, which report on substance abuse and psychiatric 
comorbidity. The prevalence of substance use/abuse/dependence (SU/A/D) in these 
studies varied quite considerably (6-33%) depending on the operationalisation of SU/A/D, 
timeframe that was assessed, and age distribution of the sample. In addition their results 
revealed that 60% of these youths had at least one comorbid psychiatric diagnosis. Conduct 
Disorder (CD) was most commonly associated with SUD, followed by depression. No 
pattern of substance-specifi c comorbidity could be discerned, nor was there much 
evidence for a gradient suggesting greater comorbidity with more severe types of SUD. 
The odds ratios (ORs) for having a comorbid psychiatric disorder were not markedly 
greater for hard drug abuse than they were for nicotine or alcohol abuse. In a large sample 
of youngsters in juvenile detention in the U.S., Abram et al. (2003) found a prevalence of 
SUD of 48%, of which 64% had at least one comorbid disorder. Among Dutch incarcerated 
boys, Vreugdenhil et al. (2003) reported a prevalence rate of SUD of 55%, of which 90% 
had a at least one comorbid disorder.
Given this strong association between substance use disorders, psychopathology and 
delinquent behavior it is important to investigate the prevalence of psychiatric comorbidity 
in adolescents treated for a substance use disorder. However, to date no systematic 
review of available published literature on prevalence rates of psychiatric comorbidity 
in adolescents treated for SUD has been conducted. Analysis of comorbidity patterns 
can prove helpful for etiological and pathogenetic considerations, and help in developing 
preventive actions and effective treatment models (Martino et al., 2000). 
This literature review aims to summarize the comorbidity of SUD and other psychiatric 
disorders in youngsters treated for SUD, and thereby fi lls the gap between what is known 
about youngsters with SUD in the general population and youngsters with SUD in the 
juvenile system. 
Abstract
Objective. In a recent review, the prevalence of comorbid psychiatric disorders in non-
treated adolescents and young adults with substance use disorders in the general population 
was summarized. This review looks into the prevalence of psychiatric comorbidity in 
adolescents and young adults treated for substance use disorders.
Method. A computerized literature search was conducted resulting in ten eligible studies.
Results. The prevalence of comorbid psychiatric disorders varied from 61% to 88%. 
Externalizing disorders, especially Conduct Disorder, were most consistently linked to 
substance use disorders in treatment seeking adolescents. Girls are distinguished by their 
high rate of comorbid internalizing disorders.
Conclusions. Comparison with data from community and juvenile justice studies shows an 
ascending trend of comorbidity rates of externalizing disorders from community to clinical 
and fi nally to juvenile justice samples. It seems that young addicts with comorbid disorders 
are at high risk of ending up in the juvenile justice system. 
KEYWORDS: substance use, psychiatric comorbidity, adolescents 
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Methods
Computer-assisted searches (Medline) were executed (search terms: substance use disorder, 
substance abuse, substance dependence and psychiatric comorbidity) and reference lists were 
scanned, looking for recent (past fi ve years), studies in English on the prevalence of 
comorbidity in substance abusing and dependent, treatment seeking adolescents and young 
adults. Empirical studies that reported on 50 or more adolescents within a fi xed age range 
(12-21 years) in drug treatment were retained and scrutinized for their methodological 
quality. Only studies which reported DSM-III-R or DSM-IV SUD criteria and comorbid 
DSM Axis I diagnoses were included. 
Together, this selection resulted in ten methodologically sound studies. Two studies 
(Fisckenscher & Novins, 2003; Kelly et al., 2004) did not report the prevalence rates 
required, but these could be deducted from the data that were presented. 
In order to facilitate the comparison of prevalence rates of this review and that of  Armstrong 
& Costello (2002), median prevalence rates were calculated for each psychiatric category. 
In contrast to means, medians account for possible skew distribution of variables
Results
Sample and methodological characteristics
Table one shows the sample and methodological characteristics of the included studies. All 
eligible (nine North American and one Icelandic) studies were published between 1998-
2004. The samples vary from N=89 to N=992 with a mean age around 16 years. In eight 
studies Caucasian males are over-represented. Fisckenscher and Novins (2003) report on 
a Native American population, and Robbins et al. (2002) only included African American 
and Hispanic adolescents.
The treatment modes differ considerably in the nature and type of care being provided. 
Studies in which only outpatient care is offered, thereby probably exclude the more severe 
cases of substance use and related problems. Studies with only inpatient units possibly are 
representative for populations with more severe problems. Furthermore, most studies 
include various types of SUD, while others (Molina et al., 2002; Tims et al., 2002) focus on 
one specifi c substance. Since none of the studies include nicotine abuse or dependence, no 
further assertions can be made on this specifi c type of SUD.
Sampling strategies of the selected cross-sectional studies consist of consecutive or 
random sampling. Four studies use (modules of) the fully structured Diagnostic Interview 
Schedule for Children (DISC-2.1 (Shaffer et al., 1993), or DISC-2.3 (Shaffer et al., 1996), 
or DISC-IV (Shaffer et al., 2000)) to assess co-occurring Axis I diagnoses. One study uses 
the more concise Diagnostic Interview for Children Predictive Scale (DISC-PS-4.21 (Lucas 
et al., 2001)). Three studies choose for semi-structured interviews such as the Schedule 
for Affective Disorders and Schizophrenia for School-Age Children (K-SADS (Kaufman et 
al., 1997)) and the Global Appraisal of Individual Needs (GAIN (Dennis et al., 2006)). Two 
studies applied clinical interviews by experienced psychiatrists. 
In six studies, the adolescent subjects are the only informants. The other four studies also 
include information from a parent or guardian. The time frame for the presence of Axis 1 
disorders varies from lifetime to current (past months).
Diagnostic categories that are reported in only one of the studies are not mentioned in 
table one, since these data could not be interpreted because of the lack of comparability.
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Prevalence rates of comorbid psychiatric disorders
Prevalence rates of comorbid psychiatric disorders in youth treated for SUD are given in
table two.
Overall, alcohol and cannabis are the most commonly used substances. The reported 
comorbidity rates are consistently high across all studies. Total psychiatric comorbidity 
varies from 61% to 88%. Prevalence rates of externalizing disorders (ADHD and CD) are 
higher than prevalence rates of internalizing disorders (mood, anxiety disorders), except 
in the Wise et al. (2001) study, which shows a relatively low rate of CD (24%). It should 
be noted here, however, that the two studies that employ unstructured clinical interviews 
by medical specialists, generate considerable lower prevalence rates of comorbid ADHD 
and CD than the studies using (semi-)structured diagnostic interviews. The prevalence of 
mood disorders varies from 3 to 48%; anxiety disorders from 1% to 38%; PTSD from 10% 
to 12%; ADHD from 3% to 38%; CD from 24% to 82%; ADHD-CD from 27% to 30%.
Three studies report prevalence rates for boys and girls separately. These studies show 
higher prevalence rates of internalizing disorders for girls and higher rates of externalizing 
disorders for boys. Grella et al. (2001) report that male subjects in their study are less 
likely to be depressed. Rowe et al. (2004) fi nd that female subjects are over-represented 
in both the internalizing and externalizing comorbid groups. Robbins et al. (2002) compare 
comorbidity rates between Hispanic and African American adolescents. Hispanics more 
often report comorbid psychiatric disorders. On average, longer time frames yield higher 
prevalence rates for psychiatric disorders. 
The question rises how these fi ndings among treated youngsters compare with community 
samples and with those even more in trouble within the penal system.
Psychiatric comorbidity among youngsters with SUD in different settings
In order to facilitate the interpretation of the fi ndings from this review, median prevalence 
rates were calculated for the various disorders and compared to the medians from the 
review on psychiatric comorbidity in youngsters with SUD in the community (Armstrong 
& Costello, 2002) and in samples of incarcerated youngsters with SUD (Abram et al., 2003; 
Vreugdenhil et al., 2003) (table three). In order to generate a more detailed overview, 
results will be discussed according to the type of comorbidity.
Comorbidity with internalizing disorders
Armstrong and Costello (2002) fi nd prevalence rates of concurrent depression in a 
community samples with SUD ranging from 11% to 32% with a median of 19%, whereas 
prevalence of depression among youths without SUD ranges from 5% to 11%. Comorbidity 
with anxiety disorders varies from 7% to 40% with a median of 17%, while prevalence among 
non-abusing youths range from 3% to 16%. Only one study reports on comorbid PTSD and 
fi nds a lifetime prevalence rate of 11% (as opposed to 4% in the non-abusing youths).
Among juveniles in detention, Abram et al. (2003) fi nd a 6 month average prevalence of 
affective and anxiety disorders of 24% (26% for girls and 21% for boys) and 32% (34% for 
girls and 29% for boys) respectively, whereas Vreugdenhil et al. (2003) report a prevalence of 
14% for the combination of mood and anxiety disorders in a population of male substance 
abusing incarcerated youngsters. The weighted mean prevalence of comorbid internalizing 
disorders among incarcerated youngsters is 24%
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study.  All prevalence rates of CD higher than 70% are found in studies that explicitly aim at 
examining the association between CD and SUD. 
Disorder rates may also differ according to different (versions of standardized) psychiatric 
interviews that are used. The highly structured DISC is amenable to epidemiological 
screening by lay interviewers. It covers a wide range of disorders and has a relatively low 
threshold for disorders and, therefore, it tends to over-diagnose. Semi-structured interviews 
(K-SADS), which have to be administered by clinicians, reduce this over-diagnosing tendency 
(Roberts et al., 1989). Open, unstandardized, clinician-based interviews seem to have the 
highest diagnostic threshold. This could explain the relatively low prevalence rates found by 
Hannesdottir et al. (2001) and Wise et al. (2001).
Comparison of studies is further hampered by the different versions of various classifi cations 
systems (DSM-III-R, DSM-IV and ICD-10) used with different criteria. In addition, it has been 
pointed out that the most commonly used classifi cation system for SUD in adults, the DSM-
IV, is not automatically appropriate for adolescents (Harrison et al., 1998). Tims et al. (2002) 
therefore choose to include the 4% of adolescents that were in drug treatment, but did not 
fully satisfy all DSM-IV criteria for SUD.
Patterns of psychiatric comorbidity
The high prevalence of externalizing disorders (table three) is reported most consistently 
across all three settings, especially the association between CD and SUD, is according to general 
expectations (Kessler, 2004). Several studies have found CD to be a powerful predictor of 
substance use and abuse in adolescents (Clark et al., 1999; White et al., 2001). The combination 
of substance abuse and CD in adolescence has been linked to a progression to Antisocial 
Personality Disorder (ASPD) and severe substance use in adulthood (Myers et al., 1998). 
Twin studies show high rates of a genetic vulnerability between certain, not disorder-specifi c 
clusters of externalizing disorders (CD, ASPD) and SUD (Hicks et al., 2004). 
The data on the relationship between ADHD and SUD are less straightforward. Though high 
rates of ADHD are consistently diagnosed in substance using and abusing adolescents, it is 
diffi cult to distinguish its specifi c association with SUD, due to ADHD’s high co-occurrence 
with CD (confounding). It has been suggested that the infl uence of ADHD is completely 
mediated through CD (Biederman et al., 1997), but more recent studies (Biederman et 
al., 1998; White et al., 2001) also show evidence for the existence of an independent link 
between ADHD and SUD. The two studies that report on a combination of comorbid 
ADHD-CD found that a majority (27% out of 30% and 30% out of 38%) of respondents 
with ADHD also had CD (Molina et al., 2002; Tims et al., 2002). In their review, Flory & 
Lynam (2003) suggest that ADHD’s interaction with CD may result in a higher risk for SUD 
than may either disorder alone. In addition, it has been suggested that the ADHD that is 
associated with SUD, is a distinct subtype of ADHD (Banaschewski et al., 2003). Further 
neuropsychological research on prefrontal cortex dysfunction may provide an explanation 
for the independent link between ADHD and SUD, since both SUD (Tarter et al., 2003) and 
ADHD (Slaats-Willemse et al., 2003) have been associated with neurobehavioral impulsivity 
and disinhibition. 
The association of internalizing disorders with SUD is less consistent. Depression and anxiety 
disorders are associated with SUD in most studies (Clark et al., 1999; Weissman et al., 1999), 
but the causal direction of this relation is unclear. It has been suggested that individuals 
with anxiety and affective disorders would be more likely, in line with the self-medication 
hypothesis, to start using substances to reduce negative affects (Pandina et al., 1992). Others 
Comorbidity with externalizing disorders
Armstrong and Costello (2002) fi nd prevalence rates of CD to vary between 44% and 68% 
with a median of 52%. CD in youths without SUD is strikingly less prevalent and varies 
between 0% and 12%. Only one study reports a separate prevalence rate for ADHD (12% 
for youths with SUD and 2% for youths without SUD). 
Among incarcerated youngsters, Abram et al. (2003) report a 6 month prevalence of 64% 
(65% of the girls and 62% of the boys) of comorbid externalizing disorders (CD, ODD, and 
ADHD) and Vreugdenhil et al. (2003) fi nd a year prevalence for these disorders of 90%. The 
weighted mean of comorbid externalizing disorders of these two studies is 74%. 
Table 3: Prevalence of psychiatric comorbidity (median and weighted mean in %) among substance abusing 
adolescents and young adults found in community, clinical and juvenile detention populations
Overall, the results of the community and juvenile justice studies show comorbidity patterns 
very similar to the median prevalence rates reported by treatment seeking youngsters (table 
three), i.e. relatively high rates of externalizing disorders  and lower rates of internalizing 
disorders. Most notable is the change of the prevalence of externalizing disorders over the 
three areas. The prevalence of comorbid externalizing disorders seems to incur from the 
community samples, to the treatment seeking, and is topped by the juvenile justice sample. 
Discussion
The psychiatric comorbidity rates in adolescents with substance use disorders highlight the 
point that these youths are not on the whole, just normal adolescents who happen to be 
experimenting with substances. Consistently reported are relatively high rates of comorbid 
externalizing disorders (ADHD and CD), whereas lower, more variable, rates of internalizing 
disorders (mood and anxiety disorders) are found. In the following section some possible 
interpretations and implications of the variation in prevalence rates are discussed. 
Methodological considerations 
Several reasons can be given for the widely varying prevalence rates of comorbidity in 
the studies reviewed here. Differences in sample characteristics and methodology play an 
undeniable role. The exclusion criteria used in the studies differ considerably. Some studies 
(Robbins et al., 2002; Rowe et al., 2004; Tims et al., 2002) exclude subjects with severe 
mental illness that require inpatient treatment (e.g. active psychotic or suicidal symptoms). 
Robbins et al. (2002) and Tims et al. (2002) also exclude subjects displaying criminal or 
violent behavior, whereas Crowley et al. (1998) explicitly require disruptive behavior as an 
inclusion criterion. This could explain the high prevalence rate for CD (82%) found in this 
Study Mood 
disorder
Anxiety 
disorder
PTSD ADHD CD Any comorbid 
psychiatric 
disorder 
Community studies
Amstrong & Costello 
(2002)
19 17 11 12 52 60
Clinical Studies 26 7 11 22 64 74
Juvenile detention
Vreugdenhil et al. (2003)
Abram et al.(2003)
≥7424 74
Chapter 2 Literature review
Couwenbergh_binnenwerk_1.6.indd   28-29 25-02-2009   19:12:14
30 31
persistent infl uence of some of the key characteristics of these disorders (e.g., sensation 
seeking and behavioral disinhibition). 
Early and adequate detection of youth with SUD and comorbid psychopathology may allow 
for intervention before either substance use, psychiatric problems or associated problems 
progress to more severe levels. But in practice, like their adult counterparts, adolescents 
with SUD and comorbid psychiatric disorders are found widely scattered over different 
health and social service systems: juvenile justice, child welfare, education, mental-health and 
substance abuse clinics (McLellan & Meyers, 2004). Referral trajectories seem random and 
institutions for youngsters are not well equipped to provide adequate care for comorbid 
adolescents. Clinicians are not suffi ciently trained in dealing with dual diagnosis patients and 
generally have a negative attitude towards engaging in treatment of patients with substance 
use related problems (Renner, Jr., 2004). The substance use related problems are often 
diagnosed too late or simply not detected at all (King et al., 2000). 
Consequently appropriate treatment is not provided or rather applied too late. Verhulst 
(2002) attributes this to a lack of coordination between the different departments of youth 
care. The increase of externalizing disorders from the community to treatment samples 
and paramount in incarcerated youth is in support of the hypothesis that due to a failure 
of regular youth care in treating adolescents with SUD and comorbid psychiatric disorders, 
they are more likely to end up in the juvenile justice system.
Since youth drug (ab)use is linked to diverse areas of life and youth culture, effective treatment 
should to be multifaceted. It is emphasized that the facets of treatment must relate directly 
to the adolescent’s life areas that need remediation, and should take into account gender 
and ethnic differences (Rounds-Bryant et al., 1999). However, presently there is too little 
understanding of the particular factors that challenge the treatment of comorbid youth.
In order to elaborate on an explanatory model for dual diagnosis in adolescents, protective 
and risk factors will have to be taken into consideration. Some risk factors may act as 
confounders. Longitudinal research, that will provide information on the complex implications 
of this type of comorbidity, is necessary in order to enable professionals to develop adequate 
prevention, treatment and guidance strategies.
Limitations
An important limitation in the comparison of the different populations (general population, 
treated SUD population, incarcerated population) is the absence of girls in Vreugdenhil’s 
study. Girls are a small minority in the juvenile justice system, but nonetheless an important 
and increasing group, that deserves attention. Finally it should be noted that the studies in 
both Armstrong and Costello’s and this review, as well as the study of Abram et al. (2003) 
and Vreugdenhil et al. (2003), use different timeframes to assess psychiatric comorbidity.
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point at the fact that anxiety levels can be raised by cannabis use (Tims et al., 2002). Moreover, 
because of the high co-occurrence of internalizing and externalizing disorders, especially CD, 
it is diffi cult to determine the independent contribution of specifi c internalizing disorders. 
Costello et al. (2003) fi nd that both anxiety disorders and CD predict the onset of SUD, while 
depression does not.  A possible explanation for the higher prevalence of comorbid anxiety 
in community studies could be that youth with these less conspicuous type of problems are 
less likely to be referred and therefore remain underrepresented in treated samples.
Gender
The literature on the role of gender in dual diagnosis in clinical samples is ambiguous. 
Whereas some studies, beyond the time span of this review, do not report differences in 
comorbid psychiatric disorders between male and female adolescents in substance abuse 
treatment (Clark et al., 1997; Grilo et al., 1996), others fi nd psychiatric comorbidity to be 
more prevalent in substance-abusing girls (Bukstein et al., 1992; Jainchill et al., 1997). 
In line with the fi ndings of this review, research reveals higher prevalence rates for mood 
disorders among girls with SUD (Bukstein et al., 1992; Deykin et al., 1992), while among 
boys behavioral disorders (CD, ADHD, ODD) are more prevalent (Hovens et al., 1994; 
Tarter et al., 1997). But whereas girls keep on reporting more internalizing disorders, the rates 
of externalizing disorders among girls rise to about equal levels as boys from the age of 15 
onwards (Dakof, 2000). This could explain why studies, like Crowley et al. (1998) and Rowe et 
al. (2004), fi nd higher levels of comorbidity in girls. In addition to the equal level of externalizing 
disorders, girls are distinguished by higher rates of comorbid internalizing disorders (Shrier et 
al., 2003).  Epidemiologic studies in adults likewise show higher comorbidity rates in substance-
abusing women (Bucholz, 1999). Moreover, several studies point at a greater level of family 
dysfunction in comorbid girls (Dakof, 2000; Jainchill et al., 1997). It is however diffi cult to draw 
straightforward conclusions from research conducted on gender and dual diagnosis since 
samples often contain only a small percentage of girls or in some no girls at all. Furthermore, 
many studies only test for a limited category of disorders (e.g. only externalizing disorders) 
and thereby give an incomplete or even misleading image of the gender differences. It may 
also be hypothesized that comorbid SUD girls are less often referred to treatment as they 
do not present a burden to society.
More research on differences in comorbidity patterns of male and female substance abusing 
adolescents is needed, since it may have important implications for providing gender-
appropriate services and treatment. 
Clinical implications
Comorbid psychiatric disorders in substance abusing adolescents constitute a big challenge 
for the health care system and society as a whole. Treatment programs have to deal with a 
complex web of interrelated problems: comorbid youth are generally younger and experience 
higher levels of substance use, severe social and family dysfunction, legal problems, suicidal 
behavior, sexual or physical abuse, and parental drug use and psychopathology (Grella et 
al., 2001; Kelly et al., 2004; King et al., 2000; Rowe et al., 2004; Tims et al., 2002). Although 
comorbid adolescents seem to receive more treatment prior to (Grella et al., 2001; Rowe 
et al. 2004) and after (Tomlinson et al. 2004) the index treatment, the outcome for dual 
diagnosed youths in substance abuse treatment is poor (Grella et al., 2001; Rowe et al., 2004; 
Tomlinson et al., 2004). Especially adolescents with externalizing disorders have high relapse 
rates after treatment (Tomlinson et al., 2004; Robbins et al., 2002). This may be due to the 
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Chapter 3 Prevalence and psychosocial correlates
Abstract
Objective: This study aims to establish the prevalence and psychosocial correlates of co-
occurring mental health problems and heavy substance use in adolescents and young adults 
in a community sample in the Netherlands.
Method: A large sample of youngsters (n=4379; 12-23 years) from a semi-rural area fi lled 
out a self-report questionnaire with information on sociodemographic and psychosocial 
characteristics as well as items on mental health problems and substance use. This 
information was used to establish a distinct group of adolescents with co-occurring mental 
health problems and heavy substance use. 
Results: Four groups were distinguished: (1) no-problem group 66.3%; (2) heavy substance 
using group 14.4%; (3) group with mental health problems 15.5%; and (4) group with 
co-occurring heavy substance use and mental health problems 3.8%. Among the most 
discriminating characteristics for the combined problem group were: history of physical 
and sexual abuse, externalizing traits, physical condition, the use of sedatives, and social 
network features. 
Conclusion: The psychosocial circumstances of adolescents and young adults with co-
occurring heavy substance use and mental health problems are a matter of great concern. 
The results highlight the need for preventive actions and multimodal treatment facilities to 
address the extensive problems of these youngsters. 
KEYWORDS: adolescents, co-occurring, substance use, mental health
 
Introduction
Adolescence is a period in which developmental pathways are set in motion and become 
entrenched (Ferdinand & Verhulst, 1995). Major biological and psychological changes, social 
challenges and opportunities occur during adolescence. Prior to adolescence, substance 
use is, even in high risk populations, very rare (Clark et al., 1998). Drug and alcohol use by 
adolescents may represent their coping responses to societal pressure and deprivations, 
attempts to fi nd pleasure, or to fi t into peer groups (Tims et al., 2002). In addition to 
these behavioral changes, hormonal and neural alterations take place during adolescence, 
which may modulate the reinforcing effects of alcohol and other substances and thereby 
potentially making adolescents more susceptible to substance use (Spear, 2000). Only a small 
proportion of the youngsters who experiment with substance use in adolescence develop 
substance abuse, but longitudinal studies show that early onset of substance use is a strong 
predictor of later dependence (Costello et al., 1999) and psychopathology (Roberts et al., 
2007). Psychiatric disorders are found to precede early onset substance use and substance 
abuse (Fergusson et al., 2007; Wittchen et al., 2007; Huizink et al., 2006). Individuals with 
psychiatric disorders may use substances to self-medicate their psychiatric symptoms, 
but substance use may also worsen pre-existing psychiatric symptoms or precipitate the 
development of a psychiatric disorder (Weissman et al., 1999). More recently, a growing 
body of evidence suggests a common neurobiological basis underlying both addiction and 
certain psychiatric disorders (Brady & Sinha, 2005). This may explain why adolescents 
engage in composite problem behaviors (Jessor & Jessor, 1977).
Contemporary models of health promotion and prevention are increasingly based on 
complex risk profi les (Hartrick et al., 1994). Very few studies, however, have tried to 
discern a comprehensive profi le of the group of adolescents with combined substance 
use and mental health pathology. Most studies focus solely on psychiatric comorbidity 
(Roberts et al., 2007), one specifi c substance (Verdurmen et al., 2005), or investigate only 
one type of associated feature, like social relations with parents (Wills et al., 2004), peers 
(Fergusson et al., 2003), or traumatic experiences (Clark et al., 2003). 
Based on self-reported substance use, mental health problems, sociodemographics, and 
psychosocial characteristics of a large sample of adolescents and young adults (n=4.379; 
age 12-23) this study tries to: 1) assess the prevalence of problem groups based on heavy 
substance use and mental health problems among adolescents and young adults (1a)  and 
its relation to gender and age (1b), and 2) to assess the associated features of the combined 
problem group compared to those in the other groups with special attention to potential 
gender differences. 
Method
Sample 
The sample was drawn from the Health Monitor Survey 2003, a cross-sectional survey 
to monitor the general physical and mental wellbeing of the youth in the North Eastern 
province of Overijssel, The Netherlands. By means of a random sample from the register 
of the general population aged 12-23, a representative group of adolescents and young 
adults was asked to participate in this survey. The response rate was 58%. In order to 
compensate for the differences in response rate and to optimize respresentativiness, 
weights based on census data (CBS, 2003) were used to adjust the estimates for biases in 
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Statistical analyses 
All analyses were conducted with SPSS 14.0 using weighted data  to adjust for potential 
biases caused by unbalanced age and gender distributions due to selective non-response.
Based on the occurrence of mental health problems and heavy substance use, four problem 
groups were defi ned:  (1) no problem group (S-M-): neither fulfi lling the criteria for  heavy 
substance  nor for mental health problems; (2) heavy substance use group (S+M-): fulfi lling 
the criteria for heavy substance use but not for mental health problems; (3) mental health 
problems group (S-M+): not fulfi lling the criteria for heavy substance use but fulfi lling the 
criteria for mental health problems and (4) the  combined problem group (S+M+) fulfi lling 
criteria for both heavy substance use and mental health problems.
A number of separate multinominal logistic regression analyses was used to compare 
sociodemographic and psychosocial characteristics of the combined problem group to 
the other three groups In each analysis ‘group’ was used as the dependent variable (with 
the combined problem group as reference category) and one specifi c characteristic as the 
independent variable. The advantage of choosing the combined problem group as reference 
category is that all other groups are compared to the combined problem group with respect 
to the independent variable. The drawback of this approach is that characteristics more 
prevalent in the combined problem group will have odds ratios less than unity (‘1’). Using 
the symmetry property of the odds ratio, we present in the tables the inverse of the odds 
ratio’s of the multinominal logistic regression analyses. In this way characteristics with odds 
ratio’s greater than 1 are more prevalent in the combined problem group compared to the 
comparison group and those with an odds ratio less than 1 are less prevalent in the combined 
problem group than in the other group(s).
 
Results
Prevalence and description of the problem groups
Two-thirds (66.3%) of the sample belonged to the no-problem group (table one). Prevalence 
of heavy substance use with no co-occurring mental health problems (S+M-), mental health 
problems with no co-occurring heavy substance use (M+S-), and combined mental health 
problems and heavy substance use (M+S+) was 14.4%, 15.5% and 3.8%  respectively. The 
observed prevalence of combined problems (3.8%) was almost two times the prevalence 
expected by chance suggesting a causal relation between mental health problems and heavy 
substance use. 
The distribution of both measures of mental health problems is quite similar for the mental 
health problem group and the combined problem group. The use of substances in the 
combined group, however, differs considerably from the heavy substance use in the heavy 
substance use group, with more heavy use of semi-legal and illegal drugs in the combined 
problem group.
Prevalence stratifi ed by age and gender
Figure one shows that the prevalence of heavy substance use with no co-occurring mental 
health problems (S+M-) is quite different for boys and girls. Starting at the about the same 
point in the age category 14-15 (3-5%), heavy substance use without co-occurring mental 
health problems in boys increases much faster than in girls (42% versus 11% at age 20-23).
age and gender distribution caused by differential non response. 
The unweighted sample (n=4379) of adolescents and young adults consists of 45.8% boys 
and 52.2% girls with a mean age of 16.9 years (SD: 3.3). The weighted sample consists of 
51.7% boys and 48.3% girls. 
Assessments
Our interest in the co-occurrence of mental health problems and heavy substance use 
precluded the use of continuous symptom-level measures of each of the outcomes in our 
analysis. Instead, a series of categorical variables refl ecting presence or absence of problems 
was created by combining the different measures of mental health and substance use. Of 
course, the absence of diagnostic measures prohibits a discussion of clinical diagnoses, and 
accordingly throughout this article these measures will be referred to as combined or co-
occurring “mental health problems and heavy substance use” rather than “mental disorders 
and substance use disorders.”
Mental health problems and heavy substance use
Mental health was assessed by the Mental Health Inventory-5 (MHI-5), which is derived from 
the 38-item Mental Health Inventory (Veit & Ware, Jr., 1983). The MHI-5 comprises fi ve 
central items on mental well-being and is especially useful to screen for mood disorders in 
community samples (Rumpf et al., 2001). In accordance with other studies, the cut-off score 
was set at ≤ 72 (Hoeymans et al., 2004). Internal consistency of the scale in the current study 
was high (Cronbach’s alpha=0.81). In addition, an item on suicidal ideation in the preceding 
month, was included. Presence of mental health problems was defi ned as a MHI-5 score 
below cut-off and/or suicidal ideation in the preceding month. 
Substance use was assessed with questions about lifetime and current use of tobacco, alcohol, 
cannabis, and hard drugs. Heavy tobacco use was defi ned as more than 10 cigarettes per day, 
heavy alcohol use as drinking alcohol on at least seven or eight occasions during the preceding 
month and at least three to four occasions of binge drinking (more than fi ve glasses of alcohol 
at one occasion) in the last two weeks, heavy cannabis use as smoking pot on at least fi ve or 
six occasions during the preceding month, and heavy hard drug use (XTC, speed/pep, cocaine, 
heroine, LSD) was defi ned as any use during the preceding month. These defi nitions of heavy 
substance use closely resemble the defi nitions applied in large North American (Johnston et 
al., 2007) and European (Hibell et al., 2004) epidemiological studies. 
To explore the sociodemographic and psychosocial correlates of sub-group membership, a 
distinction was made between (1) demographics: age and family structure (2) past experiences: 
physical and/or mental abuse by parent(s), unwanted sexual experiences; (3) current situation: 
educational level, truancy past month, externalizing traits, like hot-temperedness, defi ant 
behavior, and bullying, and social network characteristics; and (4) potential consequences of 
existing problems: use of sedatives, view on the future, and perceived physical condition. 
Most of these characteristics were assessed by single item questions (e.g. “How often did 
you skip school last month?”) that are part of a questionnaire developed to screen for 
psychosocial well-being of adolescents in prevention programs in The Netherlands (Bos et 
al., 1998).  Assessment of substance use by friends consisted of a fi ve item scale on smoking, 
drinking, cannabis and hard drug use by friends. This scale ranged from none (score:0) to all of 
these by most friends in the peer group (score:10).
Prevalence and psychosocial correlates
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Figure 1: Prevalence stratifi ed by age and gender
In males, 7% of the adolescents and young adult males with combined problems lives in a 
single parent household, 18% were victim of unwanted sexual behavior, and 9% experienced 
mental or physical abuse by parent. Almost two thirds reports experiencing problems at 
home. Twenty two percent is truant in the last month. Prevalence of externalizing traits is 
about 45% and 18% reports to have bullied frequently last year. About one in fi ve recently 
used sedatives, one in four is pessimistic about the future and 54% is not in a good general 
health condition. 
Substantial differences (OR > 2) with the heavy substance use group were found for mental 
and physical abuse by parent, unwanted sexual experiences, hot temperedness, bullying, 
problems at home, recent use of sedatives, pessimistic about the future and a bad general 
health condition. Substantial differences with the mental health problem group were found 
for bullying, substance use by friends, and recent use of sedatives. 
In females, about one in fi ve adolescents and young adult females with combined problems 
live in a single parent household, 44% was a victim of unwanted sexual behavior, and 16% 
experienced mental or physical abuse by parent. Sixty three percent is of the lowest 
educational level and 21% is truant in the last month. Prevalence of externalizing traits is 
high: about 50% is hot-tempered, 57% acts oppositional/defi ant, and 12% bullied frequently 
during the last year. Forty percent reports having problems at home. About 28% recently 
used sedatives, 28% is pessimistic about the future, and 66% is not in a good general health 
condition. 
Substantial differences (OR > 2)  with the heavy substance using group were found for 
mental or physical abuse by parent, unwanted sexual experience, low educational level, hot 
temperedness, oppositional/defi ant behavior, frequent bullying in the past year, problems at 
home, recent use of sedatives, pessimistic about the future and bad general health condition. 
Substantial differences with the mental health problem group were found for single parent 
household, mental or physical abuse by parent, unwanted sexual experience, low educational 
level, hot temperedness, oppositional/defi ant behavior, frequent bullying in the past year, 
substance use by friends, recent use of sedatives and bad general health condition.
The characteristics used in the separate regression analyses explained a substantial amount 
the differences between the four groups: Nagelkerke’s R for the multivariate multinominal 
logistic regression analysis with all characteristics entered simultaneously was 0.51.
Table 1: Drug use and mental health characteristics of the problem groups
1) S-M-= No heavy substance use nor mental health problems; S+M- = Heavy substance use; S-M+= Mental 
health problems; S+M+= Combined heavy substance use and mental health problems 
Conversely, the prevalence of mental health problems without co-occurring heavy substance use 
is two times higher in girls than in boys (overall prevalence of 20% vs. 10%), but is quite stable over 
time both in boys and girls. From age 18-19 onwards prevalence of combined problems is higher for 
boys as for girls and is almost twice as high by age 22-23. In early adolescence (age 14 to 17 years) 
a reverse pattern exists: combined problems in girls are more prevalent than in boys.  Because of 
these gender differences, the remaining results will stratifi ed by gender.
Associated features of the combined group compared to the other groups
Multinominal logistic regression analyses were used to assess whether the combined problems 
group differs from the unique problems groups with respect to a broad selection of associated 
features. Table two shows the results of the separate multinominal logistic regression analyses. We 
will mainly focus on the odds ratios in columns 8 and 9, which compare the odds of the combined 
problem groups with the odds of the heavy substance use/no mental health problem group (column 
8) and with the odds of the metal health problems/no heavy substance use group (column 9).
In general the combined problem group differs from the single problems groups. The distinction 
is generally more pronounced with the heavy substance use group than with the mental health 
problem group. All differences imply a more problematic history, a more problematic current 
situation (including more externalizing traits) and more consequences (like recent use of sedatives 
and bad general health condition) in the combined problem group compared to the single problem 
groups.  In general, this applies both to genders, but there are some differences that are useful to 
describe the fi ndings for males and females separately. 
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Total 
(4379)
S-M-
(2946)
S+M-
(586)
S-M+
(678)
S+M+
(169)
χ2 /F P
Prevalence (%) 66.3 14.4 15.5 3.8
Male (%) 51.7 50.1 77.7  33.4 56.6 χ2(3)=2994 <0.001
Age (mean) 16.9 16.4 19.2 17.0 18.8 F(3)=264 <0.001
Heavy Substance 
Use:%
Nicotine 8.9 0 45.5 0 60.8 χ2(1)=13 <0.001
Alcohol 11.7 0 68.5 0 47.6 χ2(1)=31 <0.001
Cannabis 1.7 0 6.8 0 18.0 χ2(1)=39 <0.001
Hard Drugs 0.6 0 2.3 0 8.5 χ2(1)=30 <0.001
At least one 
substance
18.2 0 100.0 0 100.0 χ2(3)=26 <0.001
Mental Health 
Problems (%)
MHI-5 ≤ 72 12.6 0 0 63.7 72.5 χ2(1)=4 n.s.
Suicidal Ideation 13.4 0 0 63.1 63.0 χ2(1)=1 n.s.
At least one 
indicator
19.3 0 0 100.0 100.0 χ2(1)=1 <0.05
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Discussion
The fi rst step in current study was to estimate the prevalence of youngsters with combined 
problems compared to adolescents with solely high substance, mental health problems, and no 
problems in a general population sample (research question 1a).  The results point at a substantial 
group of adolescents and young adults that struggle with both mental health problems and 
heavy substance use. The prevalence of these combined problems in the current community 
sample was 3.8%. Of all subjects classifi ed with mental health problems (678+169=847) in the 
current study, 20.0 % (n=169) also met criteria for heavy substance use. Large epidemiological 
studies have robustly confi rmed such a high co-occurrence of substance use disorders and 
mood disorder in adolescents; across studies that estimated concurrent comorbidity between 
substance use disorders and mood disorder, ranges from 11.1% to 32.0%, with a median of 
18.8% (Armstrong & Costello, 2002). With a 20.0% of the participants with mental health 
problems also reporting heavy substance use, the fi ndings of the current study are in line with 
these earlier results. Compared to the heavy substance use only group, participants in the 
combined problem group relatively often use ‘harder’ substances, i.e. cannabis and hard drugs. 
To study the effect of age and gender (research question 1b) on the prevalence of the different 
sub-groups, prevalence rates were presented stratifi ed for both factors. Very different patterns 
are found for heavy substance use; after starting equally low, it increases much more strongly 
over the age categories of boys than that of girls. Conversely, mental health problems are much 
more common in girls than in boys. Cross-sectional and longitudinal studies have confi rmed 
these gender differences in substance use and mental health problems (Roberts et al., 2007). 
In contrast to substance use, the prevalence of mental health problems is rather stable over 
time in both boys and girls. This stable presence of mental health problems is not in line with 
epidemiologic studies that consistently report a sharp increase in both substance misuse and 
mood disorders during adolescence (Ferdinand & Verhulst, 1995; Armstrong & Costello, 2002) 
and cannot be explained. In early adolescence prevalence of combined problems was higher 
for girls, whereas from age 18-19 onwards prevalence of combined problems is higher for boys. 
Gender differences by age have not been extensively investigated.  Although some studies have 
found gender differences (Dakof, 2000), other recent studies imply the similarities between 
boys and girls are greater than the differences (Costello et al., 1999; Roberts et al., 2007). 
Having established the prevalence of the different groups, the associations with a number of 
relevant sociodemographic and psychosocial background characteristics and the effect of gender 
on these relations were explored (research question 2). In general, youths in the combined 
pathology group were in a very unfavorable position compared to all other groups. They seem 
to combine the worst of both the adverse features of the heavy substance users as well as 
those of the mental health problem group.  Among the most discriminating characteristics 
for the combined problem group are: history of physical and sexual abuse, externalizing traits, 
perceived physical condition, the use of sedatives, and social network features. All features 
together explained more than 50% of the variance of the presence of combined pathology in 
this population. Findings regarding the separate associated features will be discussed separately 
below.
History of abuse
As the nature of the relationship between substance abuse and mood disorders has 
proven to be diffi cult to disentangle, as substance misuse may induce as well as exacerbate 
depressive feelings (Schuckit, 2006; Mueser et al., 1998), several potential mediating factors 
have been suggested. One potential mediating factor is a history of sexual or physical abuse. 
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Longitudinal studies among sexually and/or physically abused adolescents show that these 
youngsters are at high risk for developing substance abuse (Kilpatrick et al., 2000). This 
relationship persists even after controlling for sociodemographic, familial risk factors, and 
psychopathology (Kilpatrick et al., 2000; Spak et al., 1998; Bailey & McCloskey, 2005). As such, 
physical and/or sexual abuse may have a common infl uence on the development of mental 
health problems as well as substance misuse (Clark, 1998). Indeed, both mood disorder, 
substance misuse and the combination of both share many well-identifi ed psychosocial and 
health risk factors, such as low academic achievement, family dysfunction, and poor health 
status (Lewinsohn et al., 1994; Diaz et al., 2002) that are also found in the current study. 
Externalizing traits
The youngsters in the combined problem group display a great deal of externalizing behavior. 
Indeed earlier research has consistently found externalizing disorders (especially conduct 
disorder) to be the most important predictor for developing substance use disorders (Roberts 
et al., 2007; Pardini et al., 2007). Moreover, longitudinal studies have found that particularly the 
interaction between mood disorder and symptoms of conduct disorder places adolescents at 
an increased risk for substance abuse (Pardini et al., 2007; Miller-Johnson et al., 1998). It has 
been suggested that adolescents with conduct disorder and depressive symptoms may be more 
inclined to use substances to relieve their negative affects, because they are relatively unconcerned 
about violating social norms (Marmorstein & Iacono, 2003). These fi ndings also indicate that the 
lack of externalizing symptoms in the defi nition of a mental health problem in current study may 
have little effect of on the prevalence and the nature and magnitude of the relationship of the 
associated features with the various problem groups.
Physical condition and use of sedatives
The youngsters in the combined problem group perceive their physical condition relatively 
often as bad, which is consistent with fi ndings of earlier studies (Tims et al., 2002). Traumatic 
experiences have also been shown to infl uence the association between mental health problems, 
substance use and bad physical health (Stevens et al., 2003). 
Use of sedatives is another distinct feature of the combined group.  Although it is unclear how 
the youngster obtain these prescription drugs, earlier studies provide evidence that non-medical 
use of prescription drugs is indeed associated with substance use in general (McCabe et al., 2007). 
Moreover, current fi ndings indicate that especially the substance users with co-occurring mental 
health problems, not evaluated in earlier studies, are particularly at risk.
Social network: peers and family
Substance use in the peer group of the youngsters in the combined problem group is a 
discriminating factor. This is according to our expectations, because many studies report that 
adolescents in a substance-using peer context are far more likely to use substances (Bauman & 
Ennett, 1994).  All in all, the social network of the adolescents with combined problems in this 
study seems to consist of friends with whom they share the use of substances and sedatives. Two 
processes have been suggested to contribute to this similarity: socialization, wherein the peer 
group infl uences the substance use behavior of the individual; and selection, wherein individuals 
associate with peers that are similar to them in their substance use behavior. Longitudinal studies, 
in which peer substance use is prospectively linked to change in the substance use of the target 
adolescent and vice versa, have shown both effects (Bauman & Ennett, 1994; Urberg et al., 1997). 
Moreover, some results suggest a causal pathway in which deviant peer associations, among 
which substance use, lead  to increased externalizing behaviors and negative consequences, which 
fi nally cause depression (Fergusson et al., 2003).  
With respect to the family environment, youngsters in the combined problem group often live in 
single parent households and report substantial problems at home. Both have been shown to be 
predictive of substance use and mental health problems (Gau et al., 2007).  A longitudinal study 
about the role of social relations on the co-occurrence of substance abuse and depression, found 
that specifi cally the combination of problems in both friendship and family domain, was predictive 
for this condition (Aseltine, Jr. et al., 1998). Similar results are obtained in current study.
 
Strengths and limitations
The most important strength of the current study is the large sample size, the use of validated 
questionnaires and the broad spectrum of background variables that were available. 
On the other hand, the current study also has some important limitations. First of all, no diagnostic 
instruments were used and generalizations of the prevalence rates to clinical diagnoses should 
therefore be considered cautiously. Furthermore, the data rely on self-report and although 
adolescents are in general very capable of reporting their internalizing mental health problems, 
they might underreport their externalizing behavior (Jensen et al., 1999). Moreover, the defi nition 
of mental health problems in current study was based exclusively on internalizing, depressive 
symptoms, because externalizing psychopathology was not systematically assessed. Co-
occurring externalizing psychopathology, which is generally more common among adolescent 
boys (Armstrong & Costello, 2002), has been overlooked in this design. These boys are in this 
epidemiological sample likely to have ended up in the heavy substance use group, as they were 
not systematically questioned about externalizing behaviors. Therefore, the combined problem 
group is presumably even larger than reported. Nevertheless the substantial proportion of girls 
with combined problems is remarkable, as girls in clinical samples are often underrepresented. 
Lastly, although the overall response was satisfactorily, the non-response may infl uence prevalence 
rates, although this was minimized by post-stratifi cation to refl ect age and gender. Moreover, this 
limitation is less likely to infl uence the direction and size of the associations reported in current 
study.
Clinical implications
Adolescents with comorbid substance abuse and mental health problems put a tremendous 
social and fi nancial strain on the public health care system as substance use and psychiatric 
problems interact in a circular manner, thus exacerbating subsequent problems such as family 
and school dysfunction and criminality (Renner, Jr. et al., 2005). Improvement of knowledge and 
diagnostic skills of professionals working in youth welfare and general health services are needed 
in order to allow for intervention before problems progress to more severe levels, and cause 
lifelong problems. Since youth drug (ab)use is linked to diverse areas of life and youth culture, 
effective treatment should to be multifaceted. Family based treatment models, in which mental 
health problems and substance abuse are treated simultaneously, and the many problems in the 
other areas of life of these youngsters also receive attention, have obtained promising results and 
there is a great need for them in the future (Liddle, 2004).
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Introduction
Substance use disorders (SUD) and major depressive disorder (MDD) are among the most 
common psychiatric problems in adolescence (Lewinsohn et al., 1993). First onset of both 
disorders usually shows a sharp increase in this period (Kessler et al., 2001; Angold et al., 1998; 
Kessler et al., 2007). Substance use disorders and mood disorders also frequently co-occur in 
adolescence, presenting a signifi cant clinical problem (Nunes et al., 2006b). Estimated comorbidity 
rates in community samples range from 11.1% to 32.0%, with a median of 18.8% (Armstrong & 
Costello, 2002). Co-occurring SUD and depression are both independent and interactive risk 
factors for suicide (Brent, 1995) and higher rates of borderline personality disorder (Grilo et al., 
1997). Moreover, comorbid conditions are associated with earlier relapse after substance abuse 
treatment in adolescents (Cornelius et al., 2004). 
To date, little is known about the epidemiological association between the use of specifi c 
substances and depression in adolescence. More insight may be useful in further developing 
our understanding of both substance and mood disorders, and their frequent co-occurrence. 
Studies that examined SUDs and different comorbid psychiatric disorders in adolescents found 
stronger associations with disruptive disorders than with mood disorders (Angold et al., 1999). 
Only Roberts et al. (2007) investigated substance-specifi c associations and found positive 
univariate associations between alcohol, marijuana and other substance abuse/dependence and 
depressive disorders. 
Due to substance-specifi c psychotropic effects, specifi c substances may also entail greater odds 
than others for distinct depressive symptoms. Nicotine, opiates, and cannabis act through systems 
that impinge and modulate the physiology of the dopamine release and create euphoriant 
effects (Nunes et al., 2006a). Alcohol, on the other hand, has a anxiolytic and sedative effect 
(Ragan, 2006). Moreover, general withdrawal syndromes include several symptoms that overlap 
phenotypically with depressive disorders (Nunes et al., 2006a). 
Knowledge about the potential covariates gender and age within this context is sparse.  Whereas 
it is well established that that depression is more prevalent among adolescent girls (Angold & 
Rutter, 1992; Forbes et al., 2004; Lewinsohn et al., 1998) and SUD is more prevalent among boys 
(Kessler et al., 1997), little is known about gender effects for comorbid SUDs and psychiatric 
disorders. Some studies suggested that females are more likely than males to experience co-
occurring SUD and depression (Kessler et al., 1997;  Acierno et al., 2000; Sung et al., 2004), but 
other studies failed to fi nd gender differences (Brook et al., 1998). To date, only one community 
study evaluated gender differences stratifi ed by substance type and reported a much larger 
proportion of mood disorders among adolescent females with alcohol dependence than for 
adolescent males with alcohol dependence (80% and 4% respectively) (Roberts et al., 2007). 
Despite the clear age effect for separate depression and SUD with sharply increasing prevalence 
rates during adolescence, few studies assessed these age effects for co-occurring SUD and 
psychiatric disorders in adolescents. Depression is associated with an early onset of substance 
use and abuse (Costello et al., 1999; Rohde et al., 1996) and age may interact with gender to 
further complicate the association between substance use and depression (Poulin et al., 2005). 
Roberts et al. (2007) reported a clear age pattern; females with SUDs tended to have higher 
rates of comorbid disorders, as did older youths.
The aim of the present study was to assess whether heavy use of specifi c substances (tobacco, 
alcohol, cannabis, and hard drugs) is related to distinct depressive symptoms, taking age and 
gender differences into account. Supplemental to Roberts et al. (2007), who evaluated the 
Abstract
Objective: Substance use disorders and mood disorders frequently co-occur in adolescence. 
The present study evaluates whether heavy use of specifi c psychotropic substances (alcohol, 
tobacco, cannabis, hard drugs) is related to distinct depressive symptoms in adolescence, 
taking age and gender into account. 
Method: A total of 6695 adolescents from the general population participating in the 
Health Monitor Survey fi lled out the Mental Health Inventory-5 (MHI-5), answered questions 
about suicidal thoughts, and reported on their (heavy) substance use. Adjusted odds ratios 
of specifi c depressive symptoms were calculated for heavy substance users compared to 
non/low-substance users, stratifi ed for type of substance and, in case of interaction effects, 
additionally for separate gender and age categories. 
Results: Positive associations with depressive symptoms were found for tobacco, cannabis 
and hard drugs users, but not for heavy alcohol users. In general, strongest associations 
between depressive symptoms and heavy substance use are found in the youngest age 
category (12-15 yrs), for both boys and girls. Relatively few gender effects were found, but if 
present these effects pointed at stronger associations for girls.
Conclusion: The association between depressive symptoms and heavy substance use differs 
for specifi c depressive symptoms and for different types of substances, age and gender. These 
fi ndings might have implications for research methods of phenomenological studies that 
assess comorbidity of depression and substance abuse. Additionally, these fi ndings underline 
the importance of screening for co-occuring problems in adolescents who in the fi rst place 
seem to present either only heavy substance use or depressive symptoms. 
KEYWORDS: substance use, depressive symptomatology, adolescents
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alcohol, cannabis, and hard drugs. Heavy tobacco use was defi ned as more than 10 cigarettes 
per day, heavy alcohol use as drinking alcohol on at least seven or eight occasions during 
the preceding month and at least three to four occasions of binge drinking (more than fi ve 
glasses of alcohol at one occasion) in the last two weeks, heavy cannabis use as smoking pot 
on at least fi ve or six occasions during the preceding month, and heavy hard drug use (XTC, 
speed/pep, cocaine, heroine, LSD) was defi ned as any use during the preceding month. These 
defi nitions of heavy substance use closely resemble the defi nitions applied in large North 
American (Johnston et al., 2007) and European (Hibell et al., 2004) epidemiological studies. 
The above-mentioned measures are symptom scales, not diagnostic measures. Accordingly, 
throughout this article these measures will be referred to as “depressive symptoms” and 
“heavy substance use” rather than “depressive disorder” or “depression”, and “substance 
use disorders.”
Data-analysis
All analyses were conducted with SPSS 14.0 using weighted data to adjust for potential 
biases in age and gender distributions due to selective non-response.
Prior to analysis, MHI-5 total score and item scores were examined for missing values 
and fi t between their distributions and the assumptions of multivariate analysis. The total 
sample included 6695 participants. The missing values (never more than 2% per item) on the 
separate items of the MHI-5 were replaced by the sample mean score for each item. With 
regard to the additional item on suicidal thoughts, all 81 missing values (1.2%) were set at 
zero, i.e. no suicidal thoughts.
The presence of heavy substance use was compared with the presence of depressive 
symptoms by chi-square tests and signifi cance levels were adjusted for multiple testing using 
Bonferroni correction (0.05/35=0.0014).
A series of separate logistic regression analyses were performed to examine the association 
between depressive symptoms (MHI-5 items and suicidal thoughts) and each type of substance 
use. In each analysis ‘heavy use’ was used as the dichotomous dependent variable and single 
depression symptoms were used as dichotomous independent variables, controlling for age 
(category) and gender effects. 
Subsequently, the odds ratios that describe the association between specifi c substance use 
and distinct depressive symptoms were calculated. In case of signifi cant interaction effects of 
age category and/or gender, odds ratios were calculated per separate stratum. In case of no 
signifi cant interaction effects, pooled odds ratios are presented. 
Results
The sample mean of the total MHI-5 is 76.9 (95% CI 76.5-77.2). Boys report signifi cantly less 
depressive symptoms on the MHI-5 than girls, with mean scores of 79.6 (95% CI 79.1-80.1) 
and 74.1 (95% CI 73.6-74.5) respectively. Girls also report signifi cantly higher levels of our 
second indicator of depression; suicidal thoughts. Of the girls, 16.8% report having thoughts 
about ending ones life, whereas signifi cantly less of boys do so (10.3%). With respect to age, 
the MHI-5 score is signifi cantly higher (indicating less or less severe depressive symptoms) 
for the youngest age category (12-15 years old) than for the two older age groups (16-19 
and 20-23 years old), with mean scores of 78.5 (95% CI 78.0-79.0), 75.9 (95% CI 75.4-76.5) 
and 75.0 (95% CI 74.4-75.7) respectively. Again, this effect is also apparent in the presence 
of suicidal thoughts, which prevalence is signifi cantly higher in the older age categories (both 
14.5%) than in the youngest (11.8%). 
comorbidity of disorders, the present study assessed this relation on a symptom level. Previous 
studies applied a cut-off point based on the DSM-IV criteria for the specifi c disorder. The present 
analyses include ‘cases’ that report symptoms of clinical relevance.  An advantage of the present 
assessment of the association between substance use and depression is that a larger number 
of clinically relevant cases are included. From previous studies we know that even subclinical 
depressive symptoms in adolescence predict relapse and psychosocial impairments in adulthood 
(Pine et al., 1998; alto-Setala et al., 2002).  Application of subclinical measures of heavy substance 
use in this age-group may be equally relevant because early onset of subclinical substance use is 
a strong predictor of later dependence and persistent dysfunction (King & Chassin, 2007; Trim 
et al., 2007).
Methods
Sample 
The sample was drawn from the Health Monitor Survey 2003, a cross-sectional survey to 
monitor the physical and mental well-being of the youth in the North Eastern province 
of Overijssel, The Netherlands (regional capital: Zwolle). Using a random sample from the 
register of the general population aged 12-23, a representative group of adolescents and 
young adults was asked to participate in this survey. 
In order to compensate for the differences in response rate (semi-rural compared to urban 
areas) and to optimize respresentativiness, weights based on census data (CBS, 2003) were 
used to adjust the estimates for biases in age and gender distribution caused by differential 
non-response.
The unweighted sample (n=6695) of adolescents and young adults consists of 43.6% boys 
and 56.4% girls, with a mean age of 16.9 years (SD: 3.3). The weighted sample consists of 
50.7% boys and 49.3% girls, who are equally divided over the three age categories (12-15 
years, 16-19 years, 20-23 years).
Assessments of mental health problems and heavy substance use
Depressive symptoms were assessed using the Mental Health Inventory-5 (MHI-5), which 
is derived from the 38-item Mental Health Inventory (Veit & Ware, Jr., 1983). Its fi ve items 
correspond to the general construct of the depressive syndrome and the area under the 
curve for detecting DSM IV mood disorders (American Psychiatric Association, 2001) 
proved to be high (0.88) in community samples (Rumpf et al., 2001).  The MHI-5 contains 
the following items: How much of the time during the last month have you: 1) “been a very 
nervous person?”, 2). “felt calm and peaceful?”; 3) “felt downhearted and blue?”; 4) “been a 
happy person?”; and 5) “felt so down in the dumps that nothing could cheer you up?”. Items 
are scored on a six point Likert-scale ranging from “none of the time” to “all of the time”. 
Raw scores were standardized by linear transformation to a scale ranging between 0 and 100 
with high scores indicating better mental health (Berwick et al., 1991). In accordance with 
other studies, the cut-off score was set at ≤ 72, representing a clinical cut-off (Hoeymans 
et al., 2004). Internal consistency of the scale in current study was high (Cronbach’s α = 
0.81). MHI-5 total scale scores were provided to enable comparisons between the current 
and earlier studies. In addition, an item on suicidal ideation in the preceding six months, 
similar to that used in other studies (Kelly et al., 2001), was included in the assessment of 
depressive symptoms. Depressive symptoms were defi ned as a MHI-5 item score above 
three (symptom was present ‘often’ during the last month) and/or suicidal ideation in the 
preceding month. Substance use was assessed with questions about current use of tobacco, 
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Mean total MHI-5 score and prevalence rates of depressive symptoms for both heavy 
substance users and low- to non-users are shown in table one. The total MHI-5 score in 
heavy smokers, cannabis users, and in hard drug users are signifi cantly lower (indicating more 
or more severe depressive symptoms) than in non/moderate users. The total MHI-5 score 
is not associated with heavy drinking. With regard to the separate items, heavy substance 
users generally report more depressive symptoms than non- and moderate users. Except for 
the heavy drinkers, who report lower levels of depressive symptoms than teetotalers and 
moderate drinkers. Heavy substance use is not related to nervousness. Remarkable is the 
very high proportion of the cannabis users and hard drug users that report suicidal thoughts 
(37.9 and 47.3% respectively).
Table two shows the odds ratios of the association between the heavy use of specifi c 
substances and depressive symptoms stratifi ed for age category and gender in case of 
signifi cant interaction effects. Of all four types of heavy substance use, most associations with 
depressive symptoms were found in tobacco, cannabis and hard drugs users. At item level, 
heavy drinking was only related to more severe depressive symptoms in 12 to15-year olds, 
and only girls from this age category reported elevated levels of nervousness and tenseness. 
At the same time, heavy drinking is associated with a lower report of depressive symptoms 
(total MHI-5 score) in the older age categories (16-19 years and 20-23 years) and with a 
lower reported severity of the item ‘being down in the dumps’ in the age category 16-19. 
Furthermore, a clear trend was found for male heavy drinkers from the age categories 16-19 
and 20-23 to be less nervous than their non- and low-drinking peers of the same gender. 
Heavy drinking is not related to suicidal thoughts.
Overall, heavy smoking was related to elevated levels of all depressive symptoms in the age 
categories 12-15 and 16-19 years old, for both boys and girls. This association barely existed 
within the age category 20-23 years old; associations on item level were neither found 
for feeling downhearted and blue, unhappiness, suicidal thoughts, nor for the total MHI-5 
score. 
Heavy cannabis use was clearly associated with more depressive symptoms in general (total 
MHI-5 score). On item level, feeling downhearted and blue, unhappiness, and suicidal thoughts 
were related to cannabis use in all age categories and for both genders. However, tenseness 
was related to heavy cannabis use only in girls and elevated rates of nervousness were solely 
found in 16 to 19 year olds. For the item down in the dumps, no signifi cant association was 
found for the age category 20-23 year olds. 
The MHI-5 total score was also signifi cantly associated with hard drug use. On item level, the 
picture is somewhat complicated with hard drug users of 12-15 year old showing increased 
odds for all depression items, the 16-19 year old users showing no elevated levels of feeling 
downhearted and blue, unhappiness, or being down the dumps, and 20 to 23-year-olds not 
showing signifi cantly more nervousness or downhearted and blue feelings than their non-
using peers. The odds ratio for suicidal thoughts in male hard drug users is much higher than 
in female users.
 
Discussion
The aim of the present study was to assess whether heavy use of specifi c substances (tobacco, 
alcohol, cannabis, hard drugs) was related to specifi c depressive symptoms, taking age and 
gender differences into account. Heavy use of specifi c substances indeed proved to be related 
to specifi c depressive symptoms, and interesting age and gender effects were identifi ed. 
Comparing the four specifi c types of heavy substance use, most associations with depressive 
symptoms were found in heavy users of tobacco, cannabis and hard drugs with effect 
sizes increasing in that order. Few associations were found for heavy alcohol use with the 
exception of very young female heavy alcohol users. Several signifi cant interaction effects 
of age category and gender were identifi ed in reference to the association between heavy 
substance use and depressive symptoms.  
With regard to age, the strongest associations between depressive symptoms and heavy 
substance use were found in the youngest age category (12-15 year olds), both for boys 
and girls. Heavy drinking and smoking were related to larger odds for depressive symptoms 
exclusively in the youngest adolescents. These enlarged odds were not found in older 
adolescents. On the contrary, odds for depressive symptoms were even lower for heavy 
drinkers in older age categories. To rule out the possibility that this lack of associations 
between the more socially accepted heavy alcohol use and depressive symptoms is a result of 
a too low cut-off score, additional analyses with higher cut-off scores (indicating higher levels 
of alcohol use) were performed. None of these post hoc adaptations signifi cantly infl uenced 
size and direction of the reported associations. The strong age effect could be attributed to 
heavy tobacco and alcohol use being more common than cannabis and hard drugs use at 
the age of 15-23 years old (Johnston et al., 2007; Hibell et al., 2004). In contrast to cannabis 
and hard drugs, tobacco and alcohol use might not be related to depressive symptoms, but 
mainly to socially well-adapted behavior in certain peer groups of older adolescents. In early 
adolescence, this kind of heavy smoking and drinking is still exceptionally and more probable 
a symptom of underlying psychopathology.
With regard to gender, fewer effects were found. Some odds ratios were larger for girls; 
tenseness was signifi cantly associated with heavy cannabis use in girls only, and odds for 
tenseness and nervousness were high for young heavy drinking girls, but not for boys. In 
line with substance use being more common in older adolescents aged 16-23, it might well 
be possible that substance use is more part of normal socially accepted behavior in boys 
than in girls. For girls, substance abuse seems more strongly related to the presence of 
depressive symptoms. The only reverse gender-effect was found for suicidal thoughts in hard 
drug users with higher odds ratios in boys than in girls. Perhaps suicidality is not only related 
to depressive feelings, but also to impulsivity, which is, in turn, often part of a constellation of 
disruptive behavior traits that are more common among boys (Newcorn et al., 2001). Indeed 
earlier research found major depression to be associated with suicidal ideation in females, 
while among boys only SUD was (Reinherz et al., 1995). 
Our results show distinct cross-sectional associations between specifi c substance use 
and specifi c depressive symptoms, which seem to nuance the plain associations between 
substance use and depression. For example, whereas no associations between heavy drinking 
and overall MHI-5 score were observed (table one), these associations appeared after 
adjusting for age (table two). Stratifi cation for separate depressive items also yielded some 
specifi c patterns of associations, as the odds ratios for plain MHI-5 cut-off scores differed 
from those derived from a more differential analysis with stratifi ed symptom, age and gender 
levels. For example, whereas associations between general MHI-5 cut-off score and heavy 
cannabis use were found for all age categories and both genders, these proved not to apply 
for all items (such as nervousness and tenseness). We tend to conclude that the affective 
and cognitive items such as unhappiness and being down the dumps generally show stronger 
associations with heavy substance use than the more physical symptoms such as tenseness 
and nervousness. Perhaps these affective and cognitive symptoms are more central to the 
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notion of depression.  Another explanation could be that these symptoms are infl uenced 
by chronic heavy use of psychotropic substances, as some experimental studies in primates 
suggest (Nader et al., 2006). 
Findings of the present study are relevant addition to previous research. Roberts et al., 
(2007) already pointed out that the co-occurrence of substance use disorders and depressive 
disorders tends to depend on type of substance. They found an association between alcohol 
use disorders and depressive disorders. On symptom level and taking gender and age effects 
into account, only few and even reverse associations between alcohol use and depressive 
symptoms were found in the current study. Due to limitations of our dataset, we were not able 
to control for disruptive behaviors like Roberts et al. (2007) did. However, earlier research 
is not equivocal about the association between mood disorders and SUD after controlling 
for disruptive behaviors (Costello, 2007). Some studies report that the association between 
mood and SUD disappears when it is controlled for disruptive behaviors, while others 
fi nd that it remains for cannabis or alcohol (Roberts et al., 2007; Wittchen et al., 2007). 
Other studies also highlight potential interactive effects between conduct and depressive 
problems that relate to more serious maladjustment, especially relating to school success 
and substance dependence, than for each disorder seperate (Miller-Johnson et al.,1998; 
Marmorstein & Iacono, 2003). The aim of current study however, was not to determine the 
etiological connection between depression and substance use, which cannot be addressed 
with a cross-sectional design, but to examine the specifi c associations between depressive 
symptoms and types of substance use, age and gender. 
Another important difference between the present study and the study of Roberts et al., 
(2007) is their application of DSM-IV classifi cations whereas the present study assesses 
specifi c symptoms. The focus on depressive symptoms rather than depressive disorders, 
also entails that ‘cases’ with sub-clinical depression were included in present analysis. Our 
fi ndings may not be generalized to a clinical population, but rather provide knowledge about 
sub-clinical associations. 
Age was an important effect-modifi er in our study. In accordance with our results, earlier 
studies reported higher odds of comorbid depression and substance abuse in younger age 
categories and that depression is associated with earlier onset of substance use and abuse 
in both genders (Roberts et al., 2007; Costello et al., 1999). 
Considering gender, it has been speculated that associations between depression and 
substance use are higher for females (Kessler et al., 1997). However, the current study does 
not fi nd much support for this claim. Roberts et al., (2007) found that the odds of a mood 
disorder, given alcohol dependence, are much higher for girls than boys. Similar results are 
found in present study, but only for girls in the youngest age category.  This is consistent with 
another study in which heavy episodic drinking placed younger adolescent girls at higher risk 
for depression than their older peers (Poulin et al., 2005). It is suggested that heavy drinking 
may serve a different function in younger female adolescents, as it may be a means of coping 
with depressive feelings, whereas in older adolescent females and males the heavy drinking is 
mainly part of normal social behavior (Poulin et al., 2005; Engels et al., 2006).
An important strength of the current study is the large sample size, the use of validated 
questionnaires and the broad spectrum of substance use variables that were available. The 
current study also has limitations. The data rely on self-report, although adolescents are in 
general very capable of reporting their internalizing mental health problems (Jensen et al., 
1999) and substance use (Fisher et al., 2006). 
The main consequence of the present study is that future research should be sensitive to 
the fact that these associations, which have not been demonstrated before, may arise from 
a differentiated and sub-clinical perspective.  The association between depressive symptoms 
and heavy substance use differs for specifi c types of substances and age and gender categories. 
This fi nding might have implications for research methods of both phenomenological studies 
that assess comorbidity of depression and substance abuse and underline the importance of 
screening of co-occuring problems in adolescents-at-risk in normal or subclinical populations 
with either heavy substance use or depressive symptoms. Clinicians should be alert to ask 
adolescents with depressive symptoms about substance use, and vice versa. Especially since 
results for specialized treatment for co-occurring depression and substance abuse among 
adolescents are very promising (Curry et al., 2003).
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Abstract
Objective: To examine the diagnostic accuracy of the 4-item self-report and parent-report 
version of the CAGE-AID as a screen for substance use disorders (SUD) among adolescents 
in mental health care. 
Method: Patients were 190 Dutch treatment seeking adolescents (12-18 years old; mean 
age 15.5 years; 53% boys) and their parents who completed the CAGE-AID questionnaire 
during intake. DSM IV clinical diagnoses were used as gold standard in Receiver Operating 
Characteristic (ROC) analyses to determine psychometric properties.
Results: Psychometric properties for both the self-report and the parent-report version 
showed the CAGE-AID’s excellent diagnostic accuracy in predicting SUD. 
Conclusion: The CAGE-AID seems to be a brief and valid instrument for detecting SUD 
among adolescents in mental health care. However, denial may play a role in both the CAGE-
AID and the clinical interview. More research is needed to further establish the CAGE-AID’s 
usefulness in other settings.
KEYWORDS: substance abuse, mental health sample, CAGE-AID, adolescents, screening.
Introduction
Adolescence is a critical time for the development of substance use disorders (SUD) (Clark 
et al., 2006). Although only a small proportion of the youngsters who experiment with 
substance use in adolescence develop SUD, longitudinal studies show that early onset of 
substance use is a strong predictor of later dependence and persistent dysfunction (Rohde 
et al., 2007). 
This early onset substance use and abuse is often preceded by mental disorders (Boden et 
al., 2007; Huizink et al., 2006; Wittchen et al., 2007). Indeed, substance abuse in youth mental 
health care referrals is quite common, with current prevalence estimates varying from 11% 
to 23% (Aarons et al., 2001; Kramer et al., 2003; Wilens et al., 1997; King et al., 2000). These 
high rates of comorbid substance abuse and mental disorders constitutes a challenge for the 
health care system and society as a whole, since the clinical consequences of comorbidity 
are substantial (Costello et al., 1999). Treatment programs have to address a complex web 
of interrelated problems: comorbid youth generally experience higher levels of impairment, 
behavioral problems and criminal justice involvement, and treatment costs are much higher 
(Wilens et al., 1997; Kramer et al., 2003; King et al., 2000).
Early and adequate detection of youth with comorbid SUD may allow for intervention 
before either substance use, mental health or associated problems escalate to more severe 
levels. Unfortunately, substance use problems are often diagnosed too late or are simply not 
detected at all (King et al., 2000). Consequently, appropriate treatment is not provided or 
applied too late. Lack of training in how to manage positive screens and insuffi cient time for 
screening are the greatest barriers to detect adolescents with SUD (van Hook et al. 2007). 
Numerous efforts have been made to develop comprehensive self-report instruments to 
detect substance abuse among adolescents (for extensive review see Winters, 2004). These 
efforts have included many well-defi ned instruments, but many of these instruments focus 
solely on one substance and exclude others. Other instruments are very comprehensive, 
but too extensive and lengthy to be used as screeners (Shaffer et al., 1996). Moreover, 
many instruments are developed for adolescents in substance abuse treatment or paediatric 
settings rather than for mental health settings and validity in an adolescent psychiatric 
population has not been established. Since most of the commonly used psychopathology 
screening questionnaires (e.g. CBCL, YSR (Achenbach, 1990), and SDQ (Goodman et al., 
2003)) do not include a substance abuse module, there is a need for a brief, reliable, and valid 
instrument appropriate for screening SUD at intake in youth mental health care. 
To facilitate easy integration in any standardized screening procedure, we chose the CAGE-
adapted to include drugs (CAGE-AID) scale for its universal use, its brevity, and its resemblance 
to the DSM IV criteria (Brown & Rounds, 1995). The CAGE-AID is an adapted version of the 
original CAGE questionnaire which only screens for alcohol abuse and dependence (Ewing, 
1984). Thus far, reliability and validity of the CAGE-AID have been evaluated in only one adult 
psychiatric sample (Dyson et al., 1998). In this study, the CAGE-AID showed a sensitivity of 
88% and a specifi city of 55% for the detection of current SUD. In addition, the CAGE-AID 
proved to correlate well with other measures of substance abuse. 
The aim of the present study is to validate the 4-item self-report and parent-report versions of 
the CAGE-AID as a screen for SUD among adolescents in mental health care by: 1) assessing 
the diagnostic accuracy of the self-report and parent-report version of the CAGE-AID, 2) 
obtaining clinically relevant cut-off scores, and 3) examining parent and child agreement. 
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Method
Participants
Participants consisted of a convenience sample of 190 adolescents ages 12 to 18 years and 
their primary caretaker (usually their mother), who were referred to a youth mental health 
care facility in 2004. Youths were seen in several facilities dispersed over The Netherlands 
(in rural, suburban, and urban settings), all participating in a research network of the 
Netherlands Institute of Mental Health and Addiction (Trimbos Institute). The CAGE-AID 
scale was included in a comprehensive screening questionnaire to assess substance use 
problems at intake. Adolescents and one of the parents/caretakers were asked to fi ll out 
the questionnaire. Potential participants were excluded if they had insuffi cient knowledge 
of the Dutch language to read or understand the questions. The medical ethics committee 
(METIGG) approved of the total procedure and written, informed consent was obtained 
prior to participation from subjects and one parent or guardian. 
The sample consisted of 143 subjects, for whom both self-report and parent-report versions 
were available; 32 subjects with only self-report data; and 15 subjects of which only parent-
report data were available. Sample characteristics are provided in table one. 
Table 1: Sample Background Characteristics
Instruments
CAGE (Brown & Rounds, 1995) is an acronym for its four items: (1) ‘‘Have you ever felt you 
ought to Cut down on your drinking or drug use?’’ (2) ‘‘Have people Annoyed you by criticizing 
your drinking or drug use?’’ (3) ‘‘Have you ever felt bad or Guilty about your drinking or drug 
use?’’ and (4) ‘‘Have you ever had a drink or used drugs fi rst thing in the morning to steady your 
nerves or get rid of a hangover (Eyeopener)?’’ The time frame of the CAGE-AID questions was 
the preceding six months. Whereas the original CAGE and CAGE-AID consist of 4 yes/no items, 
the current study employed a slightly different format (“not true” (0), “somewhat true” (1), and 
“certainly true” (2)) to improve sensitivity in detecting potential problems.  All items are scored 
and weighted equally. In the current study, a pre-screen item regarding the use of any drugs or 
alcohol in the last 6 months preceded the CAGE-AID. If this question was answered negatively, 
the CAGE-AID questions could be skipped and were automatically scored as “not true”.
Procedure
The adolescents and one of their parents/caretakers were asked to complete the CAGE-AID 
upon intake at the mental health center. Clinicians subsequently assessed adolescents with regard 
to the presence of the DSM IV criteria of SUD (American Psychiatric Association, 2001). These 
clinical diagnoses of current SUD were used as the external criterion to validate the CAGE-AID. 
Clinicians were blind to the screening results of the CAGE-AID. Participants were rewarded with 
a small gift voucher for fi lling out the screening questionnaires.
Statistical analyses
All analyses were conducted with SPSS 14.0. Internal consistency of the CAGE-AID proved to be 
high for the self-report (Cronbach’s α =0.77) as well as for the parent-report version (Cronbach’s 
α =0.86). 
In order to determine whether the CAGE-AID has the capacity to effectively discriminate clients 
with SUD from those without SUD, receiver operating characteristics (ROC) analyses was 
employed. All clients with or without mental disorders other than SUD were grouped together 
and compared to clients with either primary or secondary SUD. The area under the curve 
(AUC) statistic can be interpreted as the probability that the CAGE-AID score from a randomly 
chosen substance abusing subject is more indicative of SUD than that of a randomly chosen 
non-substance abusing subject. An AUC < 0.7 suggests ‘low’ diagnostic accuracy, from 0.7–0.9 
‘moderate’ diagnostic accuracy, and >0.9 ‘high’ diagnostic accuracy (Swets & Pickett, 1982). 
To determine an optimal cut-off score, the sensitivity, specifi city, and overall percentage of correctly 
classifi ed cases were calculated. In addition, the positive predictive value (PPV, the probability of 
having a positive diagnosis among those with a positive screening) and the negative predictive 
value (NPV, the probability of absence of a diagnosis among those with a negative screening 
result) were calculated. The PPV and NPV will vary depending on the prevalence of a diagnosis 
in a population. Furthermore, the negative and positive likelihood are presented, expressing 
the odds of false negatives and false positives. The positive likelihood ratio (LR+) is derived by 
dividing sensitivity by (1-specifi city), whereas the negative likelihood (LR-) is calculated by dividing 
(1-specifi city) by specifi city. Finally, the cumulative percentage of total number of screen positives 
is provided to consider the clinical consequences, especially the burden of unnecessary follow-up 
assessment, for each specifi c cut-off point. 
The kappa statistic is used to test parent-child agreement. Whereas a kappa of one indicates 
perfect interrater agreement, values > 0.20 indicate fair agreement, values >0.40 moderate 
agreement, >0.60 substantial agreement (Landis & Koch, 1977). 
 
Results
Prevalence of clinically diagnosed SUD
Eleven subjects (5.8%) fulfi lled DSM IV criteria of SUD; nine boys and two girls. In this psychiatric 
sample, the number of comorbid axis I diagnoses was high. Eight out of eleven subjects with 
a substance use diagnosis had one or more comorbid axis I diagnoses, mainly externalizing 
disorders (ADHD, CD, and ODD).
CAGE-AID 
Most adolescents and their parents did not identify with any of the CAGE-AID questions (a total 
score of zero in 81.3% and 85.3% of all cases, respectively). Of all four items, the Cut down item 
was scored most frequently by both adolescents and their parents (14.4% of each indicated that 
it was “somewhat” or “certainly true”). The Eyopener item was scored least by both adolescents 
and their parents (7.6% of adolescents and 5.4% of parents indicated that it was “somewhat” or 
“certainly true”). Correlation between parent and self-report versions were consistently high 
(p<0.001 level) for all single items and total CAGE-AID score.
CAGE-AID self-report version
ROC analyses of the CAGE-AID self-report version showed an AUC of 0.996 (95% CI= 0.989-
1.00), indicating that the probability is 99.6% that someone with SUD will have a higher score on 
the CAGE-AID than someone without SUD. 
Variable Frequencies or Mean (SD)
Age 14.7 (2.1)
Gender (Boys) 54.2%
Ethnicity (non-Dutch) 8%
Low (vocational) Educational Level 39%
One or more  comorbid Axis I disorders 83%
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Table two shows the various characteristics for all potential cut-off points of the CAGE-AID 
self-report version. A satisfactory balance between these characteristics is achieved with a 
cut-off point of two. This cut-off leads to a sensitivity of 91% and a high specifi city of 98%. With 
this cut-off, the PPV of the CAGE-AID self-report version is 77%, whereas the NPV is 99%, 
and an effi ciently low (9.9%) of screen positives. Moreover, the likelihood ratio for detecting 
SUD by using the CAGE-AID self-report version with the cut-off score of 2 is 46 times higher 
compared to the odds of detecting SUD without using the CAGE-AID self-report. The negative 
likelihood expresses the odds of overlooking subjects with SUD by the CAGE-AID.  With the 
suggested cut-off score, this happens in one out of ten cases.
CAGE-AID parent-report version
ROC analysis of the CAGE-AID parent version shows an AUC of 0.997 (95% CI= 0.989 to 
1.01). Table three shows the characteristics for the various cut-off points of the CAGE-AID 
parent-report version. The optimal balance between these characteristics is achieved with a 
cut-off point of three. This cut-off leads to a sensitivity of 100% and specifi city of 99%. The 
PPV of the parent-report CAGE-AID is 88%, whereas the NPV is 100%, with a cumulative 
percentage of only 7.8% of participants screening positive.  The positive likelihood ratio with 
the cut-off score of three heightens the odds of detecting any substance use disorder 100 
times compared to the odds without using the CAGE-AID parent report version. The negative 
likelihood (the odds of overlooking SUD) is zero. 
Self-report and parent-report agreement
Using these cut-off scores, the agreement between the CAGE-AID self-report and parent 
report versions was substantial (observed agreement = 94.7%; Kappa = 0.74). For those seven 
out of eleven adolescents clinically diagnosed with SUD, whose parent data were available, 
agreement was perfect. Disagreement occurred for four adolescents who were not suffering 
from a SUD according to DSM IV clinical diagnosis, but did have either an above threshold score 
on the self-report or parent-report (three above threshold self-report and below threshold 
parent-report, one below threshold self-report and above threshold parent-report). 
Table 2: Sensitivity and Specifi city of the CAGE-AID Self-Report Version
The row in bold-type indicates the cut-off that achieves the optimal balance between sensitivity and specifi city. LR+ 
= positive likelihood ratio; LR- = negative likelihood. N=175.
Table 3: Sensitivity and Specifi city of the CAGE-AID Parent-Report Version
The row in bold-type indicates the cut-off that achieves the optimal balance between sensitivity and specifi city. LR+ 
= positive likelihood ratio; LR- = negative likelihood. N=158.
Discussion
The results provide preliminary evidence that the CAGE-AID self-report and parent-report 
versions provide an effective instrument to screen for SUD (research question 1) among 
adolescents referred to mental health care. In receiver operating characteristics analyses both 
the self-report (AUC=0.996) and the parent-report version (AUC=0.997) demonstrated 
excellent diagnostic accuracy in predicting substance use disorder diagnoses. 
Subsequently, optimal cut-off scores for clinical use were determined (research question 
2). For the self-report version, a cut-off score of two yields good accuracy at detecting the 
presence (sensitivity of 91%) and absence (specifi city of 98%) of SUD. This low cut-off score 
is consistent with the cut-off score found among adult psychiatric referrals (Dyson et al., 
1998). However, it should be noted that the latter cut-off was established using dichotomous 
answer categories and a maximum score of four instead of eight in current study. For the 
parent-report version of the CAGE-AID version a cut-off score of three seemed most 
accurate in detecting SUD (sensitivity of 100% and specifi city of 99%). Whereas in both 
versions the NPV is almost perfect (99% for the self-report version and 100% for the parent 
report version), the PPV’s are also satisfactory (77% for the self-report version and 88% for 
the parent report version).  
The prevalence of SUD in the current sample (5.8%) is considerably lower than in earlier, 
mostly North American, studies (Kramer et al., 2003; King et al., 2000). However, most of 
these studies are conducted in slightly different settings (mainly inpatient facilities) with a 
generally higher mean age. Studies in outpatient samples report lower prevalence rates 
and especially so in younger age categories (Aarons et al., 2001; Wilens et al., 1997). All in 
all, a prevalence in young (12-15 years old) outpatient mental health samples is more likely 
to amount to about 11 to 12%.  The lower prevalence in the current study may be due to 
the fact that SUD is often overlooked by clinicians (Kramer et al., 2003). Nevertheless, a 
serious underestimation is unlikely, since undiagnosed cases of SUD would have increased 
the number of CAGE-AID false positives and specifi city of the CAGE-AID could never 
remain so high. 
Another important property of the CAGE-AID is the low cumulative percentage of positive 
screens, both in the parent- and self-report version. The cumulative percentage of positive 
screens should resemble the prevalence of the disorder as close as possible, as clinicians 
Scale 
Cut-Off 
Score
Sensitivity 
%
Specifi city 
%
Positive 
Predictive 
Value %
Negative 
Predictive 
Value %
LR+ LR- Cumulative 
% screen
positives
1 100 97 73 100 33 0 11.5
2 91 98 77 99 46 0.09 9.9
3 82 100 100 98 82 0.18 6.9
4 73 96 100 98 73 0.27 6.1
5 64 100 100 98 64 0.36 5.3
6 45 100 100 95 45 0.55 3.8
7 27 100 100 94 27 0.73 2.3
8 0 100 100 92 0 1.0 0
Scale 
Cut-Off 
Score
Sensitivity 
%
Specifi city 
%
Positive 
Predictive 
Value %
Negative 
Predictive 
Value %
LR+ LR- Cumulative 
% screen
positives
1 100  98  78 100 50 0 8.7
2 100  98  78 100 50 0 8.7
3 100  99  88 100 100 0 7.8
4   71  99  88  98 71 0.29 5.8
5   71  99   88  98 71 0.29 5.8
6   71 100 100  97 71 0.29 4.9
7   57 100 100  94 57 0.43 3.9
8  14 100 100  93 14 0.86 1.0
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use screening results to make decisions about the use of scarce or expensive referrals 
to specialist care. In addition, it means that clients could be unjustly labelled as substance 
abusers. Although these concerns are valid, the high degree of impairment associated with 
comorbid substance abuse in psychiatric referrals, justifi es the need for extra attention to 
potential cases (Wilens et al., 1997; Weiner et al., 2001). Thus, as long as a positive screen is 
considered as an indicator for further evaluation, and by no means a defi nitive diagnosis, the 
potential drawbacks for clients with false positive scores are minimal. 
Finally, the level of agreement between parent- and child-report versions of the CAGE-AID 
is substantial (research question 3). Earlier research suggests that self-report on SUD is 
generally more accurate than parent-report (Fisher et al., 2006). Although, in the current 
study no such effect was found, the additional value of parent-report is small. Therefore it 
might be considered whether peer-report could perhaps prove to be a much more effective 
source of information (Andrews et al., 2002).
Clinical implications
The current study shows that the CAGE-AID can validly screen for SUD among adolescents 
in mental health care settings. By using the CAGE-AID questionnaire, clinicians can use their 
precious time at intake more effi ciently. Moreover, the 4 items of the CAGE-AID can easily 
be integrated in the standardized screening procedures in youth mental health care.
The high NPV ensures that potential substance abusers are not overlooked and a positive 
CAGE-AID screen increases the odds of the presence of a SUD by 46 (self-report) to 
100 (parent-report) times, while effi ciency (low cumulative %) is maintained. This type of 
screening for SUD in adolescents in youth mental health care is important, as these comorbid 
adolescents are often more severely impaired, have poorer treatment outcome, and higher 
health care utilization and subsequent costs (Grella et al., 2001; King et al., 2000). Moreover, 
adolescents seeking mental health treatment, in whom SUD remains undetected, are less 
likely to receive substance abuse treatment and have more involvement with the criminal 
justice system at six months follow-up (Kramer et al., 2003). Referral trajectories seem at 
random and many sectors of public care (such as paediatric, juvenile justice, and mental 
health care) are not well equipped to provide adequate care for (comorbid) substance 
abusing adolescents (Aarons et al., 2001; van Hook et al., 2007). 
Limitations
Some limitations of the present study should be noted. First, assessment of SUD relied on 
clinical diagnoses. Although clinicians adhered to DSM IV criteria, individual differences may 
exist. 
Secondly, the prevalence of SUD in the current study (5.8%) is lower than in comparable 
samples in other studies (around 11%) (Wilens et al., 1997; Aarons et al., 2001). A possible 
explanation could be that the sample was not a completely random. Facilities participated 
voluntarily and do not necessarily represent the entire Dutch youth mental health care 
system. However, most of the reported characteristics of the CAGE-AID, such as the AUC, 
sensitivity, and specifi city, are unaffected by prevalence rates.
Thirdly, the utility of an instrument varies greatly depending on the context and population in 
which it is applied. Our results showed that the CAGE-AID screens very accurately among 
adolescents referred to youth mental health care, but these fi ndings can not be generalized 
to other populations. For example, the CAGE has been proven to be less sensitive for 
screening for alcohol abuse and dependence among adolescent medical patients and 
adolescents in primary care (Knight et al., 2003; Knight et al., 2000). Moreover, because of 
the limited size of our SUD sample, the current study has not been able to examine possible 
gender or age effects. Some gender effects have been reported concerning the CAGE; it 
was less sensitive for alcohol abuse in young women compared to young men (O’Hare & 
Tran, 1997). Future research should attempt to replicate the fi ndings of the present study in 
a more gender and age diverse sample. In conclusion, our fi ndings show that employing the 
CAGE-AID offers clinicians a general, but accurate point of departure for cases that need 
more detailed diagnostic attention. The short CAGE-AID is as effective as extensive clinical 
assessment. However, denial may play a role in both the CAGE-AID and the clinical interview. 
And although there is evidence for the validity of the self–report method for the assessment 
of adolescent substance use (Winters et al., 1990), the use of a selective two stage screening 
process, employing biological indicators such as urinalysis, is always recommended when in 
doubt about the presence of (excessive) use of substances (Kilpatrick et al., 2000). 
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Abstract
Objective: Recent studies have demonstrated the validity of the Dutch translation of the 
Strengths and Diffi culties Questionnaire (SDQ) in school-based samples. This study aims 
to establish the convergent and criterion validity of the SDQ in Dutch youth referred to 
mental health services. 
Method: Participants were 190 Dutch referred adolescents (12-18 years old; mean 
age 15.5 years; 53% boys) and their parents, who completed the 25-item SDQ during 
intake. First, the internal consistency and convergent validity of the SDQ scales with the 
corresponding CBCL/YSR scales were examined. Next, criterion validity was investigated 
comparing SDQ scores and CBCL/YSR scales with specifi c diagnostic subgroups. DSM IV 
clinical diagnoses were used as gold standard in Receiver Operating Characteristic (ROC) 
analyses. 
Results: Except for the self-reported peer problems (α=0.53), SDQ scales showed 
acceptable internal consistencies (mean α parent-report = 0.75/self-report = 0.69). Moreover, 
correlations between SDQ subscales and their CBCL/YSR counterparts were substantial, 
highly signifi cant and in the expected direction. Finally, the SDQ and the CBCL/YSR were 
equally accurate in the prediction of specifi c child psychiatric disorders (AUCs ranged 
from 0.64-0.89). However, criterion validity of the self-report hyperactivity/inattention 
and total diffi culties SDQ scales did not reach signifi cance. 
Conclusions: The SDQ is a brief and valid instrument for the screening of mental health 
problems among adolescents at intake in mental health care settings. However, in clinical 
settings, the use of a multi-informant approach, especially with regard to interpersonal 
oriented and externalizing mental health problems is strongly recommended. Future 
research is needed to replicate the fi ndings of the current study in a larger sample with 
clinical diagnoses based on a semi-structured interview.
KEYWORDS: psychopathology, SDQ, mental health care sample, adolescents, screening 
Introduction
Adolescence is a critical time for the development of psychiatric disorders (Kessler et al., 
2007). In a longitudinal community study, 36.7% of all adolescents met DSM-IV criteria of 
one or more life time mental disorders (Costello et al., 2003). Whereas adolescence marks 
an increase of depression among girls, cumulative prevalence for psychiatric disorders is 
higher for boys due to the higher rates of conduct disorder (CD) and attention/defi cit 
hyperactivity disorder (ADHD)(Costello et al., 2003). It is crucial that these adolescents 
receive adequate mental health care, as these problems hamper everyday functioning and 
well-being, and effective treatment may be particularly salient to prevent persistence of 
psychopathology into adulthood (Feehan et al., 1993). However, only about 20% of these 
adolescents actually receive specialized mental health care, and thus there is a great need 
to identify more of these high risk adolescents (Burns et al., 1995). 
Several instruments to detect mental health problems among adolescents exist, of which 
the Child Behavior Checklist (CBCL) and the Youth Self Report (YSR) are among the 
most well-known (Achenbach, 1990; Achenbach, 1991). Although these instruments are 
well-established, for screening purposes, the Achenbach scales may be too extensive 
and lengthy, containing too many items that are not relevant to the majority of youth 
(Muris et al., 2003). Moreover, some studies have been unable to replicate the empirically-
derived syndrome dimensions of the Achenbach scales and to relate them to current 
conceptualisations of child and adolescent psychopathology (Lengua et al., 2001). In this 
respect, a brief, user-friendly instrument appropriate for screening of mental health 
problems at intake in youth mental health care would be a valuable addition. 
The Strengths and Diffi culties Questionnaire (SDQ) is a brief screening questionnaire that 
asks about 25 attributes, some positive and others negative, which can be easily integrated 
in any standardized screening procedure. The SDQ was originally developed in the United 
Kingdom and has since been translated into more than 60 different languages (Goodman, 
1997). The 25 SDQ items are based on contemporary diagnostic criteria and selected 
on the basis of factor analysis. Five scales of fi ve items each generate scores for conduct 
problems, hyperactivity-inattention, emotional symptoms, peer problems and prosocial 
behavior. All items of the fi rst four subscales can be summed to generate a total diffi culties 
score. Separate versions are available for parents and teachers, and a nearly identical self-
report version can be completed by youngsters from age 11 on (Goodman et al., 2003b). 
The psychometric properties of the SDQ have proven to be robust in several international 
studies (Klasen et al., 2000; Goodman, 2001; Alyahri & Goodman, 2006; Samad et al., 
2005). The SDQ performs as well as some of the other longer and well-established 
questionnaires (Goodman, 1997; Goodman & Scott, 1999). Moreover, cross-informant 
agreement is generally better than for other measures (Achenbach et al., 1987). In general, 
the SDQ is very useful for the identifi cation of  psychiatric cases, i.e. to discriminate 
between children and adolescents from the community with and without a mental disorder 
(Klasen et al., 2000; Goodman et al., 2003b). Sensitivity was substantially better with multi-
informant compared to single-informant ratings (Goodman et al., 2003a). Furthermore, 
the screening performance of the SDQ for specifi c psychiatric diagnoses is promising and 
SDQ predictions could potentially be clinically useful (Goodman et al., 2000; Becker et 
al., 2004). 
Recent studies have demonstrated that the Dutch translation of the SDQ also has 
acceptable to good psychometric properties in a school-based sample of children and 
adolescents (8-16 years old) (van Widenfelt et al., 2003; Muris et al., 2003). However, 
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the psychometric properties of the SDQ in clinic-referred Dutch youth remains to be 
established. Therefore, the aim of the present study is to validate the self-report and 
parent-report versions of the SDQ as a screen for mental health problems among 
Dutch adolescents at intake in a mental health care setting to: (1) examine the internal 
consistency of the SDQ scales and the intercorrelations with corresponding scales of 
the Dutch translations of Child Behavior Checklist (CBCL) and/or the Youth Self Report 
(YSR) to establish convergent validity and (2) investigate whether SDQ scales can predict 
the presence of specifi c diagnostic subgroups equally well as the CBCL/YSR. 
Methods
Participants
Participants consisted of a convenience sample of 190 adolescents referred to a youth mental 
health care facility aged 12-18 years and their primary caretaker (usually their mother). 
Adolescents were seen in several facilities dispersed over The Netherlands (in rural, 
suburban, and urban settings), all participating in a research network of the Netherlands 
Institute of Mental Health and Addiction (Trimbos–institute; www.trimbos.nl). The SDQ 
was included in a comprehensive screening procedure to assess mental health problems 
at intake. Both parents and adolescents were asked to fi ll out the questionnaire. Potential 
participants were excluded if they had insuffi cient command of the Dutch language to either 
read or understand the questions. The medical ethics committee (METIGG) approved the 
procedure and written informed consent was obtained prior to participation from subjects 
and one parent or guardian. Sample characteristics are provided in table one.
Table 1: Sample Characteristics (N=190) 
Procedure
All adolescents and one of their parents/caretakers were asked to complete the SDQ 
and YSR/CBCL upon intake at the mental health center. Clinicians subsequently assessed 
adolescents with regard to the presence of any DSM-IV disorder (American Psychiatric 
Association, 2001). These clinical diagnoses of current psychopathology were used 
as the external criterion to validate the SDQ. Clinicians were blind to the screening 
results. Participants were rewarded with a small gift voucher for fi lling out the screening 
questionnaires.
Measures
Strengths and Diffi culties Questionnaire (SDQ)
Information on the SDQ and copies of the questionnaire in many languages can be obtained 
free for non-commercial purposes from http://www.sdqinfo.com. The SDQ items refer to 
the preceding six months and consist of three answer categories (“not true”, ‘‘somewhat 
true”, and ‘‘certainly true”). All items have to be scored and are weighed equally. Higher 
scores on the prosocial behavior subscale refl ect strengths, whereas higher scores on 
the other four subscales refl ect diffi culties. The total diffi culties score is the sumscore 
of the four problem subscales and can be used to generate an overall prediction of any 
mental health disorder. Of the total sample, 91% (N= 172) of all subjects had a completed 
parent and self-report SDQ. No indications for differential non-response with respect to 
demographic variables or presence of (specifi c) diagnoses were found. 
Child Behavior Checklist (CBCL) and Youth Self Report (YSR)
These Achenbach scales consist of 118 items that address emotional and behavioral 
problems. Parents and adolescents were asked to fi ll out the Dutch translation of the 
parent-report CBCL (Verhulst et al., 1996) and self-report YSR (Verhulst et al., 1997). A 
total score, an externalizing score and an internalizing score can be generated to assess 
these three broad-band categories of mental health problems. In addition, items can be 
grouped into eight narrow-band scales: withdrawn, somatic complaints, anxious-depressed, 
social problems, thought problems, attention problems, delinquent behavior, and aggressive 
behavior. In all cases, higher CBCL/YSR scores refl ect higher levels of problems. For 58% 
of the sample a fully completed CBCL was available and for 40% an YSR. No indications for 
differential non-response with respect to demographic variables or presence of (specifi c) 
diagnoses were found. 
Clinical assessment
Clinicians carefully assessed participants on the basis of DSM-IV criteria (American 
Psychiatric Association, 2001). Clinical diagnoses were the “gold standard” to validate the 
SDQ. Of the total sample, 91 subjects (48%) had a known DSM-IV diagnosis, of which 45 
could be used in a meaningful comparison with the SDQ and YSR/CBCL syndrome scales, 
i.e., a diagnosis was available as well as an SDQ and YSR or CBCL for the same case. 
Diagnoses that were common, but that could not be included in  further analyses were 
eating disorders, autism spectrum disorders, and substance use disorders, because the 
SDQ does not comprise items on the symptoms of these diagnoses.
In line with a similar validation study in a German clinical sample (Becker et al., 2004), 
the diagnoses were eventually collapsed into three broad categories to provide a relevant 
comparison with the SDQ and CBCL/YSR. For the hyperactivity/inattention (SDQ) and 
attention (CBCL/YSR) scales, relevant diagnoses included all types of ADHD (combined, 
hyperactive/impulsive and attention defi cient type). Prevalence of this class of disorders 
in the sample was 7.9% (n=15). For conduct problems (SDQ) and externalizing problems 
(CBCL/YSR) scales, the relevant disorders were CD and oppositional defi ant disorder 
(ODD). Prevalence of this class of disorders in the sample was 7.4% (n=14). For the 
emotional symptoms (SDQ) and the internalizing (CBCL/YSR) scales, the relevant 
diagnoses were any mood or anxiety disorder diagnosis, including obsessive-compulsive 
disorder. Prevalence of any of these disorders in the sample was 12.1% (n=23).
Statistical analyses
All analyses were conducted with SPSS 14.0. If one or two items of a scale were missing, 
a scale score was computed by summing the remaining items and multiplying the sum 
with (number of items)/(number of items – number of missing items). Scale scores were 
considered missing if more than two items were missing.
Reliability of the various SDQ scales was indexed by means of Cronbach’s alpha (internal 
consistency). To assess convergent validity between the SDQ scales and the corresponding 
Variable Frequencies or Mean (SD)
Age 15.5 (2.1)
Gender (Boys) 52.6%
Ethnicity (non-Dutch) 8%
Low (vocational or primary school) Educational Level 39%
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CBCL/YSR, correlations were calculated. Due to the skewed distributions of the raw 
scale scores, the statistical calculations were carried out using non-parametric methods 
(Spearman rank correlations). Correlation coeffi cients of <0.30 are considered low; 
correlations between 0.30 and 0.50 are considered moderate, and correlations ≥ 0.50 are 
considered high (Cohen, 1988).
To determine whether the SDQ has the capacity to effectively detect specifi c diagnostic 
subgroups in a clinical sample to the same extent as the CBCL/YSR, Receiver Operating 
Characteristic (ROC) analysis was employed. ROC analyses do not require a priori 
defi nition of a specifi c cut-off value for separating normal and abnormal scale scores. It 
provides a visual representation of the accuracy of the SDQ and YSR/CBCL to detect 
adolescents with a disorder category by plotting rates of false positives (1 – specifi city) 
against true positives (sensitivity). The closer the curve comes to the diagonal of the ROC 
space, a divide based on pure chance, the less accurate the test. The area under the curve 
(AUC) statistic can be interpreted as the probability that the SDQ or CBCL/YSR score 
from a randomly chosen subject is more indicative of the specifi c disorder than that of a 
randomly chosen non-disorded subject. An AUC < 0.7 suggests ‘low’ predictive accuracy, 
an AUC between 0.7 and 0.9 suggests ‘moderate’ accuracy, and an AUC >0.9 represents 
‘high’ accuracy (Landis & Koch, 1977).  
To compare the areas under the two ROC curves (for the SDQ versus the CBCL/YSR) 
in the same sample, a Z ratio was calculated. This ratio is derived from the two obtained 
AUC values, their standard errors, and the correlation between the two predictor scores 
(Hanley & McNeil, 1983)
 
Results
Internal consistency SDQ subscales
Table two shows that the internal consistency for parent-rated subscales ranged from 
0.66-0.78 with the peer problems subscale performing slightly less satisfactory than the 
other four subscales. The 20-item total diffi culties score yielded a very satisfying coeffi cient 
(α=0.82). Internal consistencies of the self-report SDQ subscales were satisfactory for 
the emotional problems, the hyperactivity-inattention, and the total diffi culties subscales 
(α=0.77-0.80), but somewhat lower for the conduct problems, prosocial and the peer 
problems subscales. With the exception of the self-report peer problem subscale, both 
parent and self-report SDQ scales were suffi ciently reliable.
Convergent validity SDQ and CBCL/YSR
To assess the convergent validity of the SDQ, correlations between parent and self-report 
SDQ subscales and the corresponding CBCL/YSR scales were calculated. Because the CBCL 
does not contain a scale corresponding to the positive prosocial behavior scale of the SDQ, 
the association with the CBCL/YSR social problems scale was analysed instead. Except for 
the self-report prosocial scale, all correlations between SDQ subscales and their CBCL/YSR 
counterparts were substantial, highly signifi cant and in the expected direction. In particular, 
the 5-item parent-report conduct problems subscale of the SDQ, showed a very strong 
concurrence (0.85) with the 33-item CBCL score for externalizing symptoms. 
Criterion validity of the SDQ and the CBCL/YSR with clinical diagnosis
The results of the ROC analyses to establish the criterion validity of the SDQ and compare
it to the CBCL/YSR with respect to detecting any diagnosis and the different diagnostic 
Table 2: Reliability and concurrent validity of the Dutch parent-report and self-report SDQ
*Signifi cant correlation at p ≤ 0.05 level, ** Signifi cant correlation at p ≤ 0.01 level (Spearman rank correlations, 
two-tailed).
subcategories, with the scale scores serving as predictors of caseness, are shown in 
Table three. As there are no relevant clinical diagnoses for a meaningful comparison with 
the prosocial behavior and peer problems subscales, these were left out of the ROC 
analyses.
Using the total diffi culties score (SDQ) and total problems score (CBCL/YSR) to 
predict the presence of any relevant psychiatric disorder, only the parent-report SDQ 
(AUC=0.64) signifi cantly differentiated between subjects with and without any mental 
disorder, but criterion validity was low. The ability of the SDQ and CBCL/YSR subscales 
to effectively detect more specifi c clinical subgroups in the sample was more accurate, but 
revealed some differences between the two instruments. Both inventories were equally 
able (AUC =0.76) to detect subjects with emotional problems based on their self-report. 
For detection of emotional disorders, CBCL parent-reported emotional problems was 
slightly, but not signifi cantly, better than the parent-report version of the emotional scale 
of the SDQ (AUCs= 0.68 and 0.67, respectively). However, with respect to ODD and CD 
disorders, the parent- report SDQ conduct problems subscale performed signifi cantly 
better than the CBCL externalizing problems scale (AUCs =0.89 and 0.77, respectively). 
For the self-report SDQ conduct problems subscale and YSR externalizing scale this 
pattern was reversed (AUCs = 0.86 and 0.95, respectively). For detecting ADHD, the 
parent-report SDQ subscale (AUC=0.72) and the CBCL (AUC=0.79) were superior to 
the corresponding self-report attention problems scales of both the SDQ (AUC=0.48) 
and YSR (AUC=0.52). 
Discussion
The aim of the present study was to validate the parent and self-report versions of the 
SDQ as a screen for DSM-IV disorders among Dutch adolescents referred to mental 
health care. First, the internal consistency and the concurrence of SDQ subscales with the 
corresponding scales of the Dutch CBCL and its self-report report counterpart, the YSR, 
was examined. Although each SDQ subscale consists of only 5 items, in general, satisfying 
SDQ and CBCL/ YSR scales SDQ parent 
version
(Cronbach’s α)
SDQ self-
report version
(Cronbach’s α)
Correlation 
SDQ-P and 
CBCL
Correlation 
SDQ-S and 
YSR
SDQ – Total Diffi culties
CBCL/YSR – Total Problems
.82 .79 .76** .70**
SDQ – Emotional Symptoms
CBCL/YSR – Internalising Problems
.78 .80 .77** .75**
SDQ – Hyperactivity/Inattention
CBCL/YSR – Attention Problems
.77 .77 .65** .57**
SDQ – Conduct Problems
CBCL/YSR – Externalising Problems
.71 .60 .85** .70**
SDQ – Peer Problems
CBCL/YSR – Social Problems
.66 .53 .67** .32**
SDQ – Prosocial Behavior
CBCL/YSR – Social Problems
.78 .64 -.48** -.03
Reliability Validity
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internal consistency coeffi cients were found. The only less adequate reliabilities were found 
for parent-report peer problems and self-report conduct problems and prosocial behavior. 
However, reliability coeffi cients are greatly infl uenced by the number of items in a scale. As 
the number of items increases, the alpha coeffi cient will increase. Moreover, Kline (1999) 
suggests that due to the multidimensionality of the constructs, an alpha below 0.70 for 
psychological problem scales can be realistic (Kline, 1999). However, the Cronbach’s α of 
only 0.53 for the self-report peer problems subscale remains notably low. Previous studies 
report similar fi ndings (Goodman et al., 2000; van Widenfelt et al., 2003; Muris et al., 2003). 
This weak internal consistency of the SDQ peer problems scale may mean that some items 
do not fi t the rest of the scale or that youngsters are not very accurate informants on their 
problems with peers. 
To assess the convergent validity of the SDQ, correlations between parent- and self-report 
SDQ subscales and the corresponding CBCL/YSR scales were calculated. Except for the self-
report prosocial scale, all correlations between SDQ subscales and their respective CBCL/
YSR counterparts were substantial, highly signifi cant and in the expected direction. These 
fi ndings are consistent with fi ndings form a recent study in the Dutch general population (van 
Widenfelt et al., 2003) and support the use of the SDQ as an alternative for the more time-
consuming CBCL and YSR for screening purposes.
In order to determine whether SDQ scales can detect specifi c diagnostic subgroups in a 
clinic-referred sample to the same extent as the CBCL/YSR, ROC analyses were performed 
with the clinical DSM-IV diagnosis as the criterion. Overall, the SDQ was accurate in 
discriminating subjects with and without a particular category of psychiatric disorder, i.e. 
emotional disorders, oppositional/conduct disorders and attention defi cit/hyperactivity 
disorders. Signifi cant differences in criterion validity between the SDQ and the CBCL/YSR 
were found only for the total diffi culties scale and the conduct/externalizing subscale. The 
parent-report SDQ total diffi culties scale and the conduct problems subscale performed 
signifi cantly more accurate than the CBCL total problems scale and the CBCL externalizing 
subscale. A similar German study, also using ROC analysis in a clinical sample, did not report 
this fi nding. In this study both the SDQ and the CBCL total diffi culty scales performed 
moderately well in detecting any diagnosis (AUCs =0.77 and 0.77, respectively) (Becker et 
al., 2004). With regard to self-reported conduct problems, the pattern is reversed as the 
YSR externalizing subscale showed a signifi cantly higher detection accuracy with respect 
to oppositional and conduct disorders than the SDQ conduct problems subscale. Another 
notable fi nding in current study was the failure of both the YSR inattention problems and self-
report SDQ hyperactivity/inattention subscales to detect this category of disorders in this 
sample. As no comparable studies have been conducted for the self-report SDQ, replication 
is needed to confi rm this fi nding. For the YSR attention problems scale, however, our fi nding 
is not in line with earlier studies that showed good convergence and accurate detection of 
ADHD in different samples (Doyle et al., 2007; Vreugdenhil et al., 2006). 
In line with previous studies, the current study shows that the SDQ can be used as an accurate 
screener for specifi c mental disorders among adolescents in mental health care settings. 
The present fi ndings provide support for the concurrent and criterion validity of the SDQ 
as a brief screening tool for specifi c subcategories of mental disorders among adolescents 
referred to mental health care facilities. By using the SDQ questionnaires, clinicians can use 
their precious time at intake most effi ciently. 
The 25-items of the SDQ cover the most prevalent broad classes of psychopathology and 
can easily be integrated into the standardized screening procedures in adolescent mental Pr
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health care.
The SDQ prediction works best when the SDQ is completed by parents and secondly, by 
adolescents. Although adolescents are very capable of reporting on their internalising symptoms 
and conduct problems, the self-report peer problems and inattention/hyperactivity subscales 
seem to be less valid as signal detectors for a diagnosable disorder than their parent’s account 
on these issues. Moreover, the self-report peer problems subscale also suffers from inadequate 
internal reliability. This could also partly refl ect the inconsistency of adolescents’ self-report on 
interpersonal problems. Indeed this diffi culty with assessing one’s own interpersonal behavior 
could explain why the expected correlations between the prosocial SDQ and the YRS social 
problems scale was nonexistent, while for the parent reported scales they were. Other studies 
confi rm that adolescents in general are quite capable of reporting their internalizing mental 
health problems, but might underreport certain externalizing behaviors, such as attention/
hyperactivity problems (Jensen et al., 1999). Therefore, in clinical settings the use of a multi-
informant approach, especially for attention/hyperactivity and peer problems is essential. 
Moreover, additional information on substance use and misuse is essential, as the SDQ does not 
evaluates potential substance-related problems. Unfortunately, substance abuse often remains 
undetected in adolescents seeking help (van Hook et al., 2007). Consequently, appropriate 
treatment is not offered and these youth end up having more involvement with the criminal 
justice system (Kramer et al., 2003). Including the 4-item CAGE-AID has been shown to validly 
screen for substance abuse among adolescents in mental health care settings and can be easily 
integrated in any standardized screening procedure (Couwenbergh et al., 2008).
Strengths and limitations
The most important strengths of the current study are the relatively large total sample size, 
and the availability of the SDQ, the CBCL/YSR and a clinical diagnosis for the same cases. 
Furthermore, the sample was collected in a great number of adolescent mental health centers 
across The Netherlands.
The study also has some limitations. First, assessment of psychiatric disorders relied on clinical 
diagnoses. Although clinicians all adhered to DSM-IV criteria, the assessment procedure did 
not involve a standardized psychiatric interview and individual differences between clinicians 
in applying diagnostic criteria may have gone undetected. Second, the sample sizes of the 
different diagnostic subcategories used for the ROC analysis were relatively small. Especially 
the imperfect overlap between available SDQ, CBCL/YSR, and DSM-IV diagnosis made sample 
sizes for the ROC analysis variable and smaller than desirable. It is therefore essential that future 
research attempts to replicate fi ndings of the current study in a larger sample. Third, SDQ 
scores obtained from parents and adolescents were used. As mentioned in the introduction, 
a teacher-rated version of the SDQ also exists. Including this source of information has been 
shown to be a valuable addition to the reliability and validity of the SDQ (Goodman et al., 
2003a). Our fi ndings regarding the self-reported peer problems and inattention/hyperactivity 
subscales, underline the necessity for a multi-informant approach. Earlier studies have shown 
the value of using computerized algorithms for predicting psychiatric disorder by combining 
information on symptoms from SDQs completed by multiple informants (Goodman et al., 
2004).
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Introduction
In this fi nal chapter, the main fi ndings of the thesis are summarized, discussed and placed within 
the context of recent developments in this fi eld of research. Furthermore, methodological 
issues that are important for the interpretation and extrapolation of the results are addressed. 
Finally, possible clinical implications and suggestions for future research are given.
Main fi ndings
In Chapter 2 the literature on the prevalence of co-occurring SUD and mental disorders 
among adolescents and young adults in substance abuse treatment settings was reviewed. 
Previously, this had been done for youngsters in the general population and two large studies 
reported on comorbidity in the juvenile justice system. 
In our review, recent (past fi ve years) empirical studies that reported on 50 or more 
adolescents within a fi xed age range (12-21 years) in drug treatment were retained and 
scrutinized for their methodological quality. In order to facilitate the comparison of 
prevalence rates in these clinical settings, only studies that reported DSM-III-R or DSM-IV 
SUD criteria and comorbid DSM Axis I diagnoses were included. We found ten studies (nine 
North American and one Icelandic) that met our inclusion criteria, and examined prevalence 
rates and the different types of co-occurring DSM SUD and mental disorders in adolescents 
in addiction treatment services. 
The reported prevalence rates of co-occurring mental disorders were consistently high 
across all studies. Total psychiatric comorbidity in youngsters in substance abuse treatment 
varied from 61% to 88%. Externalizing disorders, especially Conduct Disorder (CD), were 
most consistently linked to substance use disorders in treatment seeking adolescents (24-
82%). Girls were distinguished from the boys by their high rate of comorbid internalizing 
disorders (14-65% versus 6-37%).
We than addressed the question how these fi ndings among treated youngsters compare with 
youngsters in the community and with those in the penal system.  In their review on community 
studies,  Armstrong & Costello (2002) reported the prevalence of substance use/abuse/
dependence (SU/SA/SD) to vary considerably (6-33%) depending on the operationalization 
of SU/SA/SD, the timeframe, and age distribution of the sample. Moreover, their results 
revealed that 60% of these youths with SU/SA/SD had at least one comorbid psychiatric 
diagnosis. In a large sample of youngsters in juvenile detention in the U.S.,  Abram et al. 
(2003) found a prevalence of SUD of 48%, of which 64% had at least one comorbid disorder. 
Finally, among Dutch incarcerated boys, Vreugdenhil et al. (2003) reported a prevalence rate 
of SUD of 55%, of which 90% had at least one comorbid mental disorder.
Across all three settings, the high prevalence of externalizing disorders was reported most 
consistently, especially the strong link between CD and SUD. Most notable was the trend of 
the prevalence of externalizing disorders over the three settings. The prevalence of SUD and 
comorbid externalizing disorders was lowest in the community samples, somewhat higher 
in the treatment seeking population, and highest in the juvenile justice sample. This increase 
of externalizing disorders from the community through treatment samples to incarcerated 
youth corroborates the hypothesis that regular youth care may fail to adequately treat 
adolescents with SUD and comorbid mental disorders, and many of these youngsters end 
up in the juvenile justice system.
The association of internalizing disorders with SUD on the other hand is less consistent 
and mainly seemed to differ by gender. In general, girls reported higher rates of internalizing 
comorbidity, whereas the rates of externalizing disorders among girls rise to about equal 
levels as boys from the age of 15 onwards (Dakof, 2000). So in addition to the equal level 
of externalizing disorders, girls are distinguished by higher rates of comorbid internalizing 
disorders (Shrier et al., 2003). Moreover, several studies point at a greater level of family and 
social dysfunction in comorbid girls (Dakof, 2000; Jainchill et al., 1997).
However, one should be cautious with the interpretation and extrapolation of these results. 
Even though strict selection criteria were used, differences in sample characteristics and 
methodology may infl uence the reported prevalence rates (e.g. inpatient versus outpatient 
setting, differing time frames). Moreover, samples often contained only a small percentage of 
girls or, in some cases, no girls at all. Comorbid SUD girls are probably less often referred to 
treatment as they present a lesser burden to society. Furthermore, many studies only tested 
for a limited category of disorders (e.g. only externalizing disorders) and thereby may give 
an incomplete picture of (gender) differences. 
Overall prevalence rates of co-occurring mental disorders among adolescents and young 
adults in substance abuse treatment are high and show considerable gender differences. 
Very similar results were reported in community and juvenile justice samples. The increase 
of comorbid externalizing disorders from the community through treatment samples to 
incarcerated youth could have implications for future preventive actions for this group of 
youngsters. If regular youth care succeeds to adequately detect and treat adolescents with 
substance abuse and comorbid mental disorders, less of these youngsters may end up in the 
juvenile justice system.
Chapter 3 aimed to explore the prevalence and psychosocial characteristics of co-occurring 
heavy substance abuse and mental health problems among adolescents and young adults in a 
Dutch community sample. Our aim was to distinguish this group with co-occurring problems 
not only from their healthy peers, but also from their exclusively heavy substance using 
or mentally distressed peers. Based on self-reported dimensional measures of substance 
use, mental health problems, sociodemographics, and psychosocial characteristics in a large 
community sample of adolescents and young adults (n=4379; age 12-23) this study tried 
to: 1) assess the prevalence of heavy substance use, mental health problems and their co-
occurrence among adolescents and young adults (1a) including its relation to gender and age 
(1b), and 2) to compare the associated features of the co-occurring problem group to those 
in the other three groups (2a) with special attention to potential gender differences (2b). 
First, four distinct groups of adolescents were identifi ed: (1) a no-problem group 66.3%; (2) 
a heavy substance using group 14.4%; (3) a group with mental health problems 15.5%; and 
(4) a group with co-occurring or combined heavy substance use and mental health problems 
3.8%. 
The mental health problem group and the combined problem group were quite similar in 
terms of their mental health problems. The type of substance use in the combined problem 
group, however, differed considerably from that in the heavy substance use group, with 
signifi cantly more heavy use of semi-legal and illegal drugs in the co-occurring group. 
With regard to gender and age, our fi ndings indicated that during early adolescence (12-17 
years) combined problems were more prevalent among girls than in boys: 4.8% versus 3.7%. 
From age 18 onwards this pattern reversed as the prevalence of co-occurring problems 
became higher for boys than for girls and was almost twice as high by age 22-23: 8.6% versus 
3.9% for boys and girls respectively. 
Having identifi ed these different groups, the associations with a number of relevant 
sociodemographic and psychosocial background characteristics and the effect of gender on 
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these relations were explored in a multinomal regression analysis. In general, the group with 
combined problems differed considerably from both single problem groups.  This distinction was 
generally more pronounced with the heavy substance use group than with the mental health 
problem group. However, all differences implied a more problematic situation of the combined 
problem group compared to both single problem groups. Among the most discriminating 
characteristics for the co-occurring problem group were: a history of physical and sexual abuse, 
externalizing traits, physical condition, the use of sedatives, and social network features, such 
as substance using friends and problems at home. Especially the girls in the co-occurring group 
were distinguished by alarmingly high rates of unwanted sexual experiences (44%), and physical 
and/or mental abuse by a parent (14%). Compared to the girls in both single problem groups, 
the girls in the co-occurring problem group also displayed much more externalizing traits (e.g. 
hot temperedness and bullying). Some studies have found similar gender differences (Dakof, 
2000; Latimer et al., 2002), whereas other studies reported that the similarities between boys 
and girls are greater than the differences (Costello et al., 1999). 
An important limitation of this study was that fact the defi nition of mental health problems 
was restricted to internalizing, mainly depressive symptoms, and that externalizing mental 
health problems were not systematically, other than some single item traits, assessed. As a 
consequence, many boys with co-occurring substance abuse problems and mental health 
problems ended up in the heavy substance using group. Therefore, the prevalence of combined 
problems is presumably even larger than reported, especially among boys. 
In general, the results point at a substantial group, almost twice the size expected by chance, 
of adolescents and young adults that struggle with co-occurring mental health problems 
and heavy substance use. Moreover, the youngsters in the co-occurring group were in a 
very unfavorable position compared to all other groups. And although the prevalence of 
co-occurring heavy substance use and mental health problems may be even larger than 
estimated in this study, the considerable proportion of especially young girls with these 
co-occurring problems remained remarkable, as girls are often underrepresented in clinical 
samples. The psychosocial correlates of these girls are worrisome and deserve further 
attention in research and clinical settings.
In Chapter 4 we investigated the observed co-occurrence of heavy substance use and 
mental health problems in more detail. Due to substance-specifi c psychotropic effects, 
specifi c substances may entail greater odds than others for distinct depressive symptoms. 
Nicotine and cocaine have stimulating effects, alcohol has an anxiolytic and sedative effect, 
and cannabis has a sedating and sometimes anxiety provoking effect (Nunes et al., 2006; 
Ragan, 2006). To date, little is known about the epidemiological association between the use 
of specifi c substances and depressive symptomatology in adolescence and young adulthood. 
We studied this association in a community sample of adolescents and young adults (n=6695; 
aged 12-23 years) using dimensional measures with sensitive cut-off scores to include 
subclinical cases.
The aim of this study was (1) to examine whether heavy use of specifi c psychotropic 
substances (alcohol, tobacco, cannabis, and hard drugs) was related to distinct depressive 
symptoms in adolescence, (2) taking age and gender into account.
Adjusted odds ratios of specifi c depressive symptoms were calculated for heavy substance 
users compared to non/low-substance users, stratifi ed for each type of substance and, in 
case of interaction effects, additionally for different gender and age categories. Comparing 
the four specifi c types of heavy substance use, most associations with depressive symptoms 
were found for heavy tobacco, cannabis and hard drugs use with effect sizes increasing in that 
order. Few associations were found for heavy alcohol use, except for young female heavy 
alcohol users. With regard to age, the strongest associations between depressive symptoms 
and heavy substance, and especially for alcohol use and smoking, were found in the youngest 
age category (12-15 years) for both boys and girls. Relatively few gender effects were found, 
but if present these effects pointed at stronger associations for girls. For girls, substance 
abuse seems more strongly related to the presence of depressive symptoms. The strong age 
effect we found, could perhaps be attributed to the fact that heavy tobacco and alcohol use is 
more common than cannabis and hard drugs use from age of 15 years onwards (Johnston  et 
al., 2007; Hibell et al., 2004). So, in contrast to cannabis and hard drugs, tobacco and alcohol 
use might not be related to depressive symptoms, but rather be part of socially well-adapted 
behavior in certain peer groups of older adolescents. In early adolescence, this kind of heavy 
smoking and drinking is still exceptional and more symptomatic of underlying mental health 
problems.
To date, only one large scale community study (Roberts et al., 2007) investigated a range 
of substance-specifi c associations with mental disorders and found positive univariate 
associations between alcohol, marijuana and other substance abuse/dependence and 
depressive disorders. This study reported similar age and gender patterns with females and 
older youths having higher rates of comorbid disorders. 
In conclusion, the association between all types of heavy substance use and depressive 
symptomatology were especially strong in early adolescence and more so for girls.  As 
heavy substance use is rare in early adolescence, additional attention is needed for potential 
co-occurring mental health problems as it may point at serious underlying developmental 
problems. These fi ndings underline the importance of screening for co-occurring problems 
in young adolescents-at-risk in normal or subclinical populations, especially girls, with either 
heavy substance use or depressive/mental health symptoms.
Because the results in Chapters 2 to 4 highlighted the need for appropriate screening 
among at risk youth, Chapter 5 set out to provide an instrument to detect substance 
abuse among adolescents in a mental health care setting.  Since most of the commonly 
used psychopathology screening questionnaires (e.g. CBCL, YSR, and SDQ) do not include a 
separate substance abuse module, there was a need for a brief, reliable, and valid instrument 
appropriate for screening SUD at intake in youth mental health care.  As insuffi cient time 
for screening has been shown to be one of the greatest barriers to detect adolescents 
with SUD (van Hook et al., 2007), we chose the four-item CAGE-adapted to include drugs 
(CAGE-AID) scale for its brevity, its broad coverage, and its resemblance to the DSM-IV 
criteria (Brown & Rounds, 1995). The CAGE-AID is an adapted version of the original CAGE 
questionnaire which only screens for alcohol abuse and dependence (Ewing, 1984). The aim 
of this study was to validate the 4-item self-report and parent-report versions as a screener 
for SUD among adolescents in mental health care by: 1) assessing the diagnostic accuracy of 
the self-report and parent-report versions of the CAGE-AID, 2) obtaining clinically relevant 
cut-off scores, and 3) examining parent and child agreement. 
A sample of 190 Dutch adolescents referred to mental health agencies (12-18 years old; 
mean age 15.5 years; 53% boys) and their parents completed the CAGE-AID questionnaire 
during intake. DSM-IV clinical diagnoses were used as gold standard in Receiver Operating 
Characteristic (ROC) analyses to determine the screening qualities of the CAGE-AID.
Our results provided preliminary evidence that the CAGE-AID self-report (AUC 0.996; 
Chapter 7 General discussion
Couwenbergh_binnenwerk_1.6.indd   98-99 25-02-2009   19:12:22
100 101
95% CI 0.989-1.00) and parent-report versions (AUC 0.997; 95% CI 0.96-1.01) demonstrate 
excellent diagnostic accuracy to screen for SUD among treatment seeking adolescents. 
Optimal cut-off scores were chosen, resulting in high sensitivity (90% self-report and 100% 
parent report version) and specifi city (87% self-report and 94% parent report version). The 
positive predictive values for the self-report and the parent report versions were rather 
low (18% and 35% respectively), but still defendable given the low prevalence of SUD (5.8%) 
in this population. Furthermore, the level of agreement between parent- and child-report 
versions of the CAGE-AID was substantial.
The most important limitation of this study was the reliance on clinical diagnoses for the 
assessment of SUD. Although clinicians adhered to DSM-IV criteria, individual differences 
between clinicians may have existed. Secondly, the prevalence of SUD in our sample (5.8%) 
was lower than in comparable samples in other studies (around 11%) (Wilens et al., 1997; 
Aarons et al., 2001).  A possible explanation could be that the sample was not completely 
random. Facilities participated voluntarily and did not necessarily represent the entire Dutch 
youth mental health care system. However, most of the reported characteristics of the 
CAGE-AID, such as the AUC, sensitivity, and specifi city, are unaffected by prevalence rates. 
All in all, our fi ndings showed that employing the CAGE-AID offered clinicians in mental 
health care an accurate point of departure for cases that need more detailed diagnostic 
attention. By using the CAGE-AID questionnaire, clinicians can use their precious time at 
intake more effi ciently. Moreover, the 4 items of the CAGE-AID can easily be integrated in 
the standardized screening procedures in youth mental health care. 
Complementary to the CAGE-AID for the screening of SUD, in Chapter 6 we tested 
an equally useful screener for the detection of specifi c mental health problems among 
adolescents in a clinical setting. Several instruments to detect mental health problems among 
adolescents already exist, of which the Child Behavior Checklist (CBCL) and the Youth 
Self Report (YSR) are among the most well-known (Achenbach, 1990; Achenbach, 1991). 
Although these instruments are well-established, for screening purposes, these Achenbach 
questionnaires may be too extensive and lengthy, containing too many items that are not 
relevant to the majority of youth (Muris et al., 2003). In this respect, a brief, user-friendly 
instrument appropriate for screening of mental health problems at intake in youth mental 
health care would be valuable. We therefore chose the 25-item Strengths and Diffi culties 
Questionnaire (SDQ), which is based on contemporary diagnostic criteria and could be 
easily integrated in any standardized screening procedure. 
Recent studies have demonstrated that the Dutch translation of the SDQ has acceptable 
to good psychometric properties in a school based sample of children and adolescents 
(8-16 years old) (van Widenfelt et al., 2003; Muris et al., 2003). The aim of this study was to 
validate the self-report and parent-report versions of the SDQ as a screen for mental health 
problems among Dutch adolescents referred to mental health agencies, i.e. (1) to examine 
the internal consistency of the SDQ scales and the intercorrelations with corresponding 
scales of the Dutch CBCL or the YSR to establish convergent validity and (2) to investigate 
whether SDQ scores can detect the presence of specifi c diagnostic subgroups equally well 
as the CBCL/YSR.
Participants were 190 Dutch treatment adolescents referred to mental health agencies (12-
18 years old; mean age 15.5 years; 53% boys) and their parents, of whom 91% (N=172) 
completed the SDQ during intake. First the internal consistency and convergent validity of 
the SDQ scales with the corresponding CBCL/YSR scales were examined. Next, criterion 
validity was investigated comparing SDQ scores and CBCL/YSR scales with the presence 
of specifi c diagnostic subgroups. DSM-IV clinical diagnoses were used as gold standard in 
Receiver Operating Characteristic (ROC) analyses. 
Except for the self-reported peer problems (α=0.53), SDQ scales showed acceptable 
internal consistencies (mean α parent-report 0.75/self-report 0.69). Moreover, correlations 
between SDQ subscales and their respective CBCL/YSR counterparts were substantial, 
highly signifi cant and in the expected direction. The only exception was the self-reported 
prosocial scale. Finally, the SDQ performed equally well as the CBCL/YSR in the detection 
of specifi c child psychiatric disorders (AUCs ranged from 0.64-0.89). However, criterion 
validity of the self-reported hyperactivity/inattention and total diffi culties SDQ scales did 
not reach signifi cance.
The study also had some limitations. First, assessment of psychiatric disorders relied on clinical 
diagnoses. Although clinicians all adhered to DSM-IV criteria, the assessment procedure did 
not involve a standardized psychiatric interview and individual differences between clinicians 
in applying diagnostic criteria may have gone undetected. Second, the sample sizes of the 
different diagnostic subcategories used for the ROC analysis were relatively small. Especially 
the imperfect overlap between available SDQ, CBCL/YSR, and DSM-IV diagnosis made 
sample sizes for the ROC analysis variable and smaller than desirable. Future research is 
needed to replicate fi ndings of current study in a larger sample with clinical diagnoses based 
on a structured interview.
Overall, our results showed that, in line with previous studies, the Dutch translation of the 
SDQ is a brief and valid instrument for the screening for mental health problems among 
adolescents referred to mental health care (Klasen et al., 2000; Goodman, 2001; Alyahri & 
Goodman, 2006; Samad et al., 2005). Our fi ndings regarding the self-reported peer problems 
and inattention/hyperactivity subscales, underlined the necessity for a multi-informant 
approach. 
Methodological issues important for the interpretation and extrapolation of 
the results
Throughout Chapters 2 to 6 several methodological strengths and limitations of the studies 
in this thesis have been mentioned. The most important ones and their consequences for the 
interpretation and extrapolation of the results are discussed in the following section. 
First of all, because of the cross-sectional nature of the samples discussed in this thesis, 
the directions of the relationships between substance abuse, mental health problems, and 
psychosocial correlates remain uncertain. The complex nature of these interactions makes it 
very diffi cult to disentangle these relations, even in prospective longitudinal studies. However, 
the aim of the current studies was not to determine the etiological basis of co-occurring 
substance abuse and mental health problems, but rather to explore its prevalence among 
adolescents and young adolescents in the Dutch general population, including associated 
background characteristics, to better identify these high risk youths and their needs.
Second, as already discussed in the General introduction, the studies in this thesis used 
different measures for substance abuse and mental health problems. In Chapter 3 and 4, 
dimensional measures (with low-threshold, sensitive cut offs) of substance abuse and mental 
health problems were employed. In contrast, in Chapters 2, 5, and 6 categorical DSM diagnoses 
of SUD and mental disorders form the basis of our analysis. These differences are a result of 
the different study populations (community versus clinical) and our choice to include high 
risk subclinical cases to explore the prevalence and associated background correlates of the 
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co-occurrence of substance abuse and mental health problems in the community setting 
making the fi ndings relevant for prevention and early intervention. In a clinical setting, with 
treatment seeking or referred patients, and probably higher levels of symptoms and disability, 
it seemed more appropriate to use (clinical, high threshold) DSM diagnoses. 
Using different types of measures in different settings has advantages and disadvantages.  An 
advantage of using subclinical dimensional measures in community settings is the resulting 
broad defi nition of co-occurring problems and background variables. Early onset substance 
abuse and co-occurring mental health problems are, even at the subclinical level, strong 
predictors for the persistence of these problems and greater dysfunction in adulthood (Pine 
et al., 1998; Trim et al., 2007; Rohde et al., 2007; McGue et al., 2006). Moreover, ideally high risk 
youths and their needs should be identifi ed before substance abuse and co-occurring mental 
health problems have progressed to (clinically relevant) levels of severity. Preventive actions 
and additional clinical attention can be aimed at these young and/or female adolescents that 
proved to be especially vulnerable.  A disadvantage of the fl exible cut-off scores of dimensional 
measures is that due to their high sensitivity, they might be too inclusive. Furthermore, it 
limits the comparability of the results of the different studies and settings.
Another important issue is our reliance on self-report in Chapter 3 and 4.  Although 
adolescents are in general very capable of reporting their internalizing mental health 
problems, they might underreport externalizing behaviors and drug use (Jensen et al., 1999; 
Fisher et al., 2006; Harrison, 2008). Nevertheless, other studies support the validity of 
adolescent self-reports on substance abuse and psychopathology and its agreement with 
other relevant sources of information (Winters et al., 2000; Johnston & O’Malley, 1997). 
However, in clinical settings the use of a selective two stage screening process, employing 
biological indicators such as urinalysis, remains always recommended when in doubt about 
the presence of (excessive) use of substances (Kilpatrick et al., 2000). In addition, especially 
for externalizing mental health problems, using multiple sources of information is essential 
(Jensen et al., 1999). 
Fourth, the defi nition of mental health problems that was used in the explorative community 
sample in Chapter 3 and 4 was based exclusively on internalizing, predominantly depressive 
symptoms. Unfortunately, externalizing mental health problems, other than some single item 
traits, were not systematically assessed. Consequently, co-occurring externalizing mental health 
problems, which are generally more common among adolescent boys (Armstrong & Costello, 
2002), have not been controlled for in this design, as it has been the case in many studies up till 
now (Rey et al., 2002; Chen et al., 2002). 
Furthermore, the response rates in the community sample used in Chapter 3 and 4 differed 
quite considerably across certain geographical regions. This was perhaps due to the different 
methods of data collection. In the semi-rural area outside the city of Zwolle, the questionnaire 
was sent to a representative group of adolescents and young adults by regular mail. Within 
the city of Zwolle, the questionnaire was distributed through the Internet to all registered 
inhabitants aged 12-23. The response rate in the semi-rural areas outside Zwolle was much 
higher (58%, n=4419) than in Zwolle (13%, n=2276). Despite these differences in the data 
collection strategy, response rate and sociocultural characteristics, fi ndings for Zwolle and its 
surrounding semi-rural area were very similar and associations always in the same direction. 
However, we chose to adhere to high methodological standards, often required by leading 
international journals, and left out the data from the city of Zwolle in Chapter 3.  As statistical 
associations are not as vulnerable to non-response as prevalence estimates, we chose to use 
pooled data from Zwolle and the semi-rural areas outside Zwolle in Chapter 4. Nevertheless, 
we checked for any interaction effects of our results with geographical region (city versus 
semi-rural), but none existed. In order to compensate for the differences in response rate and 
to optimize representativeness, weights based on census data (CBS, 2003) were used in both 
chapters to adjust the estimates for biases in age and gender distribution caused by differential 
non response. 
Finally, in Chapter 5 and 6, the assessment of DSM-IV SUD and other mental disorders relied on 
clinical diagnosis.  All clinicians adhered to DSM-IV criteria, but minor individual differences in 
the assessment may have existed. Although this is closest to the reality in most clinical settings, 
it may have led to a less uniform screening procedure as is attained by using standardized clinical 
interviews, such as the DISC (Shaffer et al., 1996) or the K-SADS (Ambrosini, 2000). SUD has 
been shown to be overlooked by clinicians (Kramer et al., 2003), but a serious underestimation 
in Chapter 5 is unlikely, since undiagnosed cases of SUD would have increased the number of 
CAGE-AID false positives and specifi city of the CAGE-AID could never remain so high.
Clinical implications
Adolescents and young adults with co-occurring substance abuse and mental health 
problems comprise a big challenge for the health care system and society as a whole. As 
this study has shown, this group does not constitute a very large proportion of the total 
adolescent and young adult population (3.8%), but these youths are characterized by some 
very worrisome psychosocial circumstances, such as a frequent history of physical and/or 
sexual abuse. Moreover, referral trajectories for these youths seem random and mental 
health care institutions may not be well equipped to provide adequate care (Aarons et 
al., 2001; van Hook et al., 2007). Substance use related problems in adolescents in mental 
health care are often diagnosed too late or simply not detected at all (King et al., 2000). 
Consequently, appropriate treatment is not applied and these adolescents are more likely to 
be involved in the criminal justice system at six months follow-up (Kramer et al., 2003).
These fi ndings underscore the need for routine assessment of co-occurring mental health 
problems and substance abuse in mental health care. The CAGE-AID and SDQ can validly 
screen for substance abuse and mental health problems among adolescents in mental 
health care settings. By including these questionnaires in standard assessments, clinicians 
can use their precious time at intake more effi ciently. Furthermore our results indicate 
that two groups need special attention. First of all, our and previous studies point at a 
strong association between age and the co-occurrence of substance abuse and mental health 
problems. The association between substance use and co-occurring mental health problems 
is strongest for the youngest group of adolescents (Costello et al., 1999; Rohde et al., 1996). 
Moreover, especially this type of early onset of substance abuse and co-occurring mental 
health problems are, even on a subclinical level, strong predictors for the persistence of 
these problems and greater dysfunction in adulthood (Pine et al., 1998; Rohde et al., 2007; 
Trim et al., 2007; McGue et al., 2006). Unfortunately, these early-onset users have low lifelong 
rates of treatment seeking and receiving (Kessler et al., 2001; Wu et al., 2003). Furthermore, 
when they do come into contact with professional help, younger adolescents were less likely 
to receive substance abuse treatment, even when their substance abuse problems were 
as severe as those of the older adolescents (Wu et al., 2003). One possible explanation is 
that early-onset substance abusers can develop lifestyles that allow them to continue using 
without disrupting established roles, however deviant and dysfunctioning these may be, and 
thereby reduce the necessity for seeking treatment (Kessler et al., 2001).
A second matter of concern is the relatively high proportion of girls with co-occurring heavy 
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substance abuse and co-occurring mental health problems. Associations between substance 
abuse and co-occurring mental health problems are not only stronger for girls than for boys, 
their psychosocial circumstances are even more alarming (e.g. the high rates of physical and 
sexual abuse). Moreover, in substance abuse treatment girls are distinguished by higher rates 
of comorbid internalizing disorders and the probably related use of benzodiazepines. Yet girls 
with heavy substance use and co-occurring mental health problems are underrepresented in 
many clinical settings. Perhaps because of the relatively small societal burden these girls pose, 
problems are not noticed by their direct surroundings. In their study, Zwaanswijk et al. (2003) 
found that although adolescents with internalizing problems did recognize the problematic 
nature of their state, their treatment needs did not result in referral. Internalizing problems also 
had a signifi cant effect on a self-perceived unmet need for treatment.
Therefore, we emphasize the importance of pro-active screening for the co-occurrence of 
substance abuse in young and female adolescents with (internalizing) mental health problems. If 
help is sought at earlier stages of substance abuse, outcomes of treatment are more favorable 
(McLellan et al., 1983). This fi nding highlights the importance of early intervention. Since youth 
drug (ab)use is linked to diverse areas of life and youth culture, effective treatment should 
to be multifaceted and evidence based programs should be practiced much more often in 
adolescents treatment facilities than they now are (McLellan & Meyers, 2004). In their review 
Vaughn & Howard (2004) conclude that multidimensional family therapy (MDFT, Liddle et al. 
(2001)), followed by cognitive behavioral group treatment (CBT, Kaminer & Burleson (1999)) 
have received the most empirical support. 
MDFT combines counseling with assessment and intervention of multiple systems, both inside 
and outside the family.  As such it is developmentally and ecologically oriented and aims to 
include all the relevant dimensions of the adolescent’s life. MDFT is delivered in 16 to 25 in-
home or in-offi ce sessions over four to six months. Besides reducing alcohol and drug use, 
increasing treatment retention, improving family interaction and school involvement, it also 
reduces internalizing and externalizing problems (Ozechowski & Liddle, 2000).  Another 
promising family therapy intervention that has been applied successfully in a variety of (cultural) 
contexts to treat a range of high-risk youth and their families, is Functional Family Therapy (FFT, 
Waldron & Turner (2008); Breuk et al. (2006)). 
CBT approaches substance abuse as a range of cognitive processes and a maladaptive way 
of coping. Treatment is applied in a highly structured in-offi ce group intervention in which 
adolescents learn to identify and manage high-risk situations for relapse. Similar coping skills 
training techniques have also been found effective for youth with conduct disorders (Kazdin, 
1995) and depression (Brent, 1995) and have been successfully applied to adolescents with co-
occurring mental health problems (Kaminer et al., 1998; Curry et al., 2003).
Another important fi nding in this thesis is the worrisome psychosocial circumstances that these 
youths with co-occurring substance abuse and mental health problems are in. The psychosocial 
needs of these adolescents have to be met in preventive and treatment settings. Inclusion of the 
assessment of these needs is essential, as the appropriate intensity of substance abuse treatment 
may even be better informed by pre-treatment psychosocial risks, than by the severity of the 
substance abuse problem itself (Latimer et al., 2000). Childhood maltreatment, especially sexual 
abuse (Clark et al., 1997a), has long been recognized as one of the major psychosocial risk 
factors for co-occurring mental health problems and substance abuse (Langeland & Hartgers, 
1998; Stewart, 1996).  Furthermore, children of emotional dysfunctioning mothers (Langeland 
et al., 2004) and substance abusing parents (McGue et al., 2000) are at risk for substance abuse 
and co-occurring mood disorders and related symptoms as they grow up (Clark et al., 1997b). 
So perhaps the well-being of these at-risk children should be monitored preventively. Indeed, 
preventive and early interventions to improve parenting, comparable to preventive measures 
in somatic health care, have been suggested (van Dantzig, 2003). Poor quality of parent-child 
relationships and a perceived lack of parental support predict adolescent substance use (Johnson 
& Pandina, 1991). Essential for this approach is an integral and multidisciplinary cooperation 
between the various professionals in the broad mental health care system. Linking of different 
registration systems, as is recently done in pilot regions in the Netherlands, of this so-called 
referral index, can be very helpful to keep track of high risk youngsters. Cooperation and 
information sharing should be guaranteed so that necessary referral pathways can be realized 
without obstructions or delays.
In addition, like somatic chronic disease management, care should be planned longitudinal instead 
of delivered episodic without continuity of care. From a developmental perspective, adolescence 
marks a signifi cant transition period and provides an important opportunity for prevention and 
intervention (Holmbeck & Kendall, 2002). So interventions should occur in compliance with 
changing developmental needs and with attention for individual needs (Cicchetti & Rogosch, 
2002). The severe and chronic nature of co-occurring substance abuse and mental health 
problems and the associated unfavorable psychosocial circumstances, imposes us to be modest 
about the chances to succeed in solving all the problems of these adolescents at once. Total cure 
may be a naïve goal, which makes a longitudinal and developmental approach especially salient 
for this group of multi-problem youth. 
Suggestions for future research
Throughout this general discussion as well as in the discussions included in Chapters 2 through 
6, a number of suggestions for future research have been made. A brief summary is provided 
here together with the most important remaining issues.
Since the association between substance abuse and mental health problems has been well 
established in the last decade, there is a need to investigate the fi ner details of the underlying 
mechanism of this association. First of all, more longitudinal studies are needed to ameliorate 
or eliminate the confounding effects of retrospective recall regarding the occurrence or time of 
occurrence of signifi cant events, and to uncover the development of the association over time. 
To obtain a comprehensive model it is essential to include both biological and psychosocial 
correlates in these studies. Ideally, these studies focus on community rather than clinical samples 
to overcome the confounding effects of the methodological bias that individuals with two or 
more illnesses are more likely to seek treatment than people with either one of those illnesses 
separately (Berkson, 1946).
Secondly, on a more practical note, community and school surveys of adolescents should always 
contain robust scales on externalizing mental health problems. Until recently, these surveys too 
often defi ned mental health problems as emotional problems and exclusively contained measures 
of internalizing mental health problems (Bos et al., 1998). Externalizing problems are often labelled 
as ‘risk behaviors’, but not as essential mental health problems. However, it is essential to recognize 
that these externalizing behaviors are equally disabling and persistent forms of psychopathology, 
instead of forms of social deviancy and a lack of good manners (Hicks et al., 2007). 
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In addition, future studies should be designed in such manner that opportunities for 
meaningful comparison are provided. As is also evident in this thesis, studies differ in terms 
of types of substances and co-occurring mental health problems investigated (internalizing 
versus externalizing), in terms of the used measures to assess each of these, and in terms 
of the psychosocial correlates that are included. These differences infl uence the validity and 
generalizability of the results, posing further challenges for attempts to clarify the underlying 
mechanisms of the association between substance abuse and mental health problems. It 
might even prove useful to coordinate similar studies at multiple sites, accommodating and 
controlling for differences at these sites. 
The translation of this knowledge into meaningful policy and effective intervention strategies 
is a next suggested line of studies. Because it remains to be seen whether the promising results 
of treatment programs in controlled study settings are equally effective in less controlled 
conditions of the real world (Bukstein & Winters, 2004). Future studies should focus on 
uncovering the exact mechanisms of changes that take place in complex and extensive 
intervention programs, such as MDFT and FFT.  This knowledge can then be used to decide 
whether some elements can be left out if unnecessary for certain other populations and 
settings, so-called dismantling studies. Only after these condensed interventions proof to 
be good alternatives in some situations, it could be seen whether more children with less 
severe problems could be served in a shorter, less invasive, treatment period.
Over the last years many specialized clinics for adolescents with co-occurring substance 
abuse and mental health problems have opened across the Netherlands, because it seems 
that the problems that these youngsters face have become progressively recognized by 
clinicians and policy makers. The effectiveness of these treatments should be monitored 
and shared. This could result in a protocol, similar to the one that already exists for their 
adult counterparts, that summarizes the best evidence based practices for these youths and 
specifi c subgroups. 
Furthermore the role of important risk factors, such as sexual and/or physical abuse, should 
be further investigated. Shared environmental factors may also account for some of the high 
prevalence of certain patterns of co-occurring substance abuse and psychopathology. For 
example, both acute and chronic stress has been linked to depression and substance abuse 
through alterations it evokes in the brain (Volkow, 2004). Traumatic experiences such as 
child abuse, could perhaps function as stressors that start these brain alterations. The effect 
of potentially promising preventive strategies in the case of such traumatic experiences and 
active screening practices for their occurrence should be investigated to protect children 
against the development of serious problems later in life.
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Background and aims
Adolescence is a period in which developmental pathways are set in motion and become 
entrenched. Major biological and psychological changes, social challenges and opportunities occur 
during adolescence. It is also a period that certain mental health problems surface. Emotional 
and behavioral problems increase and substance use becomes more prevalent. Although most 
adolescents experiment with substance use, only a very small proportion, about 5.3%, of the 
youngsters who experiment with substance use in adolescence develop serious substance abuse 
problems, substance use disorders (SUD). But in many who do, these are further complicated 
by other mental health problems.
The reason why the heavy use of substances is so strongly associated with the onset and 
simultaneous presence of mental disorders is not fully understood. It has been suggested 
that substances are used to self-medicate psychiatric symptoms, which could in turn lead to 
dependence. However, substance use may also worsen pre-existing psychiatric symptoms 
or precipitate the development of a psychiatric disorder. Finally, psychiatric conditions and 
problematic substance use may share an underlying genetic or environmental vulnerability or 
predisposition to both conditions. Due to the cross-sectional nature of the studies, this thesis 
refrains from further speculations about these temporal and causal pathways of co-occurring 
substance abuse and mental health problems. It is, however, very clear that adolescents and 
young adults with co-occurring substance abuse and mental health problems face enormous 
problems as substance use and psychiatric problems interact in a circular manner: severe social 
and family dysfunction, criminality, suicidal behavior, sexual and/ or physical abuse, and parental 
drug use and parental psychopathology.  As such, they also put a tremendous social and fi nancial 
strain on the public health care system.
Adolescents and young adults with co-occurring substance abuse and mental health problems 
can be found in almost all health and social service systems: juvenile justice, child welfare, 
special education, mental-health and substance abuse clinics. Referral trajectories seem random 
and youth mental health services are not well equipped to provide adequate care for these 
adolescents. Clinicians are not suffi ciently trained in dealing with co-occurring substance abuse 
and mental health problems and generally have a negative attitude towards engaging in treatment 
of patients with substance use related problems. Substance use related problems are often 
diagnosed too late or simply not detected at all. Early and adequate detection of youth with 
co-occurring problems may allow for intervention before either substance use, mental health 
problems or associated problems progress to more severe levels and cause lifelong problems. 
The goal of this study is to improve the early identifi cation of co-occurring substance abuse 
and mental health problems among adolescents and young adults and the assessment of their 
psychosocial needs.
To further this early identifi cation of co-occurring substance abuse and mental health problems 
among adolescents and young adults and assess their needs, our studies took a broader 
developmental perspective on psychopathology that was not limited to the study of clinical 
settings. Only a small percentage of adolescents with substance abuse and mental health problems 
actually end up in the professional care system. From previous studies we know that even 
subclinical mental health and substance abuse symptoms in adolescence are strong predictors 
for further problems in adulthood and persistent dysfunction.  A broader dimensional approach 
with sensitive cut-off scores, to detect subclinical cases is therefore useful to help understand 
what happens at the interface between normal and abnormal in the course of development. This 
is why highly sensitive dimensional measures were used in a community study investigating the 
prevalence of co-occurring mental health problems and heavy substance use in Chapter 3 and 
the relationship between heavy use of specifi c substances and depressive symptoms in Chapter 
4. Preventive actions are preferably targeted at this subclinical group of high risk youngsters in 
which co-occurring problems have not yet progressed to severe levels. It is also very important 
that when adolescents and young adults with co-occurring substance abuse and mental health 
problems do come into contact with professional assistance agencies, their problems are not 
overlooked. This is why in Chapter 5 and 6, a mental health youth care sample was chosen to 
test two proposed screeners, one for the identifi cation of substance use disorders and another 
for specifi c mental health problems in youngsters, using DSM-IV diagnoses as golden standard. 
Unlike the Netherlands, the U.S. has had specialized substance abuse treatment facilities for 
adolescents for sometime. Chapter 2 reviewed the prevalence rates and types of co-occurring 
mental health problems of adolescents treated in these facilities. 
Main fi ndings
In Chapter 2, the literature on the prevalence of co-occurring SUD and mental disorders 
among adolescents and young adults in substance abuse treatment was reviewed. We found ten 
studies (nine North American and one Icelandic) that met our inclusion criteria, and examined 
prevalence rates of the different types of co-occurring SUD and mental disorders. Results show 
that the overall prevalence rates of co-occurring mental disorders among adolescents and young 
adults in substance abuse treatment are high (ranging from 61% to 88%). Externalizing disorders, 
especially conduct disorder (CD), are very consistently linked to substance abuse (comorbidity 
ranging from 24 to 82%). The association of internalizing disorders with SUD is less consistent 
and seems to differ by gender. Girls are distinguished from boys by additional higher rates 
of comorbid internalizing disorders (14-65% versus 6-37%) and may thus experience greater 
psychosocial distress. Very similar results were reported in previous studies in community and 
juvenile justice samples. Most notable was the trend of the prevalence of externalizing disorders 
over the three settings. The prevalence of SUD and comorbid externalizing disorders was 
lowest in the community samples, somewhat higher in the treatment seeking population, and 
highest in the juvenile justice sample. The increase of comorbid externalizing disorders from the 
community through treatment samples to incarcerated youth could have implications for future 
preventive actions for this group of youngsters. If regular youth care succeeds to adequately 
detect and treat adolescents with substance abuse and comorbid mental disorders, less of these 
youngsters may end up in the juvenile justice system.
In Chapter 3, the prevalence and psychosocial characteristics of co-occurring heavy substance 
use and mental health problems among adolescents and young adults in a Dutch community 
sample (N=4379; aged 12-23) was explored using dimensional measures with sensitive cut-off 
scores to include subclinical cases. The results point at a substantial group (3.8%) of adolescents 
and young adults in the Dutch general population that struggle with co-occurring mental health 
problems and heavy substance use. Moreover, these youths are distinguished from their healthy 
peers by unfavorable psychosocial conditions, but also from those youngsters with “only” 
heavy substance use or “only” mental health problems. Especially the girls in the co-occurring 
group were characterized by alarmingly high rates of sexual abuse (44%), and physical and/or 
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mental abuse by parents (14%).  Although the prevalence of co-occurring heavy substance use 
and mental health problems may be even larger than estimated in this study, the substantial 
proportion of young girls in this group is remarkable, as girls are often underrepresented in 
clinical samples. Moreover, the psychosocial problems of these girls are worrisome and deserve 
further attention in research and clinical settings.
In Chapter 4, the observed co-occurrence of heavy substance use and mental health problems 
was investigated in more detail. Due to substance-specifi c psychotropic effects, specifi c substances 
may entail greater odds than others for the co-occurrence of depressive symptoms. To date, 
little was known about the epidemiological association between the use of specifi c substances 
and depressive symptoms in adolescence and young adulthood. We studied this association in 
a community sample of adolescents and young adults (n=6695; aged 12-23) using dimensional 
measures with sensitive cut-off scores to include subclinical cases. Results showed distinct 
cross-sectional associations between the use of specifi c substances and specifi c depressive 
symptoms. Comparing the four specifi c types of heavy substance use, most associations with 
depressive symptoms were found for heavy tobacco, cannabis and hard drugs use with effect 
sizes increasing in that order. Few associations were found for heavy alcohol use, except for 
young female heavy alcohol users. The reported associations between heavy substance use and 
depressive symptoms are especially strong in early adolescence and again especially so for girls. 
As heavy substance use is rare in early adolescence, additional attention is needed for potential 
co-occurring mental health problems as it may point at serious underlying developmental 
problems. These fi ndings underscore the importance of screening for co-occurring problems in 
young adolescents at risk in normal or subclinical populations, especially girls, with either heavy 
substance use or (depressive) mental health symptoms.
Because the results in Chapters 2 to 4 highlighted the need for appropriate screening among 
at risk youth, Chapter 5 set out to provide an instrument to detect substance abuse among 
adolescents in mental health care settings. We chose to use the 4-item CAGE-adapted to 
include drugs (CAGE-AID) scale for its brevity, its broad coverage, and its resemblance to 
the DSM-IV criteria. Participants consisted of a convenience sample of adolescents (N=190, 
ages 12-18) and their primary caretaker (usually their mother), who were referred to a youth 
mental health care facility, participating in a research network of the Netherlands Institute of 
Mental Health and Addiction (Trimbos Institute). Our results showed that the 4-item self-report 
and parent-report versions of the CAGE-AID were very accurate in detecting SUD among 
adolescents in mental health care. Employing the CAGE-AID offers clinicians in mental health 
care a general, but accurate point of departure for cases that need more detailed diagnostic 
attention. By using the CAGE-AID questionnaire, clinicians can use their precious time at intake 
more effi ciently. Moreover, the four items of the CAGE-AID can easily be integrated in the 
standardized screening procedures in youth mental health care. 
Complementary to the CAGE-AID for the screening of SUD, in Chapter 6 we tested an 
equally useful and user-friendly screener for the detection of specifi c mental health problems 
among adolescents in a clinical setting: the Strengths and Diffi culties Questionnaire (SDQ). 
Participants consisted of a convenience sample of adolescents (N=190, aged 12-18) and their 
primary caretaker (usually their mother), who were referred to a youth mental health care 
facility, participating in a research network of the Netherlands Institute of Mental Health and 
Addiction (Trimbos Institute). Our study showed that the self-report and parent-report versions 
of the SDQ are brief and valid instruments for the screening of mental health problems among 
adolescents at intake in mental health care settings. However, with regard to interpersonal 
problems (peer problem scale) and certain externalizing  behaviors, reliance on self-report is 
not suffi cient. Therefore, in clinical settings, the use of a multi-informant approach, especially 
with regard to interpersonal oriented and externalizing mental health problems is strongly 
recommended.
Strengths and limitations
Throughout this thesis, limitations and their consequences for the interpretation and 
extrapolation of the results were discussed.  Among these are the cross-sectional nature of the 
samples and the different (subclinical and clinical) measures used to operationalize substance 
abuse and mental health problems.  A disadvantage of the fl exible cut-off scores of dimensional 
measures is that due to their high sensitivity, they might be too inclusive. Furthermore, it limits 
the comparability of the results of the different studies and settings. Other important limitations 
are the reliance on self-report, response rates, the absence of externalizing mental health 
problems measures in Chapters 3 and 4, and the reliance on clinical diagnoses and relatively 
small sample sizes in Chapters 5 and 6.
Clinical implications
Adolescents and young adults with co-occurring substance abuse and mental health problems 
comprise a big challenge for the health care system and society as a whole.  As this study has 
shown, this group does not constitute a very large proportion of the total adolescent and 
young adult population (3.8%), but these youths are characterized by some very worrisome 
psychosocial circumstances, such as a frequent history of physical and/or sexual abuse. 
These fi ndings underscore the need for routine assessment of co-occurring mental health 
problems and substance abuse in mental health care. If help is sought at earlier stages,  outcomes 
of treatment are more favorable. Indeed, several promising treatment interventions, such as 
multidimensional family therapy (MDFT), functional family therapy (FFT), and cognitive behavioral 
group treatment (CBT) are available. 
The fi ndings also show that the CAGE-AID and SDQ can be used effectively as screeners for 
substance abuse and mental health problems among adolescents in mental health care settings. 
By including these questionnaires in standard assessments, clinicians can use their precious 
time at intake more effi ciently. Furthermore our results indicate that two groups need special 
attention. First of all, ours and previous studies point at a strong association between age and 
the co-occurrence of substance abuse and mental health problems. The association between 
substance use and co-occurring mental health problems is strongest in early adolescence. 
Unfortunately, especially these early-onset users have a low probability of treatment seeking 
and when they do come into contact with professional help they are less likely to be referred 
to specialty clinics than their older peers.  A second matter of concern is the relatively high 
proportion of girls with co-occurring heavy substance abuse and mental health problems. 
Associations between substance abuse and mental health problems are not only stronger for 
girls than for boys, their psychosocial circumstances are even more alarming (e.g. the high rates 
of physical and sexual abuse). Perhaps because of their relatively small societal burden, these girls 
with heavy substance use and internalizing mental health problems are still underrepresented 
in many clinical settings. 
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Suggestions for future research
First, more longitudinal studies in community samples are needed to ameliorate or eliminate 
the confounding effects of retrospective recall. Longitudinal studie can also help to uncover 
the development of the association of substance abuse and mental health problems over time. 
Furthermore, these studies should be designed in such manner that opportunities for meaningful 
comparison are guaranteed. It might even prove useful to coordinate similar studies at multiple 
sites, accommodating and controlling for differences at these sites
Second, on a more practical note, community and school surveys of adolescents should always 
contain specifi c scales for externalizing mental health problems. It is essential to recognize that 
externalizing behaviors are disabling and persistent forms of psychopathology, instead of forms 
of social deviancy and a lack of good manners. 
The translation of evidence based knowledge into meaningful policy and effective intervention 
strategies is a third suggested line of studies. Future studies should examine whether some 
elements of intensive treatment interventions, such as FFT and MDFT,  can be left out for certain 
populations and settings, so-called dismantling studies. Only after these condensed interventions 
proof to be good alternatives in some situations, it could be seen whether more children with 
less severe problems could be served in a shorter, less invasive, treatment period. Moreover, the 
effectiveness of the treatment programs provided by the recently opened Dutch specialized 
clinics for adolescents with co-occurring substance abuse and mental health problems should 
be monitored and shared. This could result in a protocol, similar to the one that already exists 
for their adult counterparts. This protocol would summarize the best evidence based practices 
for these youths and specifi c subgroups. 
Lastly, the role of important risk factors, such as sexual and/or physical abuse, should be further 
investigated. Shared environmental factors may also account for some of the high prevalence of 
certain patterns of co-occurring substance abuse and psychopathology. For example, both acute 
and chronic stress have been linked to depression and substance abuse through long-lasting 
alterations it evokes in the brain. Traumatic experiences such as child abuse could perhaps 
function as stressors that start these brain alterations. The effect of potentially promising 
preventive strategies in the case of such traumatic experiences and active screening practices 
for their occurrence should be investigated to protect children against the development of 
serious problems later in life.
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Samenvatting
 Middelenmisbruik en het gelijktijdig voorkomen ervan 
met andere psychische problemen bij adolescenten 
Couwenbergh_binnenwerk_1.6.indd   120-121 25-02-2009   19:12:23
122 123
subklinische psychische problemen en symptomen van middelenmisbruik in de adolescentie 
sterke voorspellers zijn van verdere problemen en persistent disfunctioneren als men volwassen 
is. Een meer dimensionale benadering met gevoelige afkapwaarden om subklinische gevallen op 
te sporen is derhalve nuttig om te helpen begrijpen wat er gebeurt op het grensvlak van normaal 
en abnormaal gedurende de ontwikkeling. Dit is waarom zeer gevoelige dimensionale maten 
worden gebruikt in een bevolkingsstudie naar de prevalentie van het gelijktijdig voorkomen 
van psychische problemen en zwaar middelengebruik in Hoofdstuk 3 en het verband tussen 
zwaar gebruik van specifi eke middelen en depressieve symptomen in Hoofdstuk 4. Preventieve 
acties worden bij voorkeur gericht op deze subklinische groep van hoogrisicojongeren bij wie 
gelijktijdig voorkomende problematiek nog niet in ernstige mate is gevorderd. Het is echter ook 
van groot belang dat de problemen van deze adolescenten en jong volwassenen niet over het 
hoofd worden gezien wanneer zij wel in contact komen met de professionele hulpverlening. 
Dit is waarom in Hoofdstuk 5 en 6 voor een steekproef uit de JGGZ is gekozen om twee 
voorgestelde screeningsinstrumenten te testen: één voor het identifi ceren van middelenmisbruik 
en afhankelijkheid (SUD) en een andere voor specifi eke psychische problemen met de DSM-
IV als “gouden standaard”. In tegenstelling tot Nederland bestaan in de Verenigde Staten reeds 
enige tijd gespecialiseerde behandelingsinstellingen voor adolescenten die aan middelenmisbruik 
lijden. Hoofdstuk 2 geeft een overzicht van de prevalenties en de verschillende types gelijktijdig 
voorkomende psychische stoornissen van adolescenten die in deze instellingen werden 
behandeld.
Belangrijkste bevindingen
In Hoofdstuk 2 wordt een overzicht gegeven van de literatuur over de prevalentie van gelijktijdig 
voorkomende (comorbide) middelenstoornissen en psychische stoornissen onder adolescenten 
en jong volwassenen die werden behandeld voor middelenmisbruik. Er werden 10 onderzoeken 
gevonden (negen Noord-Amerikaanse en één IJslandse) die voldeden aan onze insluitingscriteria 
en waarin de prevalentie van verschillende middelenstoornissen en psychische stoornissen werd 
onderzocht. De resultaten laten zien dat de totale prevalentie van gelijktijdig voorkomende 
psychische stoornissen onder adolescenten en jong volwassenen die worden behandeld voor 
middelenmisbruik hoog is (variërend van 61% tot 88%). Externaliserende stoornissen, in het 
bijzonder de gedragsstoornis (CD), zijn zeer consistent gekoppeld aan middelenmisbruik 
(comorbiditeit variërend van 24% tot 82%). Het verband tussen internaliserende stoornissen 
en middelenmisbruik is minder consistent en lijkt te verschillen per geslacht. Meisjes verschillen 
van jongens door grotere aantallen comorbide internaliserende stoornissen (14-65% versus 
6-37%) en kunnen aldus grotere psychische problemen ervaren. Zeer vergelijkbare resultaten 
werden beschreven in eerdere onderzoeken in bevolkings- en justitiële steekproeven. Het 
meest opmerkelijk was de trend van de prevalentie van externaliserende stoornissen over de 
drie settings. De prevalentie van middelenmisbruik en comorbide externaliserende stoornissen 
was het laagst in de bevolking, enigszins hoger onder jongeren die hulp zoeken en het hoogst 
in de justitiële jeugdinrichtingen. Deze toename van comorbide externaliserende stoornissen 
onder jongeren in de bevolking naar jongeren in behandeling tot jeugd in justitiële inrichtingen 
zou gevolgen kunnen hebben voor toekomstige preventieve acties voor deze groep jongeren. 
Als de reguliere jeugdzorg erin slaagt om adolescenten met middelenmisbruik en comorbide 
psychische stoornissen adequaat te signaleren en te behandelen, zou het kunnen dat minder van 
deze jongeren eindigen in het justitiële systeem.
Achtergrond en doelstellingen van het onderzoek
Adolescentie is een periode waarin ontwikkelingspaden in gang worden gezet en verankerd. Er 
treden grote biologische en psychologische veranderingen op en er doen zich sociale uitdagingen 
en kansen voor. Het is ook een periode waarin problemen in de geestelijke gezondheid veelal 
voor het eerst zichtbaar worden. Emotionele problemen en gedragsproblemen nemen toe en 
middelengebruik wordt gangbaarder. Alhoewel de meeste adolescenten experimenteren met 
middelengebruik, ontwikkelt slechts een klein deel van hen (ca. 5,3%) serieuze problemen in 
de vorm een stoornis die samenhangt met het gebruik van middelen (middelenstoornis, SUD). 
Deze stoornis wordt dan vaak verder gecompliceerd door andere psychische problemen.
Waarom zwaar middelengebruik zo vaak samen gaat met het ontstaan en het gelijktijdig 
voorkomen van psychische problemen wordt nog niet helemaal begrepen. Geopperd is dat 
middelen worden gebruikt als zelfmedicatie voor psychiatrische symptomen, hetgeen kan leiden 
tot verslaving. Middelengebruik kan echter ook reeds bestaande psychiatrische problemen 
verergeren of de ontwikkeling van een psychiatrische stoornis versnellen. Tenslotte kunnen bij 
psychiatrische stoornissen en problematisch middelengebruik ook onderliggende genetische- en/
of omgevingsfactoren een rol spelen, die iemand ontvankelijker maken voor beide aandoeningen. 
Vanwege de cross-sectionele aard van de beschreven studies wordt in dit proefschrift afgezien 
van verdere speculaties over de chronologische volgorde of causale verbanden tussen gelijktijdig 
voorkomend middelenmisbruik en psychische problemen. Het is echter onomstreden dat 
adolescenten en jong volwassenen met deze problematiek grote problemen het hoofd 
moeten bieden, omdat beide problemen elkaar versterken en gepaard gaan met ernstig sociaal 
disfunctioneren en ontwrichting van het gezin, criminaliteit, suïcidaliteit, drugsgebruik van ouders 
en ouders met psychiatrische problemen. Als zodanig vormen deze jongeren een enorme sociale 
en fi nanciële belasting voor de publieke gezondheidszorg.
Adolescenten en jong volwassenen met gelijktijdig middelenmisbruik en andere psychische 
problemen zijn verspreid over bijna alle gezondheidszorg- en sociale voorzieningen: jeugddetentie, 
maatschappelijk werk, speciaal onderwijs, geestelijke gezondheidszorg en verslavingsklinieken. 
Verwijzingstrajecten lijken willekeurig en zorgvoorzieningen voor geestelijke gezondheid 
voor de jeugd (JGGZ) zijn onvoldoende toegerust om adequate hulp te bieden aan deze 
adolescenten. Behandelaars zijn niet voldoende getraind in het behandelen van een combinatie 
van middelenmisbruik en andere psychische problemen en hebben over het algemeen een 
negatieve houding ten opzichte van het behandelen van patiënten met aan middelen gerelateerde 
problemen. Daar komt bij dat deze problemen vaak te laat worden gediagnosticeerd of 
eenvoudigweg helemaal niet gesignaleerd. Vroegtijdige en adequate signalering van jongeren met 
deze problemen zou kunnen leiden tot ingrijpen voordat het middelenmisbruik, de psychische 
problemen, of aanverwante problemen verergeren en levenslang problemen veroorzaken.
Het doel van dit onderzoek is om de vroegtijdige identifi catie van jongeren met gecombineerd 
middelenmisbruik en andere psychische problemen, alsmede de beoordeling van hun 
psychosociale behoeften te verbeteren.
Om dit te bereiken heeft ons onderzoek een breed ontwikkelingsperspectief op psychopathologie 
en beperkt het zich niet tot een klinische setting. Slechts een klein percentage van adolescenten 
met middelenmisbruik en psychische problemen komt namelijk daadwerkelijk in aanraking 
met de professionele gezondheidszorg. Uit eerder onderzoek weten we echter dat zelfs 
SamenvattingSamenvatting
Couwenbergh_binnenwerk_1.6.indd   122-123 25-02-2009   19:12:24
124 125
laten zien dat de vier-item zelfrapportage en ouderrapportage versies van de CAGE-AID zeer 
nauwkeurig waren in het detecteren van SUD onder adolescenten in de JGGZ. Het gebruik 
van de CAGE-AID biedt clinici een algemeen, maar nauwkeurig uitgangspunt voor jongeren die 
gedetailleerdere diagnostische aandacht behoeven. Door de CAGE-AID vragenlijst te gebruiken 
kunnen clinici hun kostbare tijd bij de intake effi ciënter gebruiken. Bovendien kunnen de vier 
items van de CAGE-AID eenvoudig worden geïntegreerd in een standaard intake procedures 
in de JGGZ.
Naast de CAGE-AID voor het screenen op SUD wordt in Hoofdstuk 6 een even bruikbaar 
als gebruiksvriendelijk screeningsinstrument getest voor de signalering van specifi eke 
psychische problemen onder adolescenten in een klinische setting: de “Strenghts and Diffi culties 
Questionnaire” (NL: Sterktes en Moeilijkheden Vragenlijst, afk. SDQ). Deelnemers bestonden 
uit een steekproef van adolescenten (N=190, leeftijd 12-18) en hun hoofdverzorger (gewoonlijk 
hun moeder), die waren doorverwezen naar een instelling voor JGGZ, welke deelnam aan een 
onderzoeksnetwerk van het Trimbos Instituut. Onze resultaten laten zien dat de zelfrapportage 
en ouderrapportage versies van de SDQ korte en valide instrumenten zijn voor het screenen op 
psychische problemen onder adolescenten bij de intake in de JGGZ. Echter, met betrekking tot 
inter-persoonlijke problemen (sociale probleemschaal) en bepaalde externaliserende gedragingen 
is afgaan op zelfrapportage onvoldoende. Derhalve wordt in klinische settings het gebruik van 
een multi-informant benadering, in het bijzonder met betrekking tot inter-persoonlijk gerichte 
en externaliserende problemen sterk aanbevolen.
Sterkten en beperkingen
Door dit proefschrift heen worden de beperkingen van de studies en de consequenties daarvan 
voor de interpretatie en extrapolatie van de resultaten besproken. Hieronder zijn de cross-
sectionele aard van de studies en de verschillende (subklinische en klinische) maten die worden 
gebruikt om middelenmisbruik en psychische problemen te operationaliseren. Een nadeel van 
de fl exibele afkapwaarden van dimensionale maten is dat ze vanwege hun hoge gevoeligheid 
te veel kunnen meenemen. Voorts beperkt dit de vergelijkbaarheid van de resultaten van de 
verschillende onderzoeken. Andere belangrijke beperkingen zijn het uitgaan van zelfrapportage, 
de mate van respons, de afwezigheid van een maat voor externaliserende psychische problemen 
in Hoofdstukken 3 en 4 en het afgaan op klinische diagnoses en relatief kleine steekproef in 
Hoofdstukken 5 en 6.
Klinische implicaties
Adolescenten en jong volwassenen met gelijktijdig middelenmisbruik en psychische problemen 
vormen een grote uitdaging voor de gezondheidszorg en de maatschappij. Zoals dit onderzoek 
heeft aangetoond, maakt deze groep niet een zeer groot deel uit van de totale populatie 
adolescenten en jong volwassenen (3,8%) in Nederland. Echter deze jongeren worden 
gekenmerkt door een aantal uiterst zorgwekkende psychosociale omstandigheden, zoals een 
frequente geschiedenis van lichamelijk en/of seksueel misbruik. Deze bevindingen onderstrepen 
de behoefte aan een routinematige beoordeling van gelijktijdig voorkomende psychische 
problemen en middelenmisbruik in de JGGZ. Indien hulp in een vroeger stadium wordt verschaft, 
is de uitkomst van behandeling gunstiger. Een aantal veelbelovende behandelingsinterventies, 
zoals multidimensionale gezinstherapie (MDFT), functionele gezinstherapie (FFT) en cognitieve 
gedrag groepstherapie (CBT) is beschikbaar.  
De bevindingen tonen ook aan dat de CAGE-AID en SDQ effectief kunnen worden ingezet voor 
In Hoofdstuk 3 worden de prevalentie en psychosociale kenmerken van gelijktijdig voorkomend 
zwaar middelengebruik en psychische problemen onder adolescenten en jong volwassenen in 
een Nederlandse bevolkingssteekproef (N=4379; leeftijd 12-23) onderzocht met dimensionale 
maten en gevoelige afkapscores om subklinische gevallen mee te nemen. De resultaten duiden 
op een substantiële groep (3,8%) adolescenten en jong volwassenen in de Nederlandse bevolking 
die worstelen met gelijktijdig voorkomende psychische problemen en zwaar middelengebruik. 
Bovendien worden deze jongeren ten opzichte van hun gezonde leeftijdsgenoten, maar ook 
ten opzichte van jongeren met ‘alleen’ zwaar middelengebruik of ‘alleen’ psychische problemen, 
gekenmerkt door zeer ongunstige psychosociale omstandigheden. In het bijzonder de meisjes 
in de combinatiegroep worden gekenmerkt door een alarmerend hoge mate van seksueel 
misbruik (44%) en lichamelijk of psychisch misbruik door ouders (14%). Ofschoon de prevalentie 
van gelijktijdig voorkomende psychische problemen en zwaar middelengebruik zelfs groter zou 
kunnen zijn dan geschat op basis van deze studie, is het substantiële aandeel meisjes in deze groep 
opmerkelijk, aangezien meisjes vaak ondervertegenwoordigd zijn in klinische steekproeven. 
Bovendien zijn de psychosociale problemen van deze meisjes zorgwekkend en verdienen ze 
meer aandacht in onderzoek en klinische settings.
In Hoofdstuk 4 wordt de waargenomen combinatie van zwaar middelengebruik en psychische 
problemen nader onderzocht. Vanwege de middelspecifi eke psychotropische effecten zou 
het gebruik van sommige middelen gepaard kunnen gaan met een grotere kans dan andere 
op het voorkomen van depressieve symptomen. Tot dusverre was er weinig bekend over 
het epidemiologische verband tussen het gebruik van specifi eke middelen en depressieve 
symptomen in de adolescentie en jong volwassenheid. Dit verband werd onderzocht in een 
bevolkingssteekproef van adolescenten en jong volwassenen (n=6695; leeftijd 12-23) met 
dimensionale maten en gevoelige afkapscores om subklinische gevallen mee te nemen. De 
resultaten lieten directe dwarsverbanden zien tussen het gebruik van specifi eke middelen 
en bepaalde depressieve symptomen. Bij vergelijking van de vier specifi eke typen zwaar 
middelengebruik werden de meeste verbanden met depressieve symptomen gevonden voor 
zwaar tabak-, cannabis-, en hard drugsgebruik, met een toenemende mate van effect in die 
volgorde. Weinig verbanden werden gevonden voor zwaar alcoholgebruik, met uitzondering van 
jonge, vrouwelijke, zware drinkers. De verbanden tussen zwaar middelengebruik en depressieve 
symptomen zijn het sterkst in de vroege adolescentie en –opnieuw- in het bijzonder voor meisjes. 
Aangezien zwaar middelengebruik zeldzaam is in de vroege adolescentie, verdienen potentiële 
gelijktijdig voorkomende psychische problemen extra aandacht in deze leeftijdscategorie, 
omdat deze zouden kunnen wijzen op ernstige onderliggende ontwikkelingsproblemen. Deze 
bevindingen onderstrepen het belang van screening op gelijktijdig voorkomende problemen bij 
jonge risicojongeren in normale of subklinische populaties, in het bijzonder meisjes, met ofwel 
zwaar middelengebruik ofwel depressieve of psychische symptomen.
Omdat de resultaten in Hoofdstukken 2 tot 4 de behoefte aan geschikte screening onder 
risicojongeren duidelijk maken, beoogt Hoofdstuk 5 een instrument te verschaffen om 
middelenmisbruik (SUD) onder adolescenten in de JGGZ te signaleren. Gekozen is voor de vier-
item CAGE-adapted to include drugs (NL: CAGE aangepast om drugs te omvatten, afk.CAGE-
AID) schaal omwille van de bondigheid, brede dekking en de gelijkenis met de DSM-IV criteria 
ervan. Deelnemers bestonden uit een steekproef van adolescenten (N=190, leeftijd 12-18) en 
hun hoofdverzorger (gewoonlijk hun moeder), die waren doorverwezen naar een instelling voor 
JGGZ, welke deelnam aan een onderzoeksnetwerk van het Trimbos Instituut. Onze resultaten 
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preventiestrategieën in het geval van dergelijke traumatische ervaringen en actieve screening op 
het voordoen ervan, dienen te worden onderzocht teneinde kinderen te beschermen tegen de 
ontwikkeling van ernstige problemen later in het leven.
het screenen op middelenmisbruik en psychische problemen onder adolescenten in de JGGZ. 
Door deze vragenlijsten op te nemen in  de standaard intake procedure kunnen clinici hun kostbare 
tijd bij intake effi ciënter gebruiken. Bovendien geven onze resultaten aan dat twee groepen 
bijzondere aandacht nodig hebben. In de eerste plaats wijzen onze en eerdere onderzoeken 
op een sterk verband tussen leeftijd en het gelijktijdig voorkomen van middelenmisbruik en 
psychische problemen. Dit verband is namelijk het sterkst in de vroege adolescentie. Helaas is 
de kans dat deze zeer jonge gebruikers (in de leeftijd tussen de 12 en 15 jaar) een behandeling 
zoeken én ontvangen klein. Ook wanneer ze in contact komen met professionele hulp, worden 
zeer jonge gebruikers minder vaak naar gespecialiseerde behandelingen doorverwezen dan hun 
wat oudere lotgenoten. Een tweede punt van zorg is het relatief grote aandeel van meisjes 
met gelijktijdig middelenmisbruik en psychische problemen. Het verband is niet alleen sterker 
voor meisjes dan voor jongens, hun psychosociale omstandigheden zijn ook alarmerender (bijv. 
de grote mate van lichamelijk en seksueel misbruik). Misschien zijn deze meisjes nog steeds 
ondervertegenwoordigd in veel klinische settings vanwege hun relatief geringe maatschappelijke 
last.
Suggesties voor verder onderzoek
In de eerste plaats zijn er meer longitudinale onderzoeken in de algemene bevolking nodig om de 
verstorende effecten van retrospectieve herinnering te verminderen en om het ontstaan van de 
relatie tussen middelenmisbruik en psychische problemen duidelijk te krijgen. Bovendien dienen 
deze onderzoeken zodanig te worden opgezet dat mogelijkheden voor een betekenisvolle 
vergelijking zijn gewaarborgd. 
Ten tweede dienen, vanuit een praktischer oogpunt, studies naar het welbevinden van adolescenten 
altijd specifi eke schalen te bevatten voor het meten van externaliserende problemen te bevatten. 
Het is essentieel om te erkennen dat externaliserend gedrag een ontwrichtende en persistente 
vorm van psychopathologie is in plaats van een sociale afwijking en een gebrek aan goede 
manieren.
De vertaling van op bewijs gebaseerde kennis in beleid en effectieve interventiestrategieën is 
een derde voorgestelde onderzoekslijn. Verdere studies dienen te onderzoeken of bepaalde 
elementen van intensieve behandelingen, zoals FFT en MDFT, achterwege kunnen worden gelaten 
bij minder ernstige vormen van gecombineerde problematiek, zogenaamde ontmantelingsstudies. 
Als deze gecondenseerde interventies hebben bewezen goede alternatieven te zijn voor 
mildere problematiek, kan worden bekeken of meer jongeren deze behandeling kan worden 
aangeboden in een kortere, minder intensieve behandelingsperiode. Het bereik van deze 
intensieve en kostbare behandelingen kan zo worden vergroot. Bovendien dient de effectiviteit 
van de behandelingsprogramma’s die worden aangeboden in de onlangs geopende Nederlandse 
gespecialiseerde klinieken voor adolescenten met gelijktijdig voorkomend middelenmisbruik 
en psychische problemen te worden gevolgd en gedeeld. Dit zou kunnen resulteren in een 
protocol, vergelijkbaar met het protocol dat reeds bestaat voor volwassenen, dat de beste op 
bewijs gebaseerde behandelingen voor deze jongeren samenvat.
Tot slot dient de rol van belangrijke risicofactoren, zoals seksueel en/of lichamelijk misbruik, 
nader te worden onderzocht. Gedeelde omgevingsfactoren zouden ook verantwoordelijk 
kunnen zijn voor een deel van bepaalde veel voorkomende patronen van gelijktijdig voorkomend 
middelenmisbruik en psychopathologie. Zo zijn zowel acute als chronische stress bijvoorbeeld 
in verband gebracht met depressie en middelenmisbruik door langdurige veranderingen die dit 
uitlokt in de hersenen. Traumatische ervaringen, zoals kindermisbruik zouden kunnen werken als 
stressoren die deze hersenveranderingen in gang zetten.  Het effect van potentieel veelbelovende 
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Pap en mam, van jullie heb ik geleerd door te zetten. Jullie betrokkenheid bij dit proefschrift 
-maar eigenlijk bij alles in mijn leven- is groot. Dat is een voorrecht. Dank voor de veilige basis 
die jullie mij boden -en nog altijd bieden- om op terug te vallen. Mam, door jouw steun en 
luisterend oor heb je een groot aandeel gehad in het tot stand komen van mijn proefschrift! 
Ik hoop dat ik een voorbeeld mag nemen aan hoe jij je kracht inzet voor je medemens.
En tot slot, lieve András, jij geeft mij het beste wat een mens kan krijgen, een stabiel en 
gelukkig thuis. Het voltooien van mijn proefschrift ging vaak ten koste van onze tijd samen 
en bij tijd en wijlen groeide het me boven het hoofd! Maar dankzij jouw rust en altijd 
praktische kijk op de dingen kwam dit project tot een goed einde. Wat hebben we het toch 
goed saam!
Een promotietraject is naast een inhoudelijke verdieping ook een leerproces. Een van de 
belangrijkste lessen die ik geleerd heb is dat je een proefschrift niet  alleen schrijft. Dank aan 
iedereen die heeft bijgedragen aan het tot stand komen ervan. Er zijn een aantal personen 
die ik hierbij graag speciaal wil noemen: Allereerst wil ik graag Professor van der Gaag, 
promotor en inspirator van dit onderzoek bedanken. Rutger Jan, er is altijd iemand nodig 
met een visie en enorme betrokkenheid bij het onderwerp die een project als dit van 
de grond kan tillen. Dit ben jij. Als ambassadeur voor de kwetsbare groep jongeren met 
gecombineerde psychische- en verslavingsproblematiek ben jij de motor geweest van mijn 
promotieonderzoek. Dankjewel!
Mijn tweede promotor, Professor van den Brink. Beste Wim, zonder jou was dit proefschrift 
er niet gekomen. Op cruciale momenten stond je mij met raad en daad terzijde. Jij bent voor 
mij een voorbeeld van hoe je op een integere en gepassioneerde manier wetenschappelijk 
onderzoek doet. En Bep, rechterhand van Wim, dank je dat je altijd een manier vond om mij 
in de agenda van Wim in te passen en voor je gezelligheid.
Dr. Koeter, co-promotor. Beste Maarten,ik heb het erg gewaardeerd dat jij het team kwam 
versterken. Jouw onuitputtelijke statistische knowhow was van onschatbare waarde; ik ken 
verder bijna niemand die alle statistische formules daadwerkelijk uit zijn hoofd kent! Ik ben 
je dankbaar voor de lange analyse-dagen en je persoonlijke aandacht voor mij.
Het dubbeldiagnose team, medepromovendi Patricia en Bram, dank voor het delen van jullie 
inzicht. Jullie plaatsten mijn onderzoek in een breder klinisch perspectief.
Karakter, stichting Kinder- en Jeugdpsychiatrie Oost Nederland, dank voor het mede mogelijk 
maken van dit onderzoek en het bieden van mijn dagelijkse werkplek.
GGD Overijssel, dank voor het beschikbaar stellen van de databestanden van de 
Gezondheidsmonitor. Het Trimbos Instituut, dank voor het beschikbaar stellen van de
databestanden van de SDQ en CAGE-AID validatiestudie. Ik waardeer het enorm dat jullie in 
het belang van deze kwetsbare doelgroep bereid waren jullie met pijn en moeite verzamelde 
data met mij te delen. Ik hoop dat ik met de bevindingen van deze studies jullie iets terug 
heb kunnen geven.
Professor Corine de Ruiter, dank voor je inhoudelijke bijdrage aan twee van mijn studies.
Leden van de leescommissie, dank voor het kritisch lezen van mijn manuscript.
Mede promovendi van het Radboud, dank voor de gezelligheid. Kamergenoten, Wouter 
Groen en Patricia van Deurzen, jullie komst bij Karakter betekende voor mij het delen van 
promotie wel en wee en een grote steun. Ik zie uit naar jullie proefschriften.
Geachte leden van de treincommissie, Anne-Claire, Marieke, Cathelijne, Iris en Machteld. 
Onze treinreizen van en naar Utrecht betekenden voor mij steun, gezelligheid en het delen 
van grote en kleine dingen, van hoogte- en dieptepunten die zich in onze levens afspeelden. 
Dank voor jullie vriendschap.
Mijn collega’s van Van de Bunt, dank voor de ruimte die er was om mijn proefschrift af te 
ronden. Door jullie belangstelling en begrip was het mogelijk beide banen te combineren.
Lieve vrienden, Judie, Valérie, Ruud, Annelouise, Jos, Marloes, Marjolijn en iedereen die ik nu 
niet kan noemen, dank voor jullie niet afl atende belangstelling, medeleven en afl eiding in de 
vorm van etentjes, concerten, weekends weg, etcetera.
Marieke, Noor en Soons, van vier giechelende pubers in de brugklas, naar feestende 
studenten, tot ‘serieuze young professionals’. Wat er ook in onze levens gebeurt, we staan 
klaar voor elkaar. Dank voor jullie oog voor mijn sterke kanten, maar zeer zeker ook voor 
jullie relativerende opmerkingen en humor. Marieke, wat fi jn dat je mij als paranimf terzijde 
wil staan.
Pieter en Jocelyne, we hebben een vriendschap waar je op kunt bouwen in goede en minder 
goede tijden. We hebben alles deze jaren kunnen delen en ik prijs me daar gelukkig mee. En 
Jocelyne, dat ik mijn onderzoeksperikelen met jou kon delen, heeft mij veel geholpen. Als 
ervaringsdeskundige begreep jij mij als geen ander! Maar ook met praktische raad en daad 
stond je mij terzijde. Jouw optimisme en daadkracht werken aanstekelijk. Geen berg is jou 
te hoog en ik ben dan ook blij en gerust dat jij –samen met Marieke- als paranimf achter mij 
zult staan!
Lieve familie, opa, oma, Geertje,  Arpad, Hanneke en Ilonka, dank voor jullie onvoorwaardelijke 
steun en liefde. Ik voel me rijk met jullie als familie.
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Christianne Couwenbergh werd op 24 juni 1980 geboren te Utrecht. In 1998 behaalde 
zij haar Gymnasiumdiploma aan het St. Bonifatius College te Utrecht en in september dat 
jaar startte zij aan het University College Utrecht, het internationale honors college van 
de Universiteit Utrecht. Na het behalen van het bachelor diploma in de Social Sciences en 
Arts in 2001, volgde in 2003 haar doctoraal diploma’s Algemene Sociale Wetenschappen 
en Kunstgeschiedenis aan de Universiteit Utrecht. Tijdens haar afstudeeronderzoek –onder 
begeleiding van dr. Frits van Wel- richtte zij zich op de cultuurparticipatie van allochtone 
jongeren.
Vanaf 2004 was zij als junior onderzoeker verbonden aan het UMCN St. Radboud en Karakter 
Kinder- en Jeugdpsychiatrie, waar zij het in dit proefschrift beschreven onderzoek uitvoerde 
naar gecombineerde verslavings- en psychiatrische problematiek bij jeugdigen. Ook deed zij 
onderzoek naar de leerlingpopulatie binnen het speciaal onderwijs in de provincie Overijssel. 
De resultaten van dit onderzoek werden gepresenteerd op het Jubileumsymposium ter ere 
van het 100-jarig bestaan van de Ambelt Scholengemeenschap.
Sinds 2007 is zij werkzaam als organisatie-adviseur bij Van de Bunt, adviseurs voor organisatie 
en beleid, en de Jeugdfabriek waarbij zij zich met name richt op organisatievraagstukken en 
innovatie in de zorgsector.
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